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Several innovative tandem mass spectrometric strategies have been developed for 
the structural determination and isomer differentiation of glycosides and 
oligosaccharides.  Specifically, collisionally activated dissociation (CAD) and infrared 
multiphoton dissociation (IRMPD) are used in conjunction with derivatization methods 
designed to exploit variations in binding energies or attach chromophores.  These include 
metal complexation incorporating modified neutral auxiliary ligands and covalent 
derivatization involving site-specific reactions. 
 vi
The elucidation of flavonoid isomers is accomplished by electrospray ionization 
tandem mass spectrometry (ESI-MS/MS) via formation and CAD of metal/flavonoid 
complexes containing an auxiliary ligand.  Addition of a metal salt and a suitable neutral 
auxiliary ligand to flavonoids in solution results in the formation of [M(II) (flavonoid-H) 
ligand]+ complexes by ESI which, upon collisional activated dissociation, often result in 
more distinctive fragmentation patterns than observed for conventional protonated or 
deprotonated flavonoids.  We compare and explore the use of alternative pyridyl ligands, 
with electron-releasing substituents including 4,7-diphenyl-1,10-phenanthroline.  Using 
this technique, three groups of flavonoid glycoside isomers are differentiated, including 
glycosides of apigenin, quercetin and luteolin. 
A tunable ESI-MS/MS strategy for differentiation of flavone and flavanone 
diglycoside isomers based on metal complexation with auxiliary ligands that have 
electron-withdrawing substituents is reported.  A series of auxiliary ligands with electron-
withdrawing substituents was synthesized in order to tailor the relative metal binding 
affinities of the ligands and thus directly influence the stabilities, and consequently the 
dissociation pathways, of the complexes.  Upon collisionally activated dissociation, the 
complexes yield fragmentation patterns in which the abundances of key diagnostic ions 
are enhanced, thus facilitating isomer differentiation.   
A strategy for increasing the efficiency of IRMPD in a quadrupole ion trap (QIT) 
based on another metal complexation strategy is described.  Two IR-active ligands 
(IRALs) that have an IR-active phosphonate functional groups were synthesized.  The 
IR-active groups were therefore incorporated into the analyte complexes via metal 
complexation.  We demonstrate this new IRMPD approach for the structural 
characterization of flavonoids. The fragment ions obtained by IRMPD are similar to 
those obtained by CAD and allow facile isomer differentiation of flavonoids.  Fourier 
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transform infrared absorption attenuated total reflectance (FTIR-ATR) and energy-
variable CAD experiments indicate that the high IRMPD efficiencies stem from the very 
large IR absorptivities of the IR-active ligands. 
A simplified method for determining the sequence and branching of 
oligosaccharides using IRMPD in a QIT is described.  An IR-active boronic acid 
(IRABA) reagent was synthesized and subsequently used to derivatize the 
oligosaccharides prior to IRMPD analysis.  The IRABA ligand is designed to both 
enhance the efficiency of the derivatization reaction and to facilitate the photon 
absorption process.  The resulting IRMPD spectra display oligosaccharide fragments that 
are formed from primarily one type of diagnostic cleavage, thus making sequencing 
straightforward.  The presence of sequential fragment ions, a phenomenon of IRMPD, 
permit the comprehensive sequencing of the oligosaccharides studied in a single stage of 
activation.  The approach is demonstrated for two series of oligosaccharides, the lacto-N-
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Chapter 1:  Introduction 
1.1 INTRODUCTION 
Carbohydrates are often attached to biologically important compounds including 
phytochemicals, lipids, peptides and proteins.1-6  The carbohydrate segment of the 
resulting glycoconjugates often affects the tertiary structure and activity of these 
compounds, thus participating in both architectural and biorecognitive roles.  For 
example, the position and type of single sugar moieties has been shown to dramatically 
affect the uptake and activity of glycosylated flavonoids in rats.7, 8  In addition, the 
carbohydrate portions of protein and lipid glycoconjugates specifically contribute to the 
resulting conformations, the reactivities, and chemical role in numerous biological 
processes. Oligosaccharides are known to play roles in cell-cell signaling, cellular 
differentiation, regulation of biochemical pathways, viral replication, parasitic infection, 
immune response and inflammation.9-15.   
Glycoconjugates have two major segments known as the aglycon (the non-sugar 
part of the molecule) and the glycan (sugar-containing part).  While the aglycon may be 
almost any chemical structure, naturally occurring glycans most commonly consist of the 
monosaccharide units depicted in Figure 1-1.   
Complete structural analysis of the glycan portions is complex since they are 
often highly branched and have several different linkage types between their fundamental 
monosaccharide units.  Some of the simplest glycoconjugates may have only one or two 








































































iduronic acid  (IdA) glucuronic acid (GlcA)
 
Figure 1-1.  The biologically important monosaccharide units. 
As depicted in Figure 1-1, even a simple monosaccharide such as glucose has four 
chiral centers and the identity of a sugar is largely dependent upon the stereochemistry of 
these carbon atoms, with the exception of carbon-1 (see Figure 1-2).  The cyclic forms of 
saccharides give rise to two different configurations, alpha and beta, that are determined 
by the position of the hydroxyl group at carbon-1.  This carbon is known as the anomeric 
carbon and the two different forms are anomers of each other.  When two sugars are 
joined to form a glycosidic bond, the anomeric carbon (carbon-1) is often part of the 
linkage and the anomeric configuration is one of the important determinations to be made 



















Figure 1-2. The two glucose anomers, α-Glc and β-Glc, with the carbon atoms 
numbered. 
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Another important determination to be made in the analysis of oligosaccharides is 
the particular linkage between monosaccharide units.  One monosaccharide unit may 
react with another releasing a water molecule and forming a glycosidic bond.  The 
linkage often involves the hydroxyl group attached to the anomeric carbon and any of the 
other carbon atoms on the adjoining monosaccharide.  For example, two glucose units 
may be attached between the hydroxyl group of carbon-1 and the hydroxyl group of 
carbon-4, or between the hydroxyl group of carbon-1 and the hydroxyl group of carbon-
6, each producing two different diglucosides.  These linkages are clearly shown in 
chemical structures and the detailed names of oligosaccharides.  An oligosaccharide 
whose characterization is described in Chapter 6 is shown in Figure 1-3.  To describe the 
type of glycosidic bonds formed, the format includes the anomeric configuration of 
carbon-1, the carbon number of the first sugar and the carbon number of the second sugar 
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LNFP-I     Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glc
reducing end
 
Figure 1-3. Structure of LNFP-I, detailing the anomeric configurations and linkages in 
the structure. 
One example of a class of compounds that commonly have only one or two 
monosaccharide units in their glycosidic forms is the flavonoids, phytochemicals touted 
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for their health benefits.16-21   Because of this relative simplicity, the glycan portion is 
usually analyzed attached to the aglycon.  Prior to the more modern liquid 
chromatography/mass spectrometry (LC/MS) techniques such as those mentioned in 
Chapters 3 and 4, the structural analysis of flavonoid glycosides has necessitated 
extraction from kilograms of plant material followed by preparative LC purification to 
obtain milligram quantities of purified material sufficient for NMR analyses.  An 
abundant number of preparative HPLC techniques have been developed for the isolation 
and purification of flavonoid glycosides.22, 23  The detailed structural analysis of the 
carbohydrate portions by NMR involves the use of the more complicated two-
dimensional techniques.  Flavonoid glycosides have also been characterized using mass 
spectrometry; however, until the 1990s, techniques were limited to electron impact 
ionization (EI), chemical ionization (CI) and fast atom bombardment (FAB) ionization.  
More recently, softer ionization methods have been coupled with tandem mass 
spectrometry to augment the structural information obtained using mass spectrometry and 
they are becoming established tools.24, 25  Recent reviews by Stobiecki25 and Cuyckens & 
Claeys24 describe much of this work.  Two innovative strategies employing metal 
complexation are described in Chapters 3 and 4 of this dissertation. 
For the analysis of more complex glycoconjugates, the glycan portion is often 
first chemically or enzymatically cleaved from the aglycon for characterization of the 
resulting oligosaccharides.26-28  Glycoproteins and glycopeptides are examples of 
biologically important compounds that often fall into this category.  The most popular 
enzyme for cleavage from proteins and peptides is PNGase (protein N-glycanase) for the 
cleavage of N-linked glycans.  Compounds commonly used for chemical cleavage 
include hydrazine for N-linked glycans and sodium borohydride for O-linked glycans.  
Following cleavage of the glycan portion, the resulting oligosaccharides are then 
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characterized independent of the aglycon.  Oligosaccharides are in many ways more 
structurally complex than other biologically important molecules such as proteins and 
nucleic acids in that they are often highly branched and have several different linkage 
types between their fundamental monosaccharide units.  In fact, for a single 
hexasaccharide, there are 1012 possible isomers.29  This results in a great number of 
structural possibilities that make characterization of oligosaccharides a challenging task.     
Following cleavage of the oligosaccharides, a chromatographic profile must be 
obtained to enable purification of the components since even one glycosylation site may 
yield a complex mixture of glycans.  The individual oligosaccharides are then commonly 
analyzed for sequence, linkage types and anomeric configuration of each glycosidic bond 
using enzymatic analyses, high performance liquid chromatography (HPLC), lectin-
specific binding, NMR and mass spectrometry.3, 26, 27 
Enzymatic analysis is commonly used to determine the presence or absence of a 
particular monosaccharide, glycosidic bond or motif in an oligosaccharide.  In more 
elaborate schemes, they may be used to determine sequence information.  Enzymes that 
cleave glycosidic bonds with a great degree of specificity are used (e.g., only cleave a 
particular anomeric configuration and linkage type of one monosaccharide).  Numerous 
enzymes are sold commercially and examples include Galactosidase from Streptococcus 
pneumoniae that cleave Gal β1-4 linkages and Mannosidase from Helix pomatia that 
cleave Man β1-4 linkages.30, 31  After these specific enzymatic cleavages, the resulting 
oligosaccharides are then evaluated to determine the presence of the monosaccharide unit 
or glycosidic bond in question.  To sequence an oligosaccharide, the technique requires 
several enzymes used in succession.  The amount of material required is dependent upon 
how many sequential analyses are performed and the method of detection used.  To make 
more sense of the resulting oligosaccharides following enzymatic cleavage, the original 
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oligosaccharides being analyzed are commonly modified at the reducing end with a 
fluorescent tag that is used as a fixed reference point that can be monitored 
chromatographically.32-35  The tag is usually added via reductive amination and typically 
involves the addition of an aromatic amine.36-38  Examples include 8-aminonapthalene-
1,3,6-trisulfonic acid (ANTS) and 7-aminomethylcoumarin (AMC).  The derivatization 
procedure involves the heating of the oligosaccharide in acidic solvent with excess of the 
derivatization reagent and a reducing agent such as sodium borohydride (typical times 
range from 15 mins – 2 hours).  The excess reagents are then typically removed using 
solid phase extraction (SPE).  Sometimes a purification step is also required before the 
reduction step.  While the fluorescent tag enables sensitive detection of eluting 
oligosaccharides, some of the most valuable information can be obtained by coupling the 
chromatograph to a mass spectrometer.  Obtaining the masses of the eluting 
oligosaccharides enables a mapping strategy to be used.  Depending upon the specific 
glycosidases and the type of chromatography used, information such as the number of 
monosaccharide residues removed, the skeletal structure and the linkage type of 
particular residues may be obtained. 
In one study, Lai and Her successfully used specific enzymes to differentiate 
between α1-3 and α1-6 core-fucosylated glycans in bee venom.39  The oligosaccharides 
were released from phospholipase A2 (PLA) with peptide-N-glycanase A (PNGase A) 
and peptide-N-glycanase F (PNGase F) and labeled by reductive amination with p-
aminobenzoic acid ethyl ester (ABEE).  The derivatized products were then separated 
chromatographically using reversed phase HPLC and monitored using UV and ESI-MS.  
Isobaric oligosaccharides containing both of the fucose residues being studied were 
identified and differentiated since α1-3 fucosylation cleavage is prevented by PNGase F.9  
By using the two enzymes it was determined that were no differences in the anomeric 
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configuration and linkages involving these fucose moieties in the PLA oligosaccharides 
in the venom of bees.   
In another study, Qian et al.40 used an array of specific enzymes, HPLC and mass 
spectrometry to analyze oligosaccharides in cetuximab, a therapeutic antibody used for 
cancer.  The oligosaccharides were released using PNGase F and were then derivatized 
with the fluorescent tag anthranilic acid via reductive amination.  The tagged 
oligosaccharides were then purified using SPE.  Next, normal phase HPLC was used to 
fractionate the oligosaccharides which were then concentrated for analysis and subjected 
to an array of different combinations of five specific glycosidases.  The digested 
oligosaccharides were then desalted by dialysis and analyzed using MALDI-TOF MS and 
MS/MS.  The full scan spectra yielded a species profile of the oligosaccharides that was 
used in conjunction with the MS/MS data to identify 21 distinct oligosaccharide 
structures and in some cases obtained complete sequence information.  
Another strategy utilizes lectins, proteins that bind to oligosaccharides with a high 
degree of specificity, for structural determination.  They may bind to specific 
monosaccharide units or structural motifs.  Lectins may be used for column fractionation 
of oligosaccharides after release from glycoproteins27, 41 or in microarrays for more 
specific glycoprofiling of fractionated oligosaccharides and more recently whole 
glycoconjugates or even whole cells,42-45 although the analysis of glycoproteins and cells 
is more applicable to detecting only changes in glycosylation.  The most common 
experiment involves the use of lectins with binding specificity for a particular 
disaccharide unit or larger structural motif that are used to test for the presence of that 
unit in an unknown, often as a mode of separation.  One of the most popular methods for 
immobilizing lectins for column chromatography is the linkage of lectins to agarose gel 
using a cyanogen bromide method46, 47 with a linear polyacrylic hydrazide spacer48 for 
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increased column stability and performance.  One example of a lectin used for 
immobilized affinity chromatography is Aleuria aurantia lectin (AAL) from 
mushrooms.49  The lectin is commercially available in a recombinant form produced by 
E. coli with the same properties50 and may be used to determine the presence or absence 
of an α-Fuc residue at a particular position in the core of an oligosaccharide and may 
therefore be separated from their nonfucosylated derivatives.  In one procedure, 
radioactive oligosaccharides are dissolved in buffer and loaded on the column and 
allowed to stand for 30 mins.51  Chromatography is then initiated at a flow rate of 12 
mL/hr and 1 mL fractions are collected and the radioactivity measured.  Only 
oligosaccharides with a non-fucosylated core pass through the column without 
interaction.  Addition of L-fucose to the column is required to elute the oligosaccharides 
with a fucosylated core.  Another variation involves the affinity chromatography of 
oligosaccharides labeled with a fluorescent tag which eliminates the need for radioactive 
samples. 
In one study, Madrid et al. used a series of lectins and enzymatic analyses to 
characterize N- and O-linked oligosaccharides in human goblet cells.52  Interactions 
between the oligosaccharides and lectins, and the presence of particular mono- and 
disaccharides was determined using a lectin staining procedure and microscopy.  The 
oligosaccharides were released from some proteins and this data was compared to the 
data obtained for the corresponding glycoconjugates.  It was determined that there was 
masking of the data for unreleased oligosaccharides.  The presence of specific 
monosaccharide and disaccharide units, in some cases including linkage information was 
determined.  
NMR provides a vast amount of information about the structures of 
oligosaccharides including linkage types and anomeric configuration; however it requires 
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milligram quantities of purified sample.53, 54  If there is sufficient sample, it is often the 
first type of analysis performed since it is a nondestructive technique.  Overall, one-
dimensional NMR methods are not sufficient for stereochemical information of 
oligosaccharides and there is no systematic method for structural determination because 
of its limitations.  1H NMR Nuclear Overhauser effect (NOE) experiments can help to 
determine linkage and sequence; however, there is substantial overlap of multiplets in an 
important region of the spectra that results in ambiguity of assignments.  13C NMR 
spectra have few overlapping lines; however, the chemical shift differences of the ring 
carbons are small and difficult to assign.  Two-dimensional NMR, where both the x- and 
y-axes contain chemical shift information, has helped to overcome several of these 
difficulties.  For example, two-dimensional shift correlation spectroscopy (COSY) 
enables the identification of all the protons in a sugar residue.  Briefly, an anomeric 
proton resonance is assigned and spins are correlated in a stepwise manner around the 
ring.  For identification of the sugars, vicinal coupling constants of all ring protons is also 
needed.  Other useful two-dimensional techniques include total correlation spectroscopy 
(TOCSY), relayed correlation spectroscopy (RELAY) and Homonuclear Hartmann-Hahn 
spectroscopy (HOHAHA).  To characterize an oligosaccharide using NMR often requires 
a combination of NMR experiments, most of which require a great deal of technical 
expertise to analyze.  In one study, Vanhaecke et al. used five different NMR techniques 
to fully characterize lychnose, a tetrasaccharide produced by Stellaria media.55  In 
another study, Urai, et al. used seven different NMR techniques to characterize an 
oligosaccharide produced by a marine bacterium.56   
Mass spectrometry is another powerful instrumental technique that provides 
detailed information about oligosaccharides.57-61  In addition to revealing the exact mass 
of an unknown oligosaccharide, it can be used for compositional information.  In fact, the 
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most popular method for linkage determination is a methylation derivatization in 
conjunction with mass spectrometry.62  There are a number of established methylation 
procedures; however, because of the high consumption of sample for this derivatization 
technique (methylation, glycosidic cleavage and derivatization followed by sample 
cleanup), alternative techniques for linkage determination are desirable.  Mass 
spectrometry has also been widely used in conjunction with enzymatic analysis, as 
mentioned previously in the paragraph discussing enzymatic analyses.  Soft ionization 
techniques such as fast atom bombardment (FAB), matrix assisted laser desorption 
ionization (MALDI) and electrospray ionization (ESI) are the preferred methods since 
they do not lead to fragmentation of the molecular ion.57-60, 63-65  Of these, ESI has been 
the most popular because of its amenability to HPLC.  Low-energy activation methods 
can then be used to fragment the molecular ion in a controlled fashion and promote 
cleavage at primarily glycosidic bonds, thus providing sequence information.64-71  
Additionally, in some types of instruments, a fragment ion may be selected for further 
analysis (MSn).58, 64, 65, 67, 71, 72  A significant amount of research has been dedicated to the 
analysis of oligosaccharides, and Zaia has published a recent review.60    
A systematic nomenclature for the fragmentation of oligosaccharides that was 
developed by Domon and Costello36 has become established and a diagram is shown in 
Figure 1-4.  Ions that have the charge retained at the reducing end are designated X, Y, 
and Z.  They are labeled using the format k,lXj, Yj and Zj, where j is the number of the 
bond broken starting with 0, and k and l indicate the bonds broken from cross-ring 
cleavages of the sugar.  Ions that have the charge retained at the non-reducing end are 
designated A, B, and C.  They are labeled using the format g,hAi, Bi and Ci, where i is the 
number of the bond broken, counting from the terminal sugar beginning with 1, and g and 
h indicate cross-ring cleavages of the sugar.  For branched oligosaccharides, an additional 
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notation is included that indicates the branch.  They are labeled with Greek letters starting 










































Figure 1-4. Example of nomenclature for oligosaccharide fragment ions. 
Mass spectrometers that have the capability of trapping ions such as the QIT and 
Fourier transform ion trap mass spectrometer (FTICR) are ideal for elaborate structural 
analysis since they are designed for multiple stages of ion isolation, activation and mass 
analysis (several stages of tandem mass spectrometry, or MSn).  Because of its 
affordability, ruggedness, ease of use and small size, the QIT has been the most popular 
of the trapping instruments.  For these reasons, the work presented in this dissertation 
describes novel methods for the analysis of glycosides and glycans utilizing tandem mass 
spectrometry in the QIT.  In addition to analysis of the conventional positive and negative 
ions formed, several unique methods of chemical derivatization are described that 
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dramatically enhance the characterization and isomer differentiation of the model 
compounds studied.   
Chapters 5 and 6 compare and contrast tandem mass spectral data obtained from 
collisionally activated dissociation (CAD) and infrared multiphoton dissociation 
(IRMPD).  There are several advantages to using IRMPD over CAD in an ion trap, and 
they are pointed out in the following sections and throughout this dissertation.  Since the 
use of IRMPD and its advantages are correlated with the operation of the ion trap, this is 
discussed in the following sections.  
1.2 THE QUADRUPOLE ION TRAP MASS SPECTROMETER  
1.2.1 Ion Formation and Injection 
Historically, several different ionization sources have been used in conjunction 
with the QIT including electron ionization (EI), chemical ionization (CI), matrix assisted 
laser desorption ionization (MALDI) and electrospray ionization (ESI).  For the research 
presented in this dissertation, ESI was the source used for the work presented.  The 
advantages of using ESI rather than the other common ionization sources are presented at 
the beginning of each chapter, detailed for each specific analyte type.  ESI is the most 
versatile of the techniques largely due to its amenability to high performance liquid 
chromatography (HPLC).  Moreover, ESI is a soft ionization process that does not cause 
decomposition of analytes.  As a result, tandem mass spectrometry can be utilized to 
study the structure of the intact analyte ions. 
The first use of ESI with a mass spectrometer was reported by Fenn et al.73  Since 
ESI requires little sample preparation and operates at atmospheric pressure, it is 
comparatively inexpensive and easy to operate since sample changes are made outside of 
the vacuum chamber.  For ESI, a solution of the analyte is pumped through a needle to 
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which a high voltage is applied.  Typical experimental conditions for this process are 10 
µM analyte solutions pumped at 5 µL/min with a needle voltage of ~4 – 4.5 kV.  Positive 
ions are formed by applying a positive voltage to the electrospray needle, and negative 
ions are formed by applying a negative voltage.   
Charged droplets are formed at the needle tip and a potential difference between 
the needle and the front plate of the mass spectrometer guides charged droplets into the 
front aperture of the mass spectrometer into a heated capillary (Figure 1.3).  Upon exit 
from the needle and continuing to inside the heated capillary, the charged droplets are 
reduced to desolvated ions.  After formation of desolvated ions, they are guided into the 
entrance endcap of the ion trap through a series of focusing lenses. 
Several theories involving the electrospray mechanism have been proposed, and 
there are two major models for the production of desolvated ions known as the charged 
residue model and the ion evaporation model.74-77  As the highly charged droplets 
undergo desolvation and fission events (Coulombic explosions), they become smaller and 
smaller due to greater charge repulsion.  It is in the latest stages of the production of the 
desolvated ions where the two models differ.  The charged residue model focuses on the 
evaporation of the last solvent molecules so that the analyte is left desolvated and carries 
the charge from the final droplet.  The ion evaporation model focuses on expulsion of the 
charged analyte from the smaller droplets due to the great Coulombic repulsions formed.  
There is evidence for both of these models and the electrospray process is probably best 
described as a combination of the two.   
1.2.2 The Quadrupole Ion Trap 
The core of a QITMS consists of two endcap electrodes and a central ring 
electrode that define the trapping area (Figure 1-5).  The ions formed in the source region 
are guided into the trapping area through holes in the entrance endcap electrode.  An ac 
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voltage with a frequency in the rf, known as the trapping voltage (V), is applied to the 
ring electrode and the endcap electrodes are held at ground.  This creates a trapping field 
for ions.  The periodic motion of the ions in this trapping field is related to the V applied 
and is called the secular frequency.  Ion motion in the direction of the ring electrode is 
called the radial direction (r0) and ion motion in direction of the endcap electrodes is 
called the axial direction (z0).  QITs are operated with a background He gas in the 10-3 
Torr range.  The purpose of this gas is to cool the ions and keep them closer to the center 




Figure 1-5. Diagram of the quadrupole ion trap (QIT). 
1.2.3 Tandem Mass Spectrometry 
Tandem mass spectrometry is one of the most powerful techniques to obtain 
structural information about a compound.  The most common experiment involves the 
formation of an intact ion using a soft ionization source, isolation of the intact ion from 
the other species that may be formed in the source using an ion ejection technique, 
activation (fragmentation) of the intact ion and finally detection of the product ions 
formed.  A fragment ion of interest may be further isolated and activated, known as 
MS/MS/MS or MS3.  The process may be repeated as long as the ion population is 
sufficient (MSn).79  Multiple stages of MS often reveal enough information for 
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determination of a fragmentation pathway that may better elucidate the structural details 
of a compound.  For the research presented in this dissertation, two methods of 
activation, collisionally activated dissociation (CAD) and infrared multiphoton 
dissociation (IRMPD), are used in a quadrupole ion trap instrument and are compared for 
glycosides (flavonoid diglycosides) and glycans (oligosaccharides). 
1.2.3.1  Collisionally Activated Dissociation (CAD) 
The goal of CAD is to increase the internal energies of ions through collisions 
with the background He gas which ultimately results in dissociation.  CAD is a well 
established technique in the QIT.80-83  When CAD is performed, ions at the m/z of 
interest are isolated and then their kinetic energies are excited by application of an ac 
voltage across the endcap electrodes at the frequency of the ions’ motion.  When excited, 
the ions undergo collisions with the neutral background He gas.  During the collisions, 
there is a conversion of kinetic energy to internal energy.  Multiple collisions result in an 
increase in internal energy that is great enough to break bonds in the isolated ions 
(approximately 5-10 eV).  Typically hundreds of low energy collisions occur resulting in 
a range of energy deposition and allowing several competing dissociation processes.  A 
drawback is that the ion population may also be reduced by scattering during collision. 
For successful CAD it is necessary to increase the kinetic energy of the ions for 
energetic collisions without causing ejection from the trap.  Increasing the rf trapping 
voltage results in a more efficient trapping efficiency and allows for a significant increase 
in the supplementary voltage applied to the endcaps, yielding higher energy deposition 
during CAD.  However, increasing the rf trapping voltage also raises the so-called low 
mass cutoff in which low m/z ions cannot be trapped.  Thus, there is a compromise 
between ion stability, the low mass cutoff, and energy deposition during CAD.  Usually 
the rf trapping voltage is set so the low mass cutoff is approximately one-third the mass 
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of the parent ion, giving a reasonable tradeoff between satisfactory energy deposition and 
loss of low m/z information. 
1.2.3.2  Infrared Multiphoton Dissociation (IRMPD) 
IRMPD is a technique in which the internal energies of the isolated ions are 
increased by absorption of low energy photons.84  In this case, the ions absorb many 
photons until the internal energy is increased to a point where dissociation takes place.85  
Therefore, like CAD, IRMPD results in low energy fragmentation pathways.  Because 
IRMPD does not require the use of a collision gas, it has been very successful as an 
alternative to CAD in FTICR mass spectrometers.86-94 
IRMPD is emerging as a versatile ion activation method for QITs.95-113  There are 
clear advantages to IRMPD over CAD in a QIT that include elimination of the low mass 
cutoff, no ion losses due to scattering and the formation of secondary fragment ions.  
Since IRMPD does not require the resonant excitation that CAD does, it is not necessary 
to increase the rf trapping voltages and thus the low mass cutoff problem is eliminated.  
Therefore, lower mass fragment ions that were lost in CAD may be observed and may 
provide valuable structural information.  Also, since IRMPD is not a collision based 
technique, the ion losses from scattering after collision with the bath gas are not an issue, 
resulting in higher overall ion populations.  Since IR absorption is a non-selective 
process, primary fragment ions may also absorb IR photons, gain energy, and dissociate 
into secondary fragment ions.  The result is that primary and secondary ions are observed 
from one stage of dissociation.  While these fragment ions occasionally complicate the 
spectra, they often provide additional structural information without the requirement of 
multiple stages of activation. 
Since the QIT operates at a higher pressure compared to the FTICR, a problem 
associated with IRMPD is collisional cooling with the bath gas after irradiation with 
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photons.  Collisional cooling often occurs at a faster rate than absorption of photons 
resulting in efficient dissociation.  This shortcoming has been compensated for by heating 
the bath gas,105, 114 using CAD-assisted IRMPD,108 using a pulsed gas introduction 
method,107 or optimization of the bath gas pressure between the accumulation and 
dissociation timeframes.109  However, the performance of the QIT is compromised.  It has 
been shown by a few groups that the IRMPD efficiencies of compounds containing 
phosphate functional groups are superior to that of non-phosphorylated compounds.90, 96-
98, 115  In some of the research presented in this dissertation, similar IR-active functional 
groups have been deliberately attached to analytes using chemical derivatization to 
increase their IRMPD efficiencies. 
1.3 OVERVIEW OF CHAPTERS 
Chapter 2 describes the experimental parameters for the research presented in this 
dissertation.  The instrumentation used is described and sample preparation details are 
provided. 
Chapters 3 and 4 describe the isomer differentiation of flavonoid diglycosides 
using a metal complexation strategy with an emphasis on characterization of the glycan 
moiety.  In addition to the metal, the methods employ the complexation of a neutral 
pyridyl auxiliary ligand.  In Chapter 3 the ligands are modified electron-releasing 
functional groups and in Chapter 4 the ligands are modified electron-withdrawing 
functional groups. 
Chapter 5 presents the modification of analytes with neutral auxiliary ligands that 
have IR-active functional groups to increase the efficiency of photon absorption by 
IRMPD.  The metal complexation strategy with flavonoid diglycosides is used as a model 
for the method. 
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Chapter 6 explores a chemical derivatization strategy for oligosaccharides by 
using a reagent with an IR-active group to increase the photon absorption efficiency.  A 
modified boronic acid is used to derivatize oligosaccharides and the method is used for 
isomer differentiation and sequencing of the analytes. 
Chapter 7 presents the synthetic methods employed for ligands with electron-
withdrawing groups in Chapter 4 and IR-active functional groups in Chapter 5.  In 
addition, the synthesis of the modified boronic acid used in Chapter 6 is described. 
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Chapter 2:  Experimental 
2.1 MASS SPECTROMETRY 
Electrospray ionization (ESI) coupled with a quadrupole ion trap (QIT) mass 
spectrometer was used for the experiments described in Chapters 3-6.  Two different ESI-
QIT-MS instruments were used. 
For ESI, a solution of the analyte is pumped through a needle to which a high 
voltage is applied, typically 4 – 4.5 kV.  Positive ions are formed by applying a positive 
voltage to the electrospray needle, and negative ions are formed by applying a negative 
voltage.  Charged droplets are formed at the needle tip and a potential difference between 
the needle and the front plate of the mass spectrometer guides charged droplets into the 
mass spectrometer where they undergo desolvation and are guided into the QIT.  The 
details of this process are provided in Chapter 1.  ESI is a soft ionization process that 
does not cause decomposition of analytes.  As a result, tandem mass spectrometry can be 
utilized to study the structure of the intact analyte ions. 
Two techniques known as collisionally activated dissociation (CAD) and infrared 
multiphoton dissociation (IRMPD) were used in the QITs.  CAD is an activation 
technique that involves the increase of the internal energies of the ions through collisions 
with the background helium gas which ultimately results in dissociation.  During the 
collisions, there is a conversion of kinetic energy to internal energy.  Hundreds of 
collisions results in an increase in internal energy that is great enough to break the lowest 
energy bonds between atoms in the ions.  The details of the process are described further 
in Chapter 1.  A drawback to the technique is that the ion population may also be reduced 
by scattering during collision, thereby reducing sensitivity of the fragment ions formed. 
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IRMPD is a technique in which the internal energies of the isolated ions are 
increased by absorption of low energy photons.  In this case, the ions absorb many 
photons until the internal energy is increased to a point where dissociation takes place.    
Because IRMPD does not require the use of a collision gas, the ion losses from scattering 
after collision with the bath gas are not an issue, resulting in higher overall ion 
populations.  Since IR absorption is a non-selective process, primary fragment ions may 
also absorb IR photons, gain energy, and dissociate into secondary fragment ions.  The 
result is that primary and secondary ions are observed from one stage of dissociation.   
2.1.1 Finnigan LCQ-Duo Ion Trap Mass Spectrometer 
ESI-MS CAD experiments were performed using a Finnigan LCQ-Duo QIT mass 
spectrometer using the Xcalibur (Finnigan, San Jose, CA) software package and the 
electrospray source.  During ESI, the pressure in the ion trap with helium added was 
nominally 1.9 x 10-5 Torr, measured by the ionization gauge.  The electrospray voltage 
used was typically +4.5 kV in the positive ion mode experiments and -4.0 kV in the 
negative ion mode experiments.  The heated capillary was set to 150-100 °C.  Solutions 
were typically 1.0 – 2.0 x 10-5 M in analyte and were infused using a syringe pump 
(Harvard Apparatus, Holliston, MA) at flow rates from 2-10 µL/min.  The lens and 
octapole voltages, sheath gas flow rate and capillary voltage were optimized for 
maximum intensity of the ion of interest. 
2.1.2 Finnigan LCQ Deca XP Ion Trap Mass Spectrometer 
ESI-MS CAD and IRMPD experiments were performed using a Finnigan LCQ-
Duo QIT mass spectrometer using the Xcalibur (Finnigan, San Jose, CA) software 
package and the electrospray source.  IRMPD experiments were performed using a 
Synrad Model 48-5 50-W continuous wave CO2 laser.  The vacuum manifold of the 
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instrument was modified to permit mounting of a CF viewport flange with a ZnSe 
window to permit passage of radiation into the instrument.1  The port was aligned with a 
5-mm hole drilled into the ring electrode to permit irradiation of the QIT trapping 
volume.  The laser was gated at the appropriate point in the scan function controlled by 
software TTL triggers. The electrospray voltage used was typically +4.5 kV in the 
positive ion mode experiments and -4.0 kV in the negative ion mode experiments.  The 
heated capillary was set to 150-100 °C.  Solutions were typically 1.0 – 2.0 x 10-5 M in 
analyte and were infused using a syringe pump (Harvard Apparatus, Holliston, MA) at 
flow rates from 2-10 µL/min.  The lens and octapole voltages, sheath gas flow rate and 
capillary voltage were optimized for maximum intensity of the ion of interest.  During 
ESI, the pressure in the ion trap with helium added was nominally 2.7 – 2.8 x 10-5 Torr, 
measured by an ionization gauge external to the ion trap.  Irradiation times were typically 
5 – 25 ms at 50 W and were adjusted to tune sequential fragmentation in several 
experiments. 
2.2 MOLECULAR MODELING 
The molecular modeling studies were performed using the CAChe Worksystem 
Pro (Beaverton, OR) and Gaussian ’03 (Pittsburgh, PA) software packages.  
Preoptimization and generation of coordinates was performed with CAChe Worksystem 
Pro using MM3/AM1.  Final optimizations were performed with the Gaussian ’03 
software package at the B3LYP/6-31G* level. 
2.3 FOURIER TRANSFORM INFRARED SPECTROSCOPY 
FTIR analysis was performed using a Thermo Mattson (Madison, WI) Infinity 
Gold FTIR equipped with a Spectra-Tech Thermal ARK module, and ATR accessory. 
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2.4 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 
NMR experiments were performed using a Varian 400 MHz instrument (Varian 
Inc., Pal Alto, CA). 
2.5 CHEMICALS 
Apigenin, vitexin, apigenin-7-glucoside, isorhoifolin, rhoifolin, isovitexin, 
quercetin, luteolin, quercitrin, kaempferol-3-glucoside, luteolin-4’-glucoside, luteolin-7-
glucoside, orientin, neodiosmin and narirutin were purchased from Indofine (Somerville, 
NJ).  Fortunellin, linarin, poncirin and didymin were purchased from Extrasynthese 
(Genay, France).  Naringin, neohesperidin, hesperidin, 2,2’-bipyridine, 4,7-diphenyl-
1,10-phenanthroline, 1,10-phenanthroline, 2,2’:6’,2”-terpyridine, 4,4’-dimethyl-2,2’-
bipyridine, 6,6’-dibromo-2,2’-bipyridine, 4,4’-dimethyl-2,2’-bipyridine, 5-nitro-1,10-
phenanthroline, CoBr2, NiBr2, CuBr2, CsF2 and LNDFH-Ib were purchased from Sigma-
Aldrich (Milwaukee, WI).  LNFP-I, II, III, V, LNDFH Ia and II and DSLNT were 
purchased from V-Labs (Covington, LA).  Diethyl(aminomethyl)phosphonate oxalate 
was purchased from Acros Organics (Belgium).  Glacial acetic acid, 30% hydrogen 
peroxide, fuming sulfuric acid, fuming nitric acid, acetyl bromide, phosphorus 
tribromide, diisopropylamine, butyllithium, chlorotrimethylsilane, hexabromoethane, 
sodium  chloride, thionyl chloride, bromine, diethyl phosphite, triethyl phosphite, sodium 
borohydride, ammonium hydroxide, methanol, dichloromethane, chloroform, ethyl 
acetate, tetrahydrofuran, petroleum ether, N,N-dimethylformamide, hexanes and 2-
formylphenylboronic acid were purchased from Fisher (Somerville, NJ).  
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Chapter 3:  Differentiation of Flavonoid Glycoside Isomers By Using 
Metal Complexation and Electrospray Ionization Mass Spectrometry 
3.1 OVERVIEW 
The elucidation of flavonoid isomers is accomplished by electrospray ionization 
tandem mass spectrometry (ESI-MS/MS) via formation and collisional activated 
dissociation (CAD) of metal/flavonoid complexes containing an auxiliary ligand.  
Addition of a metal salt and a suitable neutral auxiliary ligand to flavonoids in solution 
results in the formation of [M(II) (flavonoid-H) ligand]+ complexes by ESI which, upon 
collisional activated dissociation, often result in more distinctive fragmentation patterns 
than observed for conventional protonated or deprotonated flavonoids.  Previously, 2,2’-
bipyridine was used as an auxiliary ligand, and now we compare and explore the use of 
alternative pyridyl ligands, including 4,7-diphenyl-1,10-phenanthroline.  Using this 
technique, three groups of flavonoid glycoside isomers are differentiated, including 
glycosides of apigenin, quercetin and luteolin. 
3.2 INTRODUCTION 
Flavonoids are polyphenolic phytochemicals which occur in edible fruits and 
vegetables.  They have been reported to act as antioxidants,1 antimicrobials,2 free radical 
scavengers,1 metal chelators,1 and anti-viral and anti-bacterial agents.3  Since they are a 
ubiquitous part of the human diet, their effect on human health is of interest.  Flavonoids 
are known to have medicinal and chemopreventive activities in humans.4-7  For example, 
a diet rich in flavonoids has shown to have an inverse relationship with heart disease.8-10 
There is a basic structure which is common to all flavonoids; however, there is a 
great diversity of flavonoids due to different hydroxylation and glycosylation positions.  
Most flavonoids exist as glycosides in plant sources, and many only differ by the nature 
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of the aglycon, and/or by the glycosylation site, the sequence, and the interglycosidic 
linkages of the glycan portion.  The biological activities of flavonoids are affected by 
these subtle structural differences.11  Therefore, there is a critical need for the 
development of analytical methods to elucidate structurally similar compounds.   
A number of mass spectrometric techniques have been used to study the structures 
of flavonoids.12 Electron ionization (EI) has been used to evaluate the fragmentation 
pathways of some aglycons13 and for limited structural studies of glycosides.  However, 
derivatization was required to make the flavonoids sufficiently volatile for EI and in 
some cases did not result in meaningful fragmentation patterns.14-17  Fast atom 
bombardment (FAB) and liquid secondary ion mass spectrometry (LSIMS) have been 
used extensively.18-36  In addition, thermospray37-39 and atmospheric pressure chemical 
ionization (APCI)40-41  have been used for several applications involving the analysis of 
flavonoids.  Most recent, electrospray ionization (ESI) has become a popular choice.40-49  
For example, the positive ESI mode was used to identify and quantitate flavonoids in 
soya flours and baby foods,43 and in hops and beer.48  Also, the negative ESI mode was 
used to identify and quantitate flavonoids in tea extracts44 and plants such as Passiflora 
incarnate.47 
Tandem mass spectrometry has been used to elucidate many of these 
compounds.23-24,31-36,44-47,50-52 For example, CAD of deprotonated flavonoid glycosides 
commonly results in loss of the sugars (formation of Y0- and Y1- ions).  CAD of 
deprotonated flavonoid-O-glycosides allows distinction of rutinosides (1 6 
disaccharides) from neohesperidosides (1 2 disaccharides) based on the greater 
abundance of the Y1- ions for the neohesperidosides compared to the rutinosides.50  
However, unique fragment ions were not observed for each isomer in all cases, so some 
identifications were based on differences in abundances of fragment ions of the same m/z 
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values.  In addition, CAD of protonated flavonoid-C-glycosides allowed the 
differentiation between 6-C and 8-C glycosides.51  However, the isomeric distinctions 
generally relied on the relative abundances of common product ions in the MS/MS 
spectra for some compounds, and diagnostic product ions were only observed in the 
MS/MS/MS spectra.  Hvattum et al. used CAD to evaluate the formation of radical 
fragment ions from deprotonated flavonoid glycosides by loss of neutral sugar radicals.52  
The radical fragmentation processes were related to the number of hydroxyl substituents 
on the B ring of the flavonoid, in addition to the type and position of the sugar 
substituent.  It was surmised that the radical loss of the 3-O-sugar substituent was 
enhanced by the presence of multiple hydroxyl groups on the B ring due to the electron-
donating properties of the hydroxyl groups, thus weakening the glycosidic bonds.    
Due to their acidic functional groups, protonation of flavonoid glycosides is 
inefficient, often resulting in weak positive ESI mass spectra.  In some cases, the 
fragmentation patterns of protonated flavonoids do not differentiate similar compounds or 
isomers.  Although deprotonation results in more intense mass spectra in the negative ESI 
mode, the fragmentation patterns again frequently do not differentiate similar compounds 
or isomers.  Metal complexation is an alternative ionization mode which has been 
explored in the Brodbelt group in the past.53-58  It has been observed that metal 
complexation can both increase ion intensity and alter fragmentation pathways, resulting 
in many more  structurally distinctive fragment ions.  Dramatic increases in intensities of 
some flavonoids56 have been observed with the use of copper, nickel or cobalt, along with 
2,2’-bipyridine or 1,10-phenanthroline as an auxiliary ligand.  In this chapter, the 
differentiation of three series of flavonoid glycosides with the use of 2,2’-bipyridine 
(bpy) and 4,7-diphenyl-1,10-phenanthroline (dpphen), a new auxiliary ligand, is shown.  
Although some of these compounds have been differentiated in the positive ion mode 
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based on differences in the relative intensities of specific fragment ions50-51 and in the 
negative ion mode based on low intensity fragment ions formed upon CAD,50 in this 
chapter isomers are differentiated via more intense, distinctive ions in the CAD spectra. 
Two classes of flavonoids, flavones and flavonols, are considered in this chapter.  
The use of metal complexation for differentiation within these two classes of flavonoids 
is extended and expanded.  The differentiation of glycosides of apigenins, commonly 
found in olive oil,59 orange juice,60 celery,61 and garlic62 is accomplished (Figure 3-1, 
Group I); in addition to glycosides of kaempferol, commonly found in lettuce,64 green 
beans,65 and grapes,66 glycosides of quercetin, commonly found in onions,63 kale,64 
lettuce,64 and green beans65 and glycosides of luteolin, commonly found in broccoli,62 
carrots,62 and celery (Figure 3-1, Group II).62   
3.3 EXPERIMENTAL 
Experiments were performed with a Finnigan LCQ Duo quadrupole ion trap mass 
spectrometer equipped with an electrospray ionization source.  The flow rate of the 
solutions was 5 µL min-1.  The lens and octapole voltages, sheath gas flow rate and 
capillary voltage were optimized for maximum intensity of the ion of interest.  The 
capillary temperature was 200 °C.  The interface pressure, measured with the convectron 
gauge at the skimmer cone, was normally 0.9 Torr.  The pressure in the ion trap with 
helium added was nominally 1.9 x 10-5 Torr, measured by the ionization gauge.  The 























































































































Figure 3-1. Structures of flavonoids studied, with molecular weights in parentheses. 
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In the negative ESI mode, the ion corresponding to [L-H]- was optimized, where 
L is the flavonoid.  In the positive ESI mode, when solutions of flavonoid/metal/auxiliary 
ligand were used, the ion corresponding to [M(II) (L-H) A]+ was optimized, where M is 
the metal and A is the auxiliary ligand.  During MS/MS experiments, these parent ions 
were isolated and the CAD voltage was adjusted so that the parent ion intensity decreased 
to 20% of the base peak. 
Stock solutions of 4.0 x 10-4 M metal salt/methanol and 4.0 x 10-4 M auxiliary 
ligand/methanol were used to create the analytical solutions.  Solutions containing a 
flavonoid, a metal salt, and an auxiliary ligand were ~1:1:1 at 1.0 x 10-5 M.  The 
analytical solutions used for the negative ESI experiments were 1.0 x 10-5  M flavonoid in 
methanol.  The flavonoids apigenin, vitexin, apigenin-7-glucoside, isorhoifolin, rhoifolin, 
isovitexin, quercetin, luteolin, quercitrin, kaempferol-3-glucoside, luteolin-4’-glucoside, 
luteolin-7-glucoside and orientin were purchased from Indofine (Somerville, NJ).  2,2’-
Bipyridine, 4,7-diphenyl-1,10-phenanthroline, 1,10-phenanthroline, 2,2’:6’,2”-
terpyridine, 4,4’-dimethyl-2,2’-bipyridine, CoBr2, NiBr2, and CuBr2 were purchased from 
Aldrich (Milwaukee, WI).  The HPLC grade methanol was purchased from EM Science 
(Gibbstown, NJ).  All materials were used without further purification. 
The nomenclature for glycoconjugates proposed by Domon and Costello67 is used 
to describe the fragmentation pathways for O-glycosides and the neutral losses for C-
glycosides.   Fragments from a terminal sugar unit are labeled using  g,hAi, Bi and Ci, 
where i is the number of the bond broken, counting from the terminal sugar beginning 
with 1, and g and h are the cross-ring cleavages of the sugar.  Fragments which include 
the aglycon are labeled k,lXj, Yj and Zj, where j is the number of the bond broken, 
counting from the aglycon beginning with 0, and k and l are the cross-ring cleavages of 
the sugar. 
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3.4 RESULTS AND DISCUSSION 
3.4.1 Negative Ion Mode 
Since the negative ESI mode has been so widely used for mass spectrometric 
analysis of flavonoids, we have compared the relative ionization efficiencies and 
diagnostic utility of the CAD spectra for deprotonated flavonoids to those obtained for 
the metal complexes in this chapter.  The spectra collected in the negative ion mode were 
clean with intense ions due to the efficiency of deprotonation of the flavonoids.   The 
spectra were dominated by [L-H]- ions, the ion selected for the CAD studies.  Also 
observed were [L (L-H)]- ions;  dissociation of these dimer species yielded  [L-H]- ions.  
The following sections describe the CAD results for the deprotonated flavonoids of the 
three sets of isomers in order to establish benchmarks for the degree of differentiation. 
3.4.1.1   Group Ia Differentiation:  Apigenin-7-glucoside, Vitexin and Isovitexin  
  (MW 432) 
The CAD mass spectra of the Group Ia flavonoids are shown in Figure 3-2, and 
the MSn data for the Group I flavonoids in the negative ESI mode is summarized in Table 
3-1. Upon CAD of the deprotonated flavonoids, the O-bonded glucoside, apigenin-7-
glucoside, is easily differentiated from the C-bonded isomers, isovitexin and vitexin, 
because deprotonated apigenin-7-glucoside dissociates primarily by loss of the glucose 
residue (Glc) (-162 Da) resulting in the Y0- ion at m/z 269 (Figure 3-2a).  Likewise, both 
of the C-bonded glucosides, vitexin and isovitexin, are easily differentiated from 
apigenin-7-glucoside because the deprotonated species dissociate by losses of 120 Da and 
90 Da due to cross-ring sugar cleavages (corresponding to 0,2X0+ and 0,3X0+, respectively, 
Figure 3-2b and c).   Cross-ring cleavages are commonly observed in the dissociation of 
saccharides,67-71 and this type of process is also observed for the C-bonded glycosides18,23 
since the typical rearrangements across the oxygen glycosidic bond do not take place.  
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However, the CAD spectra of deprotonated vitexin and isovitexin do not have significant 
diagnostic ions which differentiate them from each other in the negative ESI mode, nor 
can the intensities of the two major fragment ions (with identical mass-to-charge values 
for each isomer) be used to reliably distinguish and quantify the two flavonoids in 





































Figure 3-2. CAD spectra for deprotonated flavonoids from Group Ia.  The parent ions 
are labeled with asterisks. 
A second stage of ion isolation and activation (i.e. MS/MS/MS) undertaken on the 
major fragment ion at m/z 311 (seen in Figure 3-2b and 2c) results exclusively in the loss 
of CO for both vitexin and isovitexin, so even MSn does not sufficiently differentiate 
these two compounds.  This lack of isomer differentiation is a good example of why other 
ionization modes that might create different types of precursor ions with more distinctive 
dissociation properties should be explored. 
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Table 3-1. MSn spectra of deprotonated Group I flavonoids. 
    MS/MS1       MS/MS/MS1 
   m/z 
  
m/z Loss 
   
%   m/z Loss 
   
% 
apigenin-7-glucoside 431 269 162 100 225 44 100 
          197 72 36 
          120 149 28 
    311 120 6       
                
vitexin 431 311 120 100 283 28 100 
    341 90 6       
                
isovitexin 431 311 120 100 283 28 100 
    341 90 28 323 18 100 
          269 72 8 
          311 30 6 
                
rhoifolin 577 269 308 100 225 44 100 
    413 164 4       
    311 266 3       
    431 146 3       
    457 120 2       
    371 206 2       
                
isorhoifolin 577 269 308 100 225 44 100 
        
1MS/MS and MS/MS/MS data correspond to their parent ions (labeled m/z) on the 
left. The standard deviations of the fragment ion intensities are typically +/- 5%. 
 
3.4.1.2  Group Ib Differentiation:  Rhoifolin and Isorhoifolin (MW 578) 
Both deprotonated rhoifolin and isorhoifolin dissociate primarily by loss of the 
disaccharide, resulting in the Y0- ion at m/z 269 (Figure 3-3a and b).  Although these two 
isomers in theory may be differentiated by the occurrence of several unique losses from 
deprotonated rhoifolin (formation of ions at m/z 311, 371, 431, and 457)50 these ions are 
less than 5% relative intensity in the CAD spectra and could fall below limits of detection 
in more complex samples.  Further fragmentation of the Y0- ion results in the loss of CO2 
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for each isomer.  Thus, CAD of deprotonated rhoifolin and isorhoifolin does not 
differentiate these isomers with confidence.   






























Figure 3-3. CAD spectra for deprotonated flavonoids from Group Ib.  The parent ions 
are labeled with asterisks.  The + symbols represent previously identified 
low-intensity ions which could fall below limits of detection in more 
complex samples. 
3.4.1.3  Group II Differentiation (MW 448) 
The CAD mass spectra for the five deprotonated flavonoids in Group II are shown 
in Figure 3-4, and the MSn data is summarized in Table 3-2.  Deprotonated orientin, the 
C-bonded isomer, is easily differentiated from the others by the losses of 120 Da and 90 
Da due to cross-ring cleavages (Figure 3-4a), which are observed for some of the Group 
Ia flavonoids.  In addition, deprotonated quercitrin is distinguished from the others 
because of the unique loss of the terminal rhamnose residue (Rha) (-146 Da), resulting in 
the Y0- ion at m/z 301 (Figure 3-4b).  The deprotonated flavonoids of the remaining three 
isomers, the O-glucosides, each dissociate by loss of their terminal Glc (-162 Da, 
formation of m/z 285) (Figure 3-4c, d and e).  In addition to the prominent loss of Glc, 
deprotonated kaempferol-3-glucoside undergoes an even more pronounced radical loss of 
the sugar, presumably via a homolytic bond cleavage52 at the 3-O-glucose bond which 
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results in the ion at m/z 284.  Note that this type of process also occurs for deprotonated 
quercitrin (leading to the Yo- ion at m/z 300), although to a much lesser extent.   































































Figure 3-4. CAD spectra for deprotonated flavonoids from Group II.  The parent ions 
are labeled with asterisks. 
These two isomers both have their sugars attached at the 3 position.  The radical 
ion pathway was only observed for 3-substituted flavonoid glycosides and not for the 7-
glucoside, luteolin7-glucoside, as has been reported.52  The exact structure of the radical 
Yo-. ion at m/z 284 is difficult to define because there are several possible sites of 
deprotonation of the flavonoids, and thus a variety of reasonable initial precursor 
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structures and final product structures can be drawn and in which the resulting oxygen 
radical site can be stabilized via resonance. 
Table 3-2. MSn spectra of deprotonated Group II flavonoids.  
    MS/MS1       MS/MS/MS1 
   m/z   m/z Loss    %   m/z Loss 
   
% 
orientin 447 327 120 100       
    357 90 54       
                
quercitrin 447 301 146 100       
    300 147 26       
                
kaempferol-3-glucoside 447 284 163 100 255 29 100 
          256 28 32 
          227 57 6 
    285 162 53       
    327 120 14       
                
luteolin-4'-glucoside 447 285 162 100 241 44 100 
          199 86 82 
          243 42 59 
          217 68 51 
          175 110 40 
          242 43 27 
          257 28 22 
          151 134 21 
          213 72 20 
          218 67 18 
          223 62 15 
          267 18 10 
                
luteolin-7-glucoside 447 285 162 100 241 44 100 
          199 86 77 
          217 68 69 
          243 42 67 
          175 110 60 
          213 72 26 
          257 28 24 
          242 43 21 
          151 134 21 
          267 18 17 
        
1MS/MS and MS/MS/MS data correspond to their parent ions (labeled m/z) on the left.  The standard 





The remaining two isomers, deprotonated luteolin-4’-glucoside and luteolin-7-
glucoside, are not differentiated by CAD nor by MS3 spectra.  While the fragmentation of 
the primary fragment ion (m/z 285) is extensive in the MS3 spectra obtained for 
deprotonated luteolin-4’-glucoside and luteolin-7-glucoside (see Table 3-2), the ions are 
similar and do not unequivocally distinguish these two isomers in the negative ion mode.  
Most of the secondary fragmentation pathways involve losses of CO, CO2 and H2O from 
the selected primary fragment ion (m/z 285).  For example, both of the MS/MS/MS 
spectra are dominated by a loss of 44, the loss of CO2, from m/z 285. 
3.4.2 Metal Complexation 
Due to the unsatisfactory differentiation of the flavonoid isomers based on CAD 
mass spectra of the deprotonated flavonoids, metal complexation was explored as an 
alternative way to ionize the flavonoids and create different types of parent structures.   
Due to our previous studies in this area,53-58 2,2’-bipyridine was selected as the first 
auxiliary ligand and CoBr2 was used as the metal salt.  For the flavonoids, acidic sites 
that may be deprotonated in solution and are adjacent to a second binding site (i.e. 
another oxygen atom) are the likely chelation sites for the metal ions.  Using luteolin-7-
glucoside as an example, the metal binding site may be between the carbonyl 
functionality and a deprotonated hydroxyl at the 5 position (Figure 3-5a), or between 
adjacent hydroxyls on the B ring, one being deprotonated (Figure 3-5b), or even involve 
the sugar moiety (Figure 3-5c).  The structures shown in Figure 3-5 are just a subset of 
reasonable possibilities, and the ESI process may generate a mixture of these metal 
complexes. Complexes of the type [M(II) (L – H) A]+ where M is the metal, A is the 
auxiliary ligand, and L is the flavonoid, were produced for copper, cobalt, and nickel, and 
all of these complexes were more intense than the deprotonated flavonoids.  While the 
copper and nickel complexes were more intense than the cobalt complexes, the latter 
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produced ions which enabled differentiation of the isomers upon CAD.  Thus, CoBr2 was 
used for the remainder of the study, and only the CAD spectra of the [Co(II) (flavonoid – 













































Figure 3-5. Proposed structures for [Co(II) (L-H) bpy]+ complexes. 
3.4.3 Complexation with Cobalt and 2,2’-Bipyridine 
Upon ESI of solutions containing one flavonoid, a cobalt salt, and 2,2’-bipyridine, 
ions observed in these spectra included [Co(II) (L - H) 2 x bpy]+ and [Co(II) (L - H) 
bpy]+, with the latter being about five times more intense than the former.  In addition, 
there were minor product ions due to in-source fragmentation of the sugar for the O-
bonded isomers, such as the loss of terminal Rha or the entire disaccharide.  The [Co(II) 
(L – H) bpy]+ complexes formed were generally an order of magnitude more intense than 
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the [L - H]- ions formed in the negative ion mode.  In addition to this improvement in 
sensitivity, the CAD fragmentation patterns were generally richer and more distinctive 
than those observed for the negative ion mode. 
3.4.3.1  Group Ia Differentiation:  Apigenin-7-glucoside, Vitexin and Isovitexin  
  (MW 432) 
The CAD spectra of the [Co(II) (L – H) bpy]+ complexes are illustrated in Figure 
3-6 for the group Ia isomers.  The CAD spectrum for the apigenin-7-glucoside complex is 
distinctive from the other two isomers in that there is only one major ion (Y0+complex, 
m/z 484) due to the loss of Glc (Figure 3-6a).  In addition, there is a low intensity ion due 
to the loss of the aglycon moiety at m/z 376.  The loss of the entire aglycon moiety from 
the complex means that the cobalt ion and 2,2’-bipyridine are coordinated only to the 
sugar moiety in the resulting product ion, suggesting that the initial structure proposed in 
Figure 3-5c may be operative or that the cobalt/2,2’-bipyridine moiety may migrate from 
the aglycon to the saccharide upon collisional activation of the complex.   
The [Co(II) (L – H) bpy]+ complex of vitexin also undergoes the loss of the Glc 
upon CAD which is common for the O-glycosides but was not expected for a C-bonded 
glycoside.  The losses of 120 Da and 90 Da due to cross-ring cleavages are also dominant 
(Figure 3-6b).  In addition, the vitexin complex dissociates by several other pathways, 
including the loss of 150 Da (0,1X0+), a similar neutral loss to which has been reported in 
the positive ion mode,23 and the loss of one or two molecules of water.  While the [Co(II) 
(L – H) bpy]+ complexes of isovitexin also undergo two of the same cross-ring cleavages 
as does the vitexin isomer, resulting in losses of 90 Da and 120  Da (Figure 3-6c), the 
losses from Glc, 150 Da and 108 Da are unique for the isovitexin complex.  The latter 
loss of 108 Da was the same as one of the neutral losses also observed in the positive ion 
mode23 and was proposed to be due to elimination of 90 Da in conjunction with water.  
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Thus, comparison of the CAD spectra in Figure 3-2b and 3-2c to those seen in Figure 3-
6b and 3-6c confirms that isovitexin and vitexin are more effectively differentiated based 

















































Figure 3-6. CAD spectra of [Co(II) (L-H) bpy]+ complexes of Group Ia flavonoids.  The 
parent ions are labeled with asterisks. 
Due to the diverse array of fragmentation pathways for the [Co(II) (L – H) bpy]+  
complex of vitexin, this complex serves as an excellent model to illustrate the general 
fragmentation genealogy of the metal complexes.  Scheme 1 shows the m/z values of the 
product ions and neutral losses based on extensive MSn experiments, and Scheme 2 
illustrates proposed structures that reasonably account for the major fragment ions.  
Schemes 1 and 2 refer specifically to the ions seen in Figure 3-6b for the vitexin 




Table 3-3. MSn spectra of Group I [Co(II) (L-H) bpy]+ complexes. 
   MS/MS1 MS/MS/MS1 
 m/z m/z Loss % m/z Loss % 
apigenin-7-
glucoside 646 484 162 100 364 120 100 
     346 138 23 
  376 270 4    
        
vitexin 646 556 90 100 497 59 100 
     538 18 60 
     510 46 42 
     526 30 19 
     484 72 9 
  526 120 46 497 29 100 
     469 57 15 
  484 162 46 364 120 100 
     346 138 20 
     377 107 5 
     456 28 5 
     254 230 3 
  628 18 38 610 18 100 
     568 60 20 
     497 131 16 
     525 103 12 
     550 78 10 
     592 36 9 
     508 120 7 
     580 48 6 
  538 108     
  496 150     
  536 110     
  610 36     
        
isovitexin 646 556 90 100 497 59 100 
     538 18 86 
     536 20 80 
     498 58 61 
     510 46 64 
     496 60 25 
     484 72 16 
  526 120 90 508 18 100 
     497 29 81 
     498 28 81 
     496 30 50 
     232 294 31 
     216 310 13 
     469 57 11 
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rhoifolin 792 484 308 100 364 120 100 
     346 138 28 
  646 146 24 484 162 100 
     376 270 4 
  376 416 10    
        
isorhoifolin 792 484 308 100 364 120 100 
     346 138 22 
  646 146 45 484 162 100 
 




































Scheme 3-1. CAD fragmentation pathways for [Co(II) (vitexin-H) bpy]+ using m/z 


































































Scheme 3-2. CAD fragmentation pathways for [Co(II) (vitexin-H) bpy]+ using 
proposed structures of the fragment ions. 
Path A represents the loss of the terminal sugar, which is most prevalent with the 
O-glucosides. This fragmentation route is followed by path E, the loss of 2,2’-bipyridine 
and addition of two water molecules, resulting in the ion at m/z 364.  Sometimes this 
pathway occurs with the addition of only one molecule of water (formation of m/z 346).  
Solvation of metal complexes in an ion trap has been noted previously72-76 and is 
attributed to the coordinative unsaturation of the metal center which is resolved by the 
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adduction of water molecules, present at low levels in the trap.   The pathway proposed as 
involving loss of 2,2’-bipyridine and attachment of water molecules (path E) was 
confirmed by CAD of a [Co(II) (L – H) phen]+ complex containing cobalt with 1,10-
phenanthroline (phen) instead of 2,2’-bipyridine.  The appearance of the same product 
ions at m/z 346 and 364 confirmed that the auxiliary ligand was lost from the metal 
complexes upon activation, otherwise these fragment ions would be shifted upwards in 
m/z value by the difference between the nominal mass of 2,2’-bipyridine and 1,10-
phenanthroline.  Thus, path E for the [Co(II) (L – H) bpy]+ complex is actually the loss of 
2,2’-bipyridine (156 Da) followed by the rapid adduction of one or two water molecules.   
Path B depicts the cross-ring cleavage resulting in a loss of 120 Da.  The resulting 
ion further dissociates predominantly by path F, resulting in an interesting radical species 
of m/z 497 via the loss of CHO. radical.  There is also a less intense secondary fragment 
ion at m/z 469, assigned as the loss of CO from m/z 497.   Path C depicts another cross-
ring cleavage resulting in a loss of 90 Da, resulting in formation of the ion of m/z 556.  
This product ion further dissociates mainly by path G, resulting in the same radical 
species at m/z 497 as proposed for path B.  Other comparatively minor pathways 
observed upon CAD of m/z 556 include the loss of water, which may occur in 
conjunction with the loss of CO (leading to the ion at m/z 510),  the loss of 
formaldehyde, and the loss of 72 Da.  The loss of formaldehyde from m/z 556 is followed 
by the loss of HCO. radical, also resulting in the radical product ion at m/z 497.  Paths B 
and C are the most prevalent fragmentation pathways for the C-bonded flavonoids 
studied.  Path D represents a simple loss of water, mostly likely from the sugar.  This 
dehydration reaction is followed by yet another loss of water or even loss of two water 
molecules.  The identities of the hydroxyl groups that are lost as water molecule can’t be 
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determined with certainty, so the dehydrated structure shown in Scheme 2 is just one 
possibility.  
3.4.3.2  Group Ib Differentiation: Rhoifolin and Isorhoifolin (MW  578) 
Both the [Co(II) (L – H) bpy]+ complexes of rhoifolin and isorhoifolin (Figure 3-
7a and 3-7b) undergo the same major loss of the disaccharide (loss of 308 Da) as was 
observed upon CAD of the deprotonated species (Figure 3-3a and b).  However, the loss 
of Rha (-146 Da) is also observed for both isomers, and this fragmentation pathway was 
not observed for the deprotonated species.  







































Figure 3-7. CAD spectra of parent [Co(II) (L-H) bpy]+ complexes of Group Ib 
flavonoids.  The parent ions are labeled with asterisks. 
In addition to these two pathways, rhoifolin also undergoes the elimination of 
aglycon in conjunction with the loss of Glc (relative intensity 11%), leading to the unique 
fragment ion at m/z 376.  Apparently the 1  6 linkage of the rutinoside on isorhoifolin 
disrupts this fragmentation pathway.  Note that both rhoifolin and apigenin-7-glucoside, 
both with sugars at the 7 position like isorhoifolin, undergo this loss of the aglycon.  This 
suggests that the loss of aglycon is indicative of a sugar at the 7-position or a 1  2 
disaccharide.  The appearance of the unique ion at m/z 376 is a promising diagnostic ion 
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for differentiation of isorhoifolin and rhoifolin, but an increase in the relative intensity of 
this key ion, which would be desirable, could not be obtained for the [Co(II) (L-H) bpy]+ 
complexes. 
3.4.3.3  Group II Differentiation (MW 448) 
The CAD spectra for the Group II [Co(II) (L – H) bpy]+ complexes are shown in 
Figure 3-8, and the MS3 data is tabulated in Table 4. The CAD spectrum of the [Co(II) (L 
– H) bpy]+  complex of orientin was the most interesting of the five Group II isomers, 
with cross-ring cleavages corresponding to both paths B and C (leading to the ions at m/z 
542 and 572), in addition to loss of the entire sugar (path A, formation of m/z 500). This 
isomer is clearly differentiated based on these cross-ring cleavages (Figure 3-8a).   























































Figure 3-8. CAD spectra of [Co(II) (L-H) bpy]+ complexes of Group II flavonoids.  The 
parent ions are labeled with asterisks. 
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Table 3-4. MSn spectra of Group II [Co(II) (L-H) bpy]+ complexes. 
    MS/MS1        MS/MS/MS1 
   m/z   m/z Loss    %   m/z Loss 
   
% 
orientin 662 572 90 100       
    500 162 60       
    542 120 45       
    644 18 40       
    541 121 10       
    528 134 15       
                
quercitrin 662 516 146 100       
                
kaempferol-3-glucoside 662 500 162 100 380 120 100 
          233 267 13 
          247 253 11 
          472 28 8 
          362 138 8 
          308 192 7 
          442 58 5 
                
luteolin-4'-glucoside 662 500 162 100 380 120 100 
          362 138 12 
          472 28 5 
          394 106 5 
                
luteolin-7-glucoside 662 500 162 100 380 120 100 
          233 267 34 
          247 253 23 
          362 138 11 
          472 28 5 
          394 106 5 
          443 57 3 
        
1MS/MS and MS/MS/MS data correspond to their parent ions (labeled m/z) on 




In addition, the [Co(II) (L – H) bpy]+ complex of quercitrin is easily differentiated 
from the others because of its loss of Rha, resulting in the Y0+ complex at m/z 516 
(Figure 3-8b), similar to what was observed for the deprotonated flavonoid.  The 
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remaining three isomers, the O-glucosides, each dissociate by loss of their terminal 
sugars, resulting in Y0+ complexes at m/z 500 (Figure 3-8c, d and e), again like what was 
observed for the deprotonated isomers.  These isomers are not differentiated via their 
MS3 spectra either (Table 4).  For example, isolation and CAD of the major primary 
fragment ion at m/z 500 for each isomer results in a dominant apparent loss of 120 Da 
which is the elimination of 2,2’-bipyridine and addition of two molecules of water 
(Scheme 1, path E),  and the apparent loss of 138 Da which is the elimination of 2,2’-
bipyridine and addition of one molecule of water.  In addition, there are ions at m/z 233 
and 247 which are non-specific complexes of 2,2’-bipyridine and cobalt with water or 
methanol, respectively.  The inability to differentiate the two luteolin-glucoside isomers 
remained a persistent problem, and prompted us to consider the examination of other 
metal complexes. 
3.4.4 Complexation with Cobalt and 4,7-Diphenyl -1,10-phenanthroline 
Based on the improvements in isomer differentiation obtained for the [Co(II) (L – 
H) bpy]+ complexes, the use of alternative auxiliary ligands in the metal complexes was 
explored with the goal of increasing the “tunability” of the CAD patterns and generating 
more distinctive fragmentation patterns for each set of isomers, particularly for rhoifolin 
and isorhoifolin in Group Ib and the three undifferentiated isomers in Group II 
(kaempferol-3-glucoside, luteolin-4’-glucoside, and luteolin-7-glucoside). The various 
auxiliary ligands were assessed based on the overall signal intensity of the metal 
complexes and the number and intensity of the diagnostic fragment ions observed in the 
CAD mass spectra.  The following ligands were evaluated in comparison to the results 
obtained for the 2,2’-bipyridine complexes:  2,2’:6’,2”-terpyridine, 1,10-phenanthroline, 
4,4’-dimethyl-2,2’-bipyridine and 4,7-diphenyl-1,10-phenanthroline.  These ligands were 
selected because they retain the chelating ability attributed to the 2,2’-bipyridine 
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skeleton, but their metal affinities are altered by the electron-releasing alkyl groups 
appended remote from the nitrogen atoms.77  An example of the series of CAD mass 
spectra obtained by varying the auxiliary ligand is shown in Figure 3-9 for rhoifolin with 
cobalt.  




































































Figure 3-9. CAD mass spectra of [Co(II) (rhoifolin-H) pyridyl ligand]+ complexes, 
showing relative intensities of the losses of aglycon and Rha with  the 
variation of auxiliary ligand.  The parent ion is designated with an asterisk, 
the loss of Rha is designated by a plus sign, the loss of disaccharide is 
designated by a solid box, and the loss of  the aglycon and Rha is designated 
by a solid triangle.  
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For the spectra shown in Figure 3-9, the CAD energy was adjusted to give 
approximately the same level of parent ion survival, thus allowing a clear comparison of 
the competition among the three dominant dissociation channels for the complexes 
containing different auxiliary ligands. The intensity of the ion due to the consecutive 
losses of aglycon and Glc increased ongoing from the complexes containing  2,2’:6,2”-
terpyridine to 4,7-diphenyl-1,10-phenanthroline, corresponding with the increasing 
binding energy of the pyridyl ligand to cobalt in the gas phase as determined previously 
by energy-variable CAD.77  Based on a comparative assessment, 4,7-diphenyl-1,10-
phenanthroline (dpphen) resulted in metal complexes that gave the most distinctive CAD 
patterns, so it was used for the remainder of the study.  In general, the types of fragment 
ions observed upon dissociation of the [Co(II) (L – H) dpphen]+ complexes are the same 
as those already observed and rationalized for the [Co(II) (L – H) bpy]+ complexes.  
However, the intensities of some of the key diagnostic ions which allow differentiation of 
isomers are increased for the [Co(II) (L – H) dpphen]+ complexes, and a few new 
diagnostic ions are also observed upon CAD.  
3.4.4.1  Group Ia Differentiation:Vitexin, Isovitexin and Apigenin-7-Glucoside  
  (MW 432) 
The CAD mass spectra of the Group Ia complexes [Co(II) (L – H) dpphen]+ are 
shown in Figure 3-10, and the MSn results are summarized in Table 5.  As noted for the 
[Co(II) (L – H) bpy]+ complex,  the CAD spectrum for the [Co(II) (L – H) dpphen]+ 
complex of apigenin-7-glucoside complex contains only one major ion (Y0+ complex) 
due to the loss of  the Glc (Figure 3-10a), but the ion due to the subsequent loss of the 
aglycon (m/z 552) is more intense for this complex (12% for the dpphen complex versus 















































Figure 3-10. CAD spectra of parent [Co(II) (L-H) dpphen]+ complexes of Group Ia 
flavonoids.  The parent ions are labeled with asterisks. 
Table 3-5. MSn spectra of Group I [Co(II) (L-H) dpphen]+ complexes. 
    MS/MS1        MS/MS/MS1 
   m/z   m/z Loss    %   m/z Loss    % 
apigenin-7-glucoside 822 660 162 100 404 256 100 
          430 230 76 
          632 28 41 
          408 252 18 
          484 176 12 
          364 296 11 
    552 270 12       
                
vitexin 822 732 90 100 673 59 100 
          714 18 34 
          686 46 26 
          702 30 16 
          660 72 8 
    702 120 56 673 29 100 
          645 57 22 
    712 110 36       
    660 162 35       
    804 18 30 786 18 100 
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          673 131 31 
          744 60 21 
          701 103 15 
    672 150 24       
    462 360 21       
    450 372 12       
                
isovitexin 822 732 90 100 673 59 100 
          712 20 76 
          714 18 64 
          450 282 42 
          686 46 38 
          392 340 38 
          408 324 19 
          462 270 17 
          424 308 13 
    702 120 74 684 18 100 
          673 29 94 
          408 294 76 
          672 30 62 
          392 310 41 
          645 57 22 
                
rhoifolin 968 660 308 100 404 256 100 
          430 230 75 
          632 28 40 
    822 146 32 660 162   
          552 270   
    552 416 30 450 102 100 
          392 160 92 
          408 144 40 
          462 90 28 
          424 128 26 
                
isorhoifolin 968 660 308 100 404 256 100 
          430 230 82 
          632 28 45 
    822 146 26 660 162 100 
          552 270 12 
1MS/MS and MS/MS/MS data correspond to their parent ions (labeled m/z) on the 
left.  The standard deviations of the fragment ion intensities are typically +/- 5%. 
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The CAD pattern of the [Co(II) (L – H) dpphen]+ complex of isovitexin is 
virtually the same as the one observed above for the analogous [Co(II) (L – H) bpy]+ 
complex.  The CAD spectrum of the [Co(II) (vitexin – H) dpphen] complex also contains 
two additional non-specific product ions (m/z 450 and 462, Figure 3-10b), which are 
dpphen-containing ions and not diagnostic for vitexin. 
3.4.4.2  Group Ib Differentiation:  Rhoifolin and Isorhoifolin (MW 578) 
The major fragmentation pathways seen in the CAD mass spectra of the [Co(II) 
(L – H) dpphen]+ complexes of rhoifolin and isorhoifolin (Figure 3-11a and 3-11b) are 
the same as those observed above for the analogous [Co(II) (L – H) bpy]+ complexes 
(Figure 3-7a and 3-7b).    





































Figure 3-11. CAD spectra of parent [Co(II) (L-H) dpphen]+ complexes of Group Ib 
flavonoids.  The parent ions are labeled with asterisks. 
A difference is that the key diagnostic ion for identifying rhoifolin (i.e. the 
pathway due to loss of the aglycon and Glc moieties, m/z 552) is significantly more 
pronounced for the [Co(II) (L – H) dpphen]+ complex (30% relative intensity for the 
dpphen complexes versus 10% relative intensity for the corresponding bpy complex, m/z 
376).  This subtle but important change in the CAD mass spectrum is a good 
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demonstration of the ability to tune the fragmentation patterns and enhance the 
differentiation of isomers by modifying the metal affinity of the auxiliary ligand.  A 
relatively small difference in the metal affinity of the auxiliary ligand alters the energetics 
for dissociation of the complex, thus changing both the accessibility of and competition 
among different fragmentation channels.  
3.4.4.3 Group II Differentiation (MW 448) 
Shown in Figure 3-12 are the CAD mass spectra of the [Co(II) (L – H) dpphen]+ 
complexes of the Group II isomers. The CAD mass spectra of the [Co(II) (L – H) 
dpphen]+ complexes of the Group II flavonoids are generally similar to those observed 
and rationalized above for the [Co(II) (L – H) bpy]+ complexes (Figure 3-8), with a few 
exceptions.  For example, the fragmentation pattern of the orientin complex (Figure 3-
12a) has one extra diagnostic ion (loss of 110 amu, m/z 728).  Also, the luteolin-7-
glucoside isomer is now differentiated from luteolin-4’-glucoside by a new fragment ion 
stemming from the loss of the aglycon with the loss of the terminal sugar, resulting in the 
fragment ion at m/z 552 with 10% relative intensity (Figure 3-12e).   
While kaempferol-3-glucoside and luteolin-4’-glucoside were better differentiated 
in the negative ion mode (Figure 3-4), luteolin-7-glucoside was only differentiated by 
using metal complexation.  To differentiate kaempferol-3-glucoside and luteolin-4’-
glucoside, the pair of isomers that remained the most resistant to mass spectral 
differentiation using metal complexation, MS3 experiments were performed.  In the 
MS/MS/MS spectra obtained for the [Co(II) (L – H) dpphen]+ complexes based on 
isolation and activation of the primary fragment ion (m/z 676, loss of the sugar, 162 Da), 
there are now numerous secondary fragment ions which uniquely differentiate 
kaempferol-3-glucoside from luteolin-4’-glucoside.  These three isomers are a good 
example of how metal complexation may be used in conjunction with the negative ion 
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mode for complete isomer differentiation.  The MSn data for the complexes of the Group 
II isomers with Co/dpphen is tabulated in Table 3-6.   
























































Figure 3-12. CAD spectra of parent [Co(II) (L-H) dpphen]+ complexes of Group II 
flavonoids.  The parent ions are labeled with asterisks. 
3.4.4.4  Position of Glycosylation 
Since complexation with cobalt and dpphen resulted in the most interesting 
fragmentation patterns in this chapter, it is worthwhile to compare the general types of 
diagnostic ions observed as a function of the positions of glycosylation for the various 
flavonoids.  For example, it is interesting to note that for C-bonded isomers (vitexin, 
isovitexin, orientin), the 0,1X0+ is only observed for those flavonoids glycosylated at the 
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8-position as with vitexin and orientin (Figures 3-10b and 3-12a, respectively), but not 
for glycosylation at the 6-position as in the isovitexin isomer (Figure 3-10c).   
Table 3-6. MSn spectra of Group II [Co(II) (L-H) dpphen]+ complexes. 
   MS/MS1 MS/MS/MS1 
 m/z m/z Loss % m/z Loss % 
orientin 838 748 90 100    
  718 120 71    
  728 110 46    
  820 18 36    
  676 162 32    
  688 150 29    
  462 376 25    
  450 388 11    
        
quercitrin 838 692 146 100    
        
kaempferol-3-glucoside 838 676 162 100 408 268 100 
     423 253 48 
     484 192 28 
     648 28 19 
     404 272 18 
     496 180 13 
     632 44 9 
     392 284 9 
     333 343 5 
        
luteolin-4'-glucoside 838 676 162 100 404 272 100 
     430 246 67 
     648 28 53 
     408 268 30 
     658 18 30 
     647 27 27 
     630 46 20 
     620 56 13 
     392 284 12 
     442 234 12 
     500 176 10 
     524 152 7 
        
luteolin-7-glucoside 838 676 162 100 408 268 100 
     423 253 51 
     404 272 14 
     619 57 10 
     430 246 10 
  675 163 30    
  552 286 11    
1MS/MS and MS/MS/MS data correspond to their parent ions (labeled m/z) on the left.  The 
standard deviations of the fragment ion intensities are typically +/- 5%. 
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For the 7-O-bonded glucosides (apigenin-7-glucoside, rhoifolin, isorhoifolin, 
luteolin-7-glucoside), the loss of the aglycon or the aglycon and terminal sugar is always 
observed (Figures 3-10a, 3-11a and 3-12e) except for the rutinosides.  The lack of this 
pathway for 7-O-bonded rutinoside isorhoifolin (Figure 3-11b) is likely related to the site 
of metal complexation and/or conformation of the disaccharide when coordinated to the 
metal ion.  These general trends in the diagnostic ions observed with the position of 
glycosylation are an extremely useful feature of metal complexation for structural 
determination of flavonoids. 
3.5 CONCLUSIONS 
Metal complexation with an auxiliary ligand has been used to differentiate 
flavonoid glycoside isomers by ESI-tandem mass spectrometry.  In the presence of a 
metal and an appropriate auxiliary ligand, complexes of the type [Co(II) (flavonoid-H) 
ligand]+ are formed which are generally one to two orders of magnitude greater in 
intensity than the intensities of the molecular ions observed in positive or negative 
ionization modes, thereby improving limits of detection.  CAD of the metal complexes 
results in fragmentation patterns which are often different that those of the protonated or 
deprotonated species and may be used separately or in conjunction with these modes for 
isomer differentiation.  This general metal complexation technique has been improved 
with the use of 4,7-diphenyl-1,10-phenanthroline as a new auxiliary chelating ligand.  In 
particular, the differentiation of disaccharide isomers with 1→ 2 and 1→ 6 linkages and 
the two luteolin-glucoside isomers is now possible based on formation and detection of 
unique fragment ions for each isomer. 
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Chapter 4:  Tunable Transition Metal-Ligand Complexation for 
Enhanced Elucidation of Flavonoid Diglycosides by Electrospray 
Ionization Mass Spectrometry 
4.1 OVERVIEW 
A tunable ESI-MS/MS strategy for differentiation of flavone and flavanone 
diglycoside isomers based on metal complexation with auxiliary ligands is described in 
this chapter. The addition of a metal salt and an auxiliary ligand to a flavonoid solution 
results in the formation of [M(II) (flavonoid-H) auxiliary ligand]+ complexes, where 
M(II) is a transition metal.  A series of auxiliary ligands with electron-withdrawing 
substituents were synthesized in order to tailor the relative metal binding affinities of the 
ligands and thus directly influence the stabilities, and consequently the dissociation 
pathways, of the complexes.   Upon collisionally activated dissociation, the complexes 
yield fragmentation patterns in which the abundances of key diagnostic ions are 
enhanced, thus facilitating isomer differentiation.   
4.2 INTRODUCTION 
Differentiation of isomers remains a challenging analytical problem, and 
confirming structures of isomers is difficult even when they can be adequately separated 
from mixtures. Tandem mass spectrometry has been used extensively for structural 
elucidation of isomers 1-12 and there continues to be interest in applying existing tandem 
mass spectrometric methods, such as MSn,9, 13, 14 and developing new ones, such as STEP, 
15, 16 a statistical-based method that relies on comparison of abundances of fragment ions 
obtained for different collision activation conditions, to differentiate isomers.  The work 
presented in this dissertation focuses on the development of metal complexation 
strategies 17-23 to enhance the differentiation of isomers because metal complexation often 
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alters the dissociation pathways of ions, thus giving additional diagnostic fragment ions.  
Several metal complexation strategies that have been useful for distinguishing flavonoid 
isomers have been reported, and in this chapter we expand this approach by developing a 
“tunable” CAD method based on the use of rationally selected auxiliary ligands to form 
metal complexes.  The concept of this tunable CAD strategy is applied for the 
differentiation of flavonoid isomers.     
Flavonoids are phytochemicals found in almost all plants, including fruits and 
vegetables.  Several studies have indicated their antioxidant, chemopreventive, anti-viral, 
anti-bacterial and radical-scavenging properties.17-21  In addition, they have been 
implicated in cardiovascular protection.22-29  While all flavonoids are structurally similar, 
many exist as glycosides and there are subtle differences in their structure that lead to 
important changes in their biological activity.  These differences include hydroxylation 
position of the aglycon, glycosylation site, sequence of glycosylation and interglycosidic 
linkages of the glycan portion.  It is because of these subtle differences that there is a 
need for sensitive analytical techniques to elucidate these similar compounds.   
Mass spectrometry has become an ideal tool for the analysis of flavonoids, and 
two recent reviews provide an excellent background of the techniques used and the 
analyses performed.30, 31  ESI-MS/MS has been used extensively to differentiate several 
sets of flavonoid isomers over the past decade.  For example, for a series of flavonoid 
diglycosides, CAD has been used to pinpoint the intersaccharide linkages (rutinosides: 
1→ 6 disaccharides versus neohesperidosides: 1 → 2 disaccharides) in flavonoid-O-
glycosides based on relative abundances of the fragment ions obtained from protonated 
flavonoids.7  However, in general it has been noted that flavonoids don’t protonate 
particularly well because they are acidic, phenolic compounds.  Although flavonoids 
deprotonate efficiently, the resulting fragmentation patterns often do not give diagnostic 
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ions adequate for differentiation of isomers.   Metal complexation is an alternative 
ionization strategy that has been explored in our group for improved analysis of 
flavonoids,32-38 and we have explored metal complexation both with and without the use 
of an auxiliary ligand to produce stable complexes.  For example, using an auxiliary 
ligand, typically a pyridyl-type chelating agent, complexes of the type [M(II) (flavonoid – 
H) auxiliary ligand]+ are formed.   Metal complexation not only provides greater ion 
abundances but also enhances the structural differentiation of isomeric flavonoids.   
In the study presented in the previous chapter, the impact of the auxiliary ligand 
on the abundances of metal complexes and the resulting fragmentation pathways of the 
complexes of flavonoid diglycosides was evaluated.36  It was demonstrated that the 
nature of the auxiliary ligand affected the types of fragment ions and their abundances in 
the CAD mass spectra.  Specifically, it was found that as the alkyl substituents of the 
ligands changed (i.e. 1,10-phenanthroline versus 4,7-diphenyl-1,10-phenanthroline), the 
abundances of several diagnostic fragment ions observed for flavone rutinoside and 
neohesperidoside isomeric pairs varied systematically.  This result revealed that it was 
possible to tune the CAD spectra by careful selection of the auxiliary ligand.  However, 
the only suitable commercially available auxiliary ligands were ones with electron-
releasing alkyl substituents, thus limiting the scope of the study.  Electron-releasing 
substituents increase the metal binding energies of pyridyl ligands and therefore in some 
cases destabilize the desired [M(II) (flavonoid – H) pyridyl ligand]+ complexes. Pyridyl 
ligands have intrinsically high metal binding energies, both in solution 39-43 and in the gas 
phase,44, 45 due to their ability to chelate metal ions via their nitrogen atoms.  Addition of 
electron-withdrawing substituents should temper the metal binding energies and thus 
expand the options for creating tunable auxiliary ligands for the differentiation of 
isomers, such as flavonoids, via metal complexation strategies.   
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In this chapter, we explore the effect of incorporating electron-withdrawing 
substituents into the pyridyl ligands for metal complexation, evaluated in terms of the 
success of differentiating flavonoid isomers.  The halogens are interesting substituents 
because of their inductive electron-withdrawing effects.    For assessment of the method, 
twelve isomers of 7-O-flavonoid diglycosides are evaluated, including three isomeric 
pairs from the flavone class (both 1 → 2 vs. 1 → 6 disaccharide linkages) and three pairs 
from the flavanone class (1 → 2 vs. 1 → 6), (Figure 4-1). 
4.3 EXPERIMENTAL 
4.3.1 Chemical Reagents 
The flavonoids rhoifolin, isorhoifolin, neodiosmin, diosmin and narirutin were 
purchased from Indofine (Somerville, NJ, USA).  Fortunellin, linarin, poncirin and 
didymin were purchased from Extrasynthese (Genay, France).  Naringin, neohesperidin, 
hesperidin, CoBr2, CuBr2, 2,2’-bipyridine, 6,6’-dibromo-2,2’-bipyridine, 4,4’-dimethyl-
2,2’-bipyridine, 1,10-phenanthroline and 5-nitro-1,10-phenanthroline were purchased 
from Sigma (St. Louis, MO, USA). 
4.3.2 Ligand Syntheses 
4,4’-dibromo-2,2’-bipyridine was synthesized from 2,2’-bipyridine according to a 
literature procedure46, 47 and was purified using silica gel flash chromatography.  1H 
NMR (CD3Cl3) δ = 7.509 (2H, dd, J = 5.2 Hz, 1.6 Hz), 8.486 (2H, d, J = 5.2 Hz), 8.608 
(2H, d, J = 1.6 Hz). 
4,4’-bis(bromomethyl)-2,2’-bipyridine was synthesized from 4,4’-dimethyl-2,2’-
bipyridine according to a literature procedure 48 and was purified using silica gel flash 
chromatography.  1H NMR (CD3Cl3) δ = 7.507 (2H, d, J = 8 Hz), 7.671 (2H, t, J = 7.6 
Hz, 8Hz), 8.378 (2H, d, J = 7.6 Hz). 
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rhoifolin (578) isorhoifolin (578)
neohesperidosides (1→2) rutinosides (1→6)




























































































































































Figure 4-1. 7-O-Flavonoid diglycosides used in this chapter.  Molecular weight is 
indicated in parentheses.   
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5,6-dibromo-1,10-phenanthroline, 3,5,6-tribromo-1,10-phenanthroline and 
3,5,6,8-tetrabromo-1,10-phenanthroline were synthesized from 1,10-phenanthroline 
according to a literature procedure.49  The phenanthrolines were purified using successive 
recrystallizations.  5,6-dibromo-1,10-phenanthroline 1H NMR (CD3Cl3) δ = 7.740 (2H, 
dd, J = 8.4 Hz, 8.0 Hz), 8.782 (2H, dd, J = 8.8 Hz, 1.2Hz), 9.226 (2H, dd, J = 4.4 Hz, 1.2 
Hz).  3,5,6-tribromo-1,10-phenanthroline 1H NMR (CD3Cl3) δ = 7.748 (1H, dd, J = 8.8 
Hz, 4.2 Hz), 8.765 (1H, dd, J = 8.8 Hz, 1.6Hz), 8.928 (1H, d, J = 2 Hz), 9.201 (2H, m).  
3,5,6,8-tetrabromo-1,10-phenanthroline 1H NMR (CD3Cl3) δ = 8.920 (2H, d, J = 2.2 Hz), 
9.190 (2H, d, J = 2 Hz).     
A Varian 400 MHz instrument was used for all NMR spectroscopy. 
4.3.3 Metal Complexation/Mass Spectrometry 
Stock solutions of 4x10-4 M metal salts and auxiliary ligands were prepared in 
methanol.  Solutions containing the flavonoid, metal salt and auxiliary ligands were 
prepared in ~1:1:1 ratios at 1x10-5 M.   
The experiments were performed using a Thermo Finnigan (San Jose, CA, USA) 
LCQ Duo quadrupole ion trap (QIT) mass spectrometer equipped with an electrospray 
ionization (ESI) source.  The flow rate of the solutions was 5 µl min-1.  The heated 
capillary temperature was 200 °C and the ESI voltage was set at +4.5 kV.  The ionization 
times were set to 5-25 ms and each spectrum was an average of 20 scans.  The lens and 
octapole voltages, sheath gas flow rate and capillary voltage were optimized for 
maximum intensity of the ion corresponding to [M(II) (flavonoid - H) L]+, where M is the 
metal and L is the auxiliary ligand. During MS/MS experiments, these parent ions were 
isolated and the CAD voltage was adjusted so that the parent ion intensity decreased to 
~10% of the base peak.  An isolation window sufficient to exclude all but the carbon-12 
isotope was used for most experiments, and an isolation window sufficient to include all 
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bromine isotopes was used for confirmation of the presence of the brominated ligands in 
selected fragment ions. 
4.3.4 Molecular Modeling 
Preoptimization and generation of coordinates was performed with CAChe 
Worksystem Pro using MM3/AM1.  Final optimization was performed with the Gaussian 
’03 software package at the B3LYP/6-31G* level. 
4.4 RESULTS AND DISCUSSION 
A series of six brominated pyridyl ligands were used in this chapter (Figure 4-2), 
three based on the 2,2’-bipyridine skeleton (4,4’-dibromo-2,2’-bipyridine, 6,6’-dibromo-
2,2’-bipyridine, and 4,4’-bis(bromomethyl)-2,2’-bipyridine) and three based on the 1,10-
phenanthroline skeleton (5,6-dibromo-1,10-phenanthroline; 3,5,6-tribromo-1,10-
phenanthroline; and 3,5,6,8-tetrabromo-1,10-phenanthroline), with the overreaching goal 
of using them as “tunable” auxiliary ligands for complexation and structural 
characterization of isomers, as demonstrated specifically for flavonoids.  Complexation 
with 4,4’- and 6,6’-dibromo-2,2’-bipyridine was compared to allow evaluation of the 
influence of the position of the electron-withdrawing groups.  4,4’-bis(bromomethyl)-
2,2’-bipyridine was synthesized to investigate the effect of moving the bromine groups 
further from the aromatic ring.  Three different brominated 1,10-phenanthroline 
compounds were synthesized to allow evaluation of the impact of the number of bromine 
groups on formation and dissociation of complexes.  5-nitro-1,10-phenanthroline was 
used to evaluate the effect of an alternative electron-withdrawing substituent.  For the 
experiments described in the following sections, ESI-MS/MS was used to analyze 
solutions containing either 2,2’-bipyridine or a brominated ligand in a solution containing 



























Figure 4-2. Ligands used in this chapter.   The ‘○’ symbols represent atoms discussed in 
the molecular modeling part of the chapter. 
4.4.1 Complexation with Bromobipyridines 
In the ESI mass spectra of each solution containing one flavonoid with 4,4’-
dibromo-2,2’-bipyridine and either CuBr2 or CoBr2, the abundances of the resulting 
complexes are comparable.  The spectra are dominated by the [M(II) (flavonoid - H) 4,4’-
dibromo-2,2’-bipyridine]+ complexes, without interference from the formation of 
numerous other metal-ligand species (Figure 4-3).  Division of the total ion current 
among several different metal-containing products has been one shortcoming noted in 
some previous metal complexation studies, thus having a negative impact on ultimate 
detection limits.   
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954 [Cu(II) (isorhoifolin-H)            
4,4’-dibromo-2,2’-bipyridine]+
 
Figure 4-3. Full scan spectrum of a solution of rhoifolin/Cu(II)/4,4’-dibromo-2,2’-
bipyridine showing the flavonoid/metal/ligand complex as the dominant 
species. 
Since both copper and cobalt resulted in the formation of equally abundant 
flavonoid complexes, the CAD spectra were acquired for all the complexes of the 
flavonoids used in this chapter.  Figure 4-4 shows this comparison for one representative 
flavonoid from each of the four classes summarized in Figure 4-1 (i.e. one flavone 
neohesperidoside, one flavone rutinoside, one flavanone neohesperidoside, one flavanone 
rutinoside).  All of the copper complexes dissociate predominantly by the loss of the 
disaccharide moiety, corresponding to the neutral loss of 308 Da (top panel of Figure 4-
4).  The copper complex of isorhoifolin exhibits two additional fragment ions due to 
cross-ring cleavages of the disaccharide (cross-ring cleavages are designated by X in the 
figures) in conjunction with loss of the 4,4’-dibromo-2,2’-bipyridine ligand, yielding the 
fragment ions at m/z 523 and 495.  The cobalt complexes exhibit more intricate 
fragmentation pathways with unique ions for each flavonoid (bottom panel of Figure 4-
4).  The most common ones include the loss of the terminal rhamnose group (-146 Da), 
loss of the disaccharide moiety (-308 Da), loss of the auxiliary 4,4’-dibromo-2,2’-
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bipyridine ligand (-314 Da), loss of the aglycon group (-A), and other combined losses 
thereof.   



















































































































































Figure 4-4. Representative spectra for CAD of flavonoid/metal/4,4’-dibromo-2,2’-
bipyridine with a flavone rutinoside/neohesperidoside and a flavanone 
rutinoside/neohesperidoside, comparing the Cu and Co complexes.  (-D) 
indicates the loss of disaccharide moiety, (-R) indicates the loss of rhamnose 
moiety, (-L) indicates the loss of ligand, and X indicates a cross-ring 
cleavage of the sugar moiety. 
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There is at least one diagnostic fragment ion for each of the isomers, and in most 
cases there are at least two.  In addition, there are two diagnostic cross-ring cleavages 
involving the disaccharide group for each of the flavone and flavanone rutinosides (i.e. 
isorhoifolin and didymin in Figure 4-4).  The resulting ions are observed at m/z 876 (-74, 
X1) and m/z 846 (-104, X2) for the isorhoifolin complex and m/z 892 (-74, X1) and m/z 
862 (-104, X2) for they didymin complex.   Proposed cleavages that are consistent with 
the observed fragment ions are shown in Scheme 1 for these cross-ring cleavages.   There 
is another notable series of cross-ring cleavages for the flavone rutinoside isomers 
(fragment ions labeled XN in the bottom panel of Figure 4-3B for the isorhoifolin 
complex, also seen for the analogous complexes of diosmin and linarin).  Some of these 
cross-ring cleavages occur in conjunction with loss of the 4,4’-dibromo-2,2’-bipyridine 






















Scheme 4-1. Proposed cleavages for a flavonoid/Co/4,4’-dibromo-2,2’-bipyridine 
cobalt complex using isorhoifolin as an example. 
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It is interesting that these extensive cross-ring fragmentations are observed for the 
flavone rutinoside complexes but not the flavanone rutinoside complexes.  We speculate 
that this striking difference in the degree of cross-ring cleavages is related to the ability of 
the rutinose moiety to interact with the metal center in the complexes, which may 
influence the migration of the metal or auxiliary ligand chelate upon activation, as well as 
the strength of the glycosidic bond.  Previous computational modeling of [Co(II) 
(flavonoid-H) (2,2’-bipyridine)]+ complexes by Zhang and Brodbelt50 revealed that the 
most favorable metal coordination sites involved the carbonyl oxygen atom and adjacent 
deprotonated oxygen atom of the aglycon.  Moreover, it was shown that for the 
rutinosides, the disaccharide folds toward the metal center, thus increasing the interaction 
of the disaccharide with the metal.50 This factor presumably could enhance the possibility 
of migration of the metal/auxiliary ligand chelate in the complexes containing the 4,4’-
dibromo-2,2’-bipyridine ligands and/or modify the electron density in the glycoside 
bonds, thus promoting cross-ring cleavages instead of glycosidic bond cleavage.  It was 
also found that the glycosidic bond energies and point charges for the aglycon-
disaccharide bonds were greater for the flavonoid rutinosides than for the flavonoid 
neohesperidosides.50  This effect may be further exaggerated for the complexes 
containing the 4,4’-dibromo-2,2’-bipyridine ligand since the electron-withdrawing 
bromine atoms should temper the metal binding energy of the auxiliary ligand which 
could translate into alternate fragmentation pathways to glycosidic bond cleavage, such 
as cross-ring cleavages. 
The analytical utility of two other brominated bipyridine ligands, 6,6’-dibromo-
2,2’-bipyridine and 4,4’-bis(bromomethyl)-2,2’-bipyridine, was also evaluated.  The only 
complexes observed by ESI-MS for solutions containing a flavonoid, a metal salt, and 
6,6’-dibromo-2,2’-bipyridine were ligand/metal complexes of the type [M(I) 6,6’-
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dibromo-2,2’-bipyridine + H2O]+.  Molecular modeling was used to evaluate the 4,4’-
dibromo-2,2’-bipyridine/Co(II) and 6,6’-dibromo-2,2’-bipyridine/Co(II) complexes in 
order to assess the potential hindrance to flavonoid binding.  The dihedral angles of the 
N-C-C-N bonds on the ligand (labeled with a ‘○’ in Figure 4-2) were found to have a 
minimum energy at 0° for both complexes, and this is consistent with previous modeling 
studies of other flavonoid metal complexes containing pyridyl ligands.50  The C-Br bond 
distances were 1.9248 Å for the 6,6’-dibromo-2,2’-bipyridine complex.  These distances, 
coupled with the dihedral angle that shows that the bromine atoms are in the same plane 
with Co, indicates that the proximity of the bromine atoms to the cobalt ion causes 
substantial steric hindrance which prevents simultaneous coordination of  6,6’-dibromo-
2,2’-bipyridine and a flavonoid to the metal ion, thus making 6,6’-dibromo-2,2’-
bipyridine a poor auxiliary ligand. 
  In contrast to the ESI-MS results for the 6,6’-dibromo-2,2-
bipridine/flavonoid/metal solutions, abundant flavonoid complexes were observed for 
solutions containing 4,4’-bis(bromomethyl)-2,2’-bipyridine and a transition metal.  
However, the CAD spectra were dominated by the loss of the rhamnose moiety and the 
loss of the disaccharide group.  These CAD spectra did not allow differentiation of the 
various isomers, and thus 4,4’-bis(bromomethyl)-2,2’-bipyridine proved to be an 
unsatisfactory auxiliary ligand.  
4.4.2 Complexation with Phenanthroline Ligands 
The complexation of each of the bromophenanthrolines (structures shown in 
Figure 4-2) was studied with each of the twelve flavonoids.  Figure 4-5 illustrates the 
CAD mass spectra of the complexes containing the 3,5,6,8-tetrabromo-1,10-
phenanthroline ligand, four representative flavonoids, and cobalt. The dominant 
dissociation route for all four flavonoid complexes in Figure 4-5 is the loss of the 
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rhamnose moiety, as well as elimination of the disaccharide group, two pathways that are 
commonly observed for other types of flavonoid/metal complexes. The presence of other 
unique fragment ions in each CAD spectrum allow each pair of isomers to be readily 
distinguished.   



































































Figure 4-5. Representative CAD mass spectra of the [3,5,6,8-tetrabromo-1,10-
phenanthroline (flavonoid – H) Co(II)]+ complexes containing the following 
flavonoids: a) rhoifolin, b) isorhoifolin, c) poncirin, and d) didymin.  (-D) 
indicates the loss of disaccharide moiety, (-R) indicates the loss of rhamnose 
moiety, and (-A) indicates the loss of aglycon. 
The types of fragment ions observed for all of the cobalt complexes containing 
each of the bromophenanthroline ligands as compared to unmodified 1,10-phenanthroline 
and each of the flavonoids are summarized in Table 4-1.  In general, the types of 
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fragmentation pathways are similar to those noted earlier for the complexes containing 
the 4,4’-dibromo-2,2’-bipyridine ligand, including the loss of the rhamnose group, the 
elimination of the disaccharide moiety, and the loss of the aglycon and rhamnose groups.  
The most notable difference between the fragmentation patterns of the flavonoid 
rutinosides and the neohesperidosides are two cross-ring cleavages (-74 Da, -104 Da) that 
were also observed for the analogous flavonoid rutinoside complexes containing the 4,4’-
dibromo-2,2’-bipyridine ligand.  In addition, the flavanone neohesperidosides are 
differentiated from the flavones by the characteristic loss of the aglycon moiety. 
The summary in Table 4-1 reveals that the number of different fragment ions 
increases as the number of electron-withdrawing bromine atoms on the 1,10-
phenanthroline auxiliary ligand increases.  The number of fragmentation pathways 
correlates with the relative stabilities of the metal complexes.  Complexes in which one 
of the two coordinated molecules (i.e. flavonoid vs. auxiliary ligand) has a significantly 
greater metal binding energy than the other tend to dissociate by just a few routes, thus 
typically being less useful for confident differentiation of isomers.  Among the three 
brominated phenanthroline ligands, the 3,5,6,8-tetrabromo-1,10-phenanthroline ligand is 
expected to have the lowest metal binding energy due to the influence of the four 
electron-withdrawing bromine atoms on the metal-coordinating nitrogen atoms.  This 
makes the metal binding energy of the 3,5,6,8-tetrabromo-1,10-phenanthroline ligand 
closer to the metal binding energy of a typical flavonoid, thus increasing the stability of 
the 3,5,6,8-tetrabromo-1,10-phenanthroline/flavonoid complexes and resulting in a 
greater array of competitive dissociation routes.  In fact, of the three 
bromophenanthroline ligands, the tetrabromo ligand (3,5,6,8-tetrabromophenanthroline) 
is the only one that allows successful differentiation of all of the flavonoid isomers, in 
terms of providing at least one unique diagnostic fragment ion for each isomer.   
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Table 4-1. Summary of fragment ion distributions observed in the CAD spectra for 
selected Co/flavonoid/ligand complexes grouped by flavonoid diglycoside 
class.   
4,4'-dibromo-2,2'-bipyridine/Co (-R) (-D) (-A) (-A,-R) (-L) X1 X2 
flavone neohesperidoside (rhoifolin) 54 100  19    
flavone rutinoside (isorhoifolin) 100 68   80 10 14 
flavanone neohesperidoside (poncirin) 95 100 8 58    
flavanone rutinoside (didymin) 100 83   29 5 7 
1,10-phenanthroline/Co (-R) (-D) (-A) (-A,-R) (-L) X1 X2 
flavone neohesperidoside (rhoifolin) 15 100  6    
flavone rutinoside (isorhoifolin) 14 100     4 
flavanone neohesperidoside (poncirin) 38 100  32    
flavanone rutinoside (didymin) 16 100  8    
5,6-dibromo-1,10-phenanthroline/Co (-R) (-D) (-A) (-A,-R) (-L) X1 X2 
flavone neohesperidoside (rhoifolin) 73 100  23    
flavone rutinoside (isorhoifolin) 94 100    15 21 
flavanone neohesperidoside (poncirin)  100      
flavanone rutinoside (didymin)  100      
3,5,6-tribromo-1,10-
phenanthroline/Co (-R) (-D) (-A) (-A,-R) (-L) X1 X2 
flavone neohesperidoside (rhoifolin) 100 89  15    
flavone rutinoside (isorhoifolin) 100 61  4  12 18 
flavanone neohesperidoside (poncirin) 79 100 5 26    
flavanone rutinoside (didymin) 94 100  8  4 11 
3,5,6,8-tetrabromo-1,10-
phenanthroline/Co (-R) (-D) (-A) (-A,-R) (-L) X1 X2 
flavone neohesperidoside (rhoifolin) 100 68  14    
flavone rutinoside (isorhoifolin) 100 36   5 8 14 
flavanone neohesperidoside (poncirin) 100 56 8 20    
flavanone rutinoside (didymin) 100 72  6  11 6 
5-nitro-1,10-phenanthroline/Co (-R) (-D) (-A) (-A,-R) (-L) X1 X2 
flavone neohesperidoside (rhoifolin) 38 100  14    
flavone rutinoside (isorhoifolin) 31 100   8 6 12 
flavanone neohesperidoside (poncirin) 100 100  66    
flavanone rutinoside (didymin) 48 100   10 6 14 
        
(-D) indicates loss of disaccharide moiety, (-R) indicates loss of rhamnose moiety, (-L) 
indicates loss of ligand, (-A) indicates loss of aglycon, and X1 and X2 represent the cross-
ring cleavages of (-74) and (-104), respectively; (+/- 2%). 
 




To further assess the impact of electron-withdrawing groups on the tunability of 
the auxiliary ligands, 5-nitro-1,10-phenanthroline was evaluated because the nitro group 
is known to be one of the most electron-withdrawing groups available.  Abundant 
complexes of the type [M(II) (flavonoid-H) 5-nitro-1,10-phenanthroline]+  were formed 
with the flavonoids, and the resulting CAD spectra also displayed the enhanced 
diagnostic cross-ring cleavages observed with the brominated ligands (Table 4-1).  This 
result further underscores the strategy of adding electron-withdrawing groups to alter the 
dissociation pathways of the targeted complexes. 
4.4.3 Comparison of All Ligands 
Figure 4-6 shows the CAD mass spectra for a series of cobalt/isorhoifolin 
complexes, each containing one of six different auxiliary ligands.  Figure 4-6 illustrates 
comprehensively how the bromination of the auxiliary ligands affects the tunability of the 
CAD patterns.  The CAD mass spectra for the complexes containing either 2,2’-
bipyridine or 1,10-phenanthroline are also shown for comparison. A quick inspection of 
the CAD mass spectra reveals notable differences in the relative abundances of specific 
fragment ions, in addition to the emergence of new diagnostic fragment ions as the 
identity of the auxiliary ligand changes.   
For all of the complexes, the elimination of the rhamnose moiety (-R) and the loss 
of the disaccharide group (-D) is consistently observed, and the relative abundances of 
the two resulting fragment ions vary significantly for the series of CAD spectra.  As the 
degree of bromination increases for the phenanthroline ligands, the ratio of (-R)/(-D) 
increases (Figure 4-6c – 4-6e).  Another notable difference is the increase in the 
abundance of the two cross-ring cleavages X1 (-74, labeled with a square) and X2 (-104, 
labeled with a circle) upon bromination of the auxiliary ligands.  Also noteworthy is the 
increase in the abundance of the fragment ion of 414 Da (Figure 4-6f, labeled with a 
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diamond) for the complex containing 4,4’-dibromo-2,2’-bipyridine, which results from 
the loss of the ligand in conjunction with a cross-ring cleavage of the sugar.  While the 
CAD spectra of complexes containing 2,2’-bipyridine or 1,10-phenanthroline yielded 
some of the same diagnostic fragments, there was an enhancement in the abundance of 
these fragment ions using the brominated ligands.   








































































Figure 4-6. Comparison of the CAD mass spectra of [Co(II) (isorhoifolin-H) L]+ 
complexes containing each brominated ligand, where L is the brominated 
ligand.  A square and a circle are used to represent the cross-ring cleavages 
resulting in losses of 74 and 104 Da, respectively.  A diamond is used to 
represent loss of the ligand in conjunction with a cross-ring cleavage of the 
sugar.  (-D) indicates the loss of disaccharide moiety, (-R) indicates the loss 
of rhamnose moiety, (-L) indicates the loss of ligand, and X indicates a 
cross-ring cleavage of the sugar moiety. 
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  Overall, Figure 4-6 and Table 4-1 clearly demonstrate the tunability of the CAD 
patterns promoted by the use of different auxiliary ligands.  This tunability is related to 
the relative metal binding energies of the auxiliary ligand and flavonoids.  Based on the 
significant differences in fragmentation pathways of pairs of isomeric complexes 
observed earlier in Figure 4-4 and compared to the performance of the other auxiliary 
ligands, 4,4’-dibromo-2,2’-bipyridine was judged to be the best overall auxiliary ligand 
for the differentiation of the series of flavonoids in this chapter. 
4.4.4 Electron-Withdrawing Group Effect 
The results presented in this chapter shows that the tunability of dissociation of 
flavonoid complexes is accomplished by adding electron-withdrawing substituents to the 
auxiliary ligands used to coordinate the transition metal and stabilize the flavonoid 
complexes.  To understand the impact of the electron-withdrawing substituents on the 
stabilities and dissociation pathways of the flavonoid complexes in the gas phase, it is 
instructive to consider the influence of electron-withdrawing substituents on the binding 
energies of pyridyl ligands in solution.  Although extensive solution data is not available, 
numerous binding constants have been measured for pyridyl ligands with Co(II) and 
Fe(II), two representative transition metals, in aqueous solution.  Fe(II) was not a metal 
used in the present ESI-MS study, but the binding constants for Fe(II) complexes were 
compiled because this is the only metal for which brominated ligands have been studied.   
The binding constants for cobalt/pyridyl ligand complexes in solution decrease in 
the order:  5,6-dimethyl-1,10-phenanthroline (log K 7.47) > 5-methyl-1,10-
phenanthroline (log K 7.14) > 1,10-phenanthroline (log K 7.08) > 5-nitrophenanthroline 
(log K 6.3) 43, thus showing the impact of the addition of electron-releasing versus 
electron-withdrawing substituents on 1,10-phenanthroline.  The binding constants for 
Fe(II)/pyridyl complexes decrease in the order:    5,6-dimethyl-1,10-phenanthroline (log 
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K 6.37) > 5-methyl-1,10-phenanthroline (log K 6.00) > 1,10-phenanthroline (log K 5.85) 
> 5-bromo-1,10-phenanthroline (log K 5.65) > 5-nitrophenanthroline (log K 5.06).43  This 
trend indicates that the metal/ligand binding energies decrease as the substituents on the 
ligand become more electron-withdrawing.  A similar inductive effect would be expected 
for the metal/ligand binding energies in the gas phase.  The variations in the metal/ligand 
binding energies may influence the energetics of dissociation pathways and also affect 
the preferred coordination sites of the flavonoid complexes.  The ligand also has an 
impact on the way the disaccharide moiety of the flavonoid interacts with the metal.  As 
mentioned previously, modeling studies have indicated that for the rutinoside isomers, 
the disaccharide folds toward the metal center.47 The addition of bromo substituents 
changes the steric environment of the auxiliary ligands, which may influence the 
conformations of the complexes and thus the degree of interaction of the disaccharide 
group with the metal center.50 
4.5 CONCLUSIONS 
The fragmentation pathways of flavonoids can be tuned by using a metal 
complexation strategy that incorporates auxiliary ligands containing electron withdrawing 
substituents.  Upon collisional activation, the resulting [Co(II) (flavonoid-H) auxiliary 
ligand]+complexes dissociate by pathways that are characteristic of flavone and flavanone 
7-O-diglycosides (i.e. loss of rhamnose and disaccharide groups), in addition to ones that 
allow differentiation of isomers that differ only in the type of intersaccharide linkage.  In 
this chapter, the pathways that distinguish flavone and flavanone disaccharides with 1→2 
and 1→6 linkages have been enhanced by adding electron-withdrawing substituents to 
the auxiliary ligands.  The addition of electron-withdrawing groups to the auxiliary 
ligands reduces their metal-ligand binding affinities and consequently alters the stabilities 
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and conformations of the [M(II) (flavonoid – H) L]+ complexes, thus resulting in the 
enhancement of diagnostic fragmentation pathways. 
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Chapter 5:  Amplification of Infrared Multiphoton Dissociation 
Efficiency in a Quadruple Ion Trap by Using IR-Active Ligands 
5.1 OVERVIEW 
A strategy for increasing the efficiency of infrared multiphoton dissociation 
(IRMPD) in a quadrupole ion trap (QIT) is described in this chapter.  IR-active ligands 
(IRALs) are incorporated into non-covalent complexes of the type [M2+ (analyte) 
IRAL]+, where M is a transition metal such as copper or cobalt and IRAL is an auxiliary 
ligand with an IR-active phosphonate functional group.  The complexes are formed via 
self-assembly in solution directly prior to ESI-MS analysis.  We demonstrate this new 
IRMPD approach for the structural characterization of flavonoids. The fragment ions 
obtained by IRMPD are similar to those obtained by CAD and allow facile isomer 
differentiation of flavonoids.  Fourier transform infrared absorption attenuated total 
reflectance (FTIR-ATR) and energy-variable CAD experiments indicate that the high 
IRMPD efficiencies stem from the very large IR absorptivities of the IR-active ligands. 
5.2 INTRODUCTION 
One of the most powerful techniques for the structural determination of analytes 
is tandem mass spectrometry (MS/MS).1, 2  Trapping instruments such as Fourier 
transform ion cyclotron resonance (FTICR) mass spectrometers and quadrupole ion trap 
(QIT) mass spectrometers are in many ways ideal for multiple stages of  ion isolation, 
activation and mass analysis (MSn) because they allow efficient manipulation of ion 
populations temporally.  The QIT has been the most popular of the trapping instruments 
over the past decade due to its cost, ruggedness and ease of use.  Collisionally activated 
dissociation (CAD) is the most common dissociation technique used with the QIT.  
However, there are shortcomings to conventional CAD that include ion losses due to 
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scattering from collisions and the loss of ions below a low mass cutoff (typically one-
third the parent mass) due to the resonant nature of the excitation in the QIT.3  New 
methods of ion activation for QITs have emerged, including electron transfer 
dissociation,4, 5 thermally assisted CAD,6 pulsed Q dissociation7 and photodissociation,8-
29 that alleviate some of the problems of conventional CAD, and these methods have 
further fueled the popularity of ion trap instruments.   
Infrared multiphoton dissociation (IRMPD) has several advantages as an 
activation method for quadrupole ion traps.8-29  For example, ion losses due to scattering, 
a collision-based phenomenon, are alleviated with photoactivation.  Reduction of ion 
losses is a critical feature when analyzing small ion populations while maintaining 
adequate detection sensitivity. Because photodissociation does not require the use of a 
collision gas, it has also been popular for FTICR applications.30-35  Another phenomenon 
of IRMPD in a QIT stems from the non-resonant nature of IR photoactivation compared 
to conventional resonant CAD, meaning that energy absorption by primary fragment ions 
during the photodissociation period can result in secondary fragmentation.  While these 
additional fragments occasionally complicate spectra, they often provide important 
additional structural information.  Thus IR photoactivation may produce a greater range 
of diagnostic ions than CAD.  Moreover, IR photoactivation is independent of the rf 
voltage used to trap ions, a significant factor in collisional activation in QITs that results 
in a low mass cut-off below which fragment ions can not be trapped and detected.  Thus, 
conventional CAD often leads to loss of information in the low m/z range.  This latter 
shortcoming has largely been overcome by the recently developed pulsed Q dissociation 
method.7  However, one well-recognized drawback to IRMPD methods is that as ions are 
irradiated by the laser, collisional cooling with the He bath gas competes with the 
increase in internal energy due to photoabsorption which ultimately may result in 
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inefficient dissociation.  This drawback has been somewhat compensated for by heating 
the bath gas,6, 18 using CAD-assisted IRMPD,23 using a pulsed gas introduction method,20 
or optimization of the bath gas pressure between the accumulation and dissociation 
timeframes.24  Although improving energy deposition, these methods have often resulted 
in lower sensitivity, mass accuracy and resolution of the QIT.  
To circumvent the problem of low energy deposition due to competition from 
collisional cooling, a new method to enhance IRMPD efficiencies by increasing the IR 
absorptivities of ions via non-covalent addition of strong IR-active ligands (IRAL) via 
metal complexation strategies is presented in this chapter.  In particular, phosphate and 
phosphonate functional groups have outstanding IR absorptivities at 10.6 µm.   In fact, it 
has been shown by our group and others that the IRMPD efficiencies of compounds 
containing phosphate functional groups, such as phosphopeptides and nucleic acids, are 
superior to that of non-phosphorylated compounds.9, 11, 35, 36  This improvement is 
surmised to be due to the efficient absorption of the phosphate groups at the 10.6 µm 
wavelength of the IR laser.35, 36  In this chapter, we improve the efficiency of ion 
dissociation by addition of IR-active phosphonate groups to analytes by using a metal 
complexation strategy, thus avoiding covalent modification of the analytes.  The 
phosphonate functional group was chosen over the phosphate because the latter can result 
in a facile loss of the IR-active group upon activation, thus resulting in few diagnostic 
fragmentation routes.9, 36  The phosphonate groups are actually incorporated into 
chelating ligands that are then non-covalently bound to the analyte of interest via metal 
coordination through a simple self-assembly process in solution prior to ESI-MS analysis.  
The resulting complexes, [M2+ (analyte - H) (phosphonated chelating ligand)]+ have high 
IR absorptivities and thus undergo significant energy deposition and dissociation faster 
than they undergo collisional cooling. The phosphonated ligands synthesized for the 
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study presented in this chapter are shown in Figure 5-1.   We demonstrate this versatile 























Figure 5-1. IR-active ligands based on the 2,2’-bipyridine skeleton synthesized and used 
in this chapter.  Molecular weight is shown in parentheses. 
Flavonoids, phenolic compounds which are known for their antioxidant properties 
and chemopreventive health benefits, have been extensively studied by our group.37-43  
We have considerable experience with the structural characterization and isomer 
differentiation of flavonoids, so they proved to be a convenient group of compounds to 
exploit our IRMPD enhancement approach afforded by the phosphonated chelating 
ligands.  Figure 5-2 shows the structures of the twelve flavonoid diglycosides that were 
used in this chapter. 
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rhoifolin (578) isorhoifolin (578)
neohesperidosides (1→2) rutinosides (1→6)




























































































































































Figure 5-2. Structures of the flavonoid diglycosides used in this chapter.  Molecular 
weight is shown in parentheses. 
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5.3 EXPERIMENTAL 
5.3.1 Chemical Reagents 
The flavonoids rhoifolin, isorhoifolin, neodiosmin, diosmin and narirutin were 
purchased from Indofine (Somerville, NJ, USA).  Fortunellin, linarin, poncirin and 
didymin were purchased from Extrasynthese (Genay, France).  Naringin, neohesperidin, 
hesperidin, CoBr2, CuBr2, 2,2’-bipyridine and 4,4’-dimethyl-2,2’-bipyridine were 
purchased from Sigma (St. Louis, MO, USA).   
5.3.2 Metal Complexation/Mass Spectrometry 
A Finnigan LCQ Deca XP mass spectrometer with an electrospray ionization 
source and interfaced with a Synrad CO2 50 W laser (10.6 µm) was used for the work 
presented in this chapter.  The details of the system were previously described.8  The 
analytes, metal salts and auxiliary ligands were each 10-5 M in methanol, and the 
resulting solutions were analyzed in the positive ion mode.  Typical IRMPD parameters 
included an irradiation time of 10-25 msec at a power of 50 W.  The helium pressure for 
both IRMPD experiments and comparative CAD experiments was nominally 2.4 x 10-5 
Torr (corresponding to approximately 1 mtorr in the QIT) as measured by an ionization 
gauge.  The non-covalent complexes are formed in solution by simple addition of the 
analyte, a transition metal salt, and an auxiliary pyridyl ligand just prior to ESI-MS 
analysis.   
5.3.3 Ligand Syntheses 
Ligands were synthesized from 2,2’-bipyridine and 4,4’-dimethyl-2,2’-bipyridine 
in two major steps involving bromination44-47 followed by phosphonation.46-49  The ligand 
structures were confirmed by proton NMR using a 400 MHz Varian instrument.  FTIR 
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analysis of the ligands was performed using a Thermo Mattson Infinity Gold FTIR 
equipped with a Spectra-Tech Thermal ARK module, an ATR accessory.   
5.4 RESULTS AND DISCUSSION 
We have employed the use of auxiliary chelating ligands and metal complexation 
strategies in the past to increase ionization efficiencies and improve the diagnostic CAD 
patterns of analytes, such as flavonoids.37-43  For example, by the  addition of a suitable 
metal and an auxiliary ligand to a flavonoid solution, complexes of the type [M2+ 
(flavonoid - H) L]+ are formed, where M is a transition metal such as copper(II) or 
cobalt(II) and L is an auxiliary ligand such as 2,2’bipyridine.  The ease of forming these 
robust non-covalent complexes made them a natural choice for use in IRMPD 
applications by incorporation of phosphonate groups into the auxiliary ligand.  The two 
ligands shown in Figure 5-1 incorporate the phosphonate groups remote from the 
chelating nitrogen atoms to prevent impairment of metal coordination.  The phosphonate 
groups in IRAL-2 are separated from the 2,2’-bipyridine skeleton by methylene units in 
order to allow evaluation of whether the connectivity of the IR-active groups has an 
impact on absorption.  ESI of the solutions containing a flavonoid, a copper or cobalt salt, 
and an IRAL result in dominant formation of [M2+ + (flavonoid – H) + IRAL]+ 
complexes with ion abundances that exceed those of protonated flavonoids by two orders 
of magnitude and deprotonated flavonoids by up to one order of magnitude.  In this 
chapter, we have exploited this system to increase the IRMPD efficiency in a QIT at 
normal operating pressures.   
5.4.1 Comparison of CAD Spectra 
CAD mass spectra of the metal/flavonoid complexes incorporating 2,2’-
bipyridine, a standard chelating ligand, and the two new IRALs were acquired as 
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benchmarks.  Both copper and cobalt were employed as metals.  The CAD mass spectra 
for neodiosmin are shown in Figure 5-3 as representative data.   
 

















































































Figure 5-3. CAD spectra of deprotonated neodiosmin and the metal complexes as 
benchmark data:  A) (neodiosmin – H)-,  B) [Cu2+ (neodiosmin – H) 2,2’-
bipyridine]+, C) [Co2+ (neodiosmin – H) 2,2’-bipyridine]+,  D) [Cu2+ 
(neodiosmin – H) IRAL-1]+,  E) [Co2+ (neodiosmin – H) IRAL-1]+, F) [Cu2+ 
(neodiosmin – H) IRAL-2]+, and G) [Co2+ (neodiosmin – H) IRAL-2]+ .  
The loss of ethylene is indicated by (-E), the loss of rhamnose moiety is 
indicated by (-R), the loss of disaccharide moiety is indicated by (-D), the 
loss of aglycon moiety is indicated by (-A) and the loss of flavonoid moiety 
is indicated by (-F). 
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In the negative ion mode (Figure 5-3a) and with Cu/2,2’-bipyridine complexation 
(Figure 5-3b), the only fragmentation routes include loss of the disaccharide moiety (-D), 
which may occur in conjunction with a loss of methyl radical (-D, -CH3). The [Co2+ 
(neodiosmin-H) 2,2’-bipyridine]+ complex undergoes the additional diagnostic loss of the 
terminal rhamnose group (-R) which may occur in conjunction with the loss of the 
aglycon group (-A,-R), (Figure 5-3c).   In the previous two chapters,37, 41 it was shown 
that the cobalt complexes typically afford more diagnostic fragment ions than the 
corresponding copper complexes.  
Similar types of fragment ions were observed upon CAD of the neodiosmin 
complexes containing the IR-active ligands.  The spectrum for the Cu/IRAL-1 complex 
(Figure 5-3d) reveals the same fragment ions as obtained for the analogous Cu/2,2’-
bipyridine complex (Figure 5-3b), along with of losses of ethylene from the ligand.  CAD 
of the Co/IRAL-1 complex (Figure 5-3e) likewise results in similar fragment ions as the 
corresponding Co/2,2’-bipyridine complex described above.  Interestingly, for the 
Co/IRAL-1 complex, there are no losses of ethylene in conjunction with the loss of the 
rhamnose moiety or the aglycon/rhamnose moieties.  Figures 5-3f and 5-3g show the data 
for the Cu/IRAL-2 and Co/IRAL-2 complexes.  The only notable difference between 
these CAD spectra and those of the corresponding IRAL-1 complexes is the new loss of 
flavonoid moiety (-F) observed for the former.  The emergence of this new fragmentation 
pathway suggests that the metal/ligand binding interactions in the IRAL-2 complexes are 
somewhat stronger than those in the IRAL-1 or 2,2’-bipyridine complexes.  The CAD 
data confirms that the flavonoid/metal/IRAL complexes give structurally diagnostic 
information for identifying the flavonoids and the fragmentation pathways are not 
significantly different between the ligand complexes. 
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5.4.2 Comparison of IRMPD Spectra of the Copper Complexes 
Next IRMPD was used to evaluate the fragmentation patterns of the same 
flavonoid complexes.  Figure 5-4 shows a striking comparison of the dissociation 
efficiencies of the neodiosmin complexes containing the standard chelating ligand, 2,2’-
bipyridine, (Figure 5-4a and 5-4b) versus those containing the new ligands, IRAL-1 or 
IRAL-2,  (Figure 5-4c and 5-4d) upon IR irradiation.  For the spectra shown in Figures 5-
4a, 5-4c and 5-4d, the isolated complexes were irradiated for 25 ms at 50 W power.  Only 
the complexes containing the two IRALs underwent extensive dissociation, while the 
analogous complex containing 2,2-bipyridine did not dissociate at all.  In fact, even when 
the latter complex was irradiated for 2.5 s, there was still no evidence of any dissociation 
(Figure 5-4b).  The lack of dissociation for the complexes containing 2,2’-bipyridine is 
attributed to rapid collisional cooling that occurs at 1 mtorr in the ion trap, in addition to 
the potential for efficient radiative relaxation that may occur for the flavonoids.  The 
addition of the phosphonate groups to the ligands apparently increases their IR 
absorptivities by a tremendous amount, thus allowing efficient cumulative energy 
deposition above and beyond the collisional cooling and radiative relaxation that occurs.  
Comparison of the IRMPD mass spectra in Figures 5-4c and 5-4d reveals greater 
abundances of ions in the mid m/z range (i.e. m/z 600 to 800) for the complexes 
containing IRAL-1 and greater abundances of ions in the lower m/z range (i.e. m/z 300 to 
520) for the complexes containing IRAL-2.  Since the types of fragmentation pathways 
are the same for both of these IRAL complexes, the shift in the fragment ion distributions 
suggests that there is more extensive secondary dissociation for the IRAL-2 complexes 
(i.e. the mid m/z fragment ions undergo IR absorption and subsequently dissociate to 
form the lower m/z fragment ions), a process which implies a greater IR absorption 
efficiency for IRAL-2.   
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Figure 5-4. Irradiation of the [Cu2+ (neodiosmin-H) auxiliary ligand]+ complexes 
containing different ligands.  A) [Cu2+ (neodiosmin – H) 2,2-bipy]+, 50 W 
for 25 ms,  B) [Cu2+ (neodiosmin – H) 2,2-bipy]+, 50 W for 2500 ms, C) 
[Cu2+ (neodiosmin – H) IRAL-1]+, 50 W for 25 ms, and D) [Cu2+ 
(neodiosmin – H) IRAL-2]+,  50 W for 25 ms.   
For both of the complexes containing the two IRALs, the dominant IRMPD 
pathway is the loss of the disaccharide moiety, which may occur in conjunction with 
ethylene losses.  This behavior is analogous to the general fragmentation patterns of the 
complexes obtained upon CAD (Figures 5-3d and 5-3f) and suggests that the IR 
activation process is similar to that of collisional activation.   
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The relative dissociation energies and efficiencies of these complexes were 
further evaluated by using energy-variable CAD.  Energy-variable CAD entails 
monitoring the extent of dissociation of selected ions as a function of internal energy 
deposition, a factor largely controlled by the magnitude of the resonant CAD voltage 
applied to the QIT.  For these experiments, the normalized CAD voltage (% of 5 Vo-p) 
was increased in 1% increments, and the relative abundances of the parent and product 
ions were recorded for the Cu/2,2’-bipyridine and Cu/IRAL-1 complexes to compare the 
dissociation behaviors in terms of the magnitude of CAD voltage needed to initiate 
dissociation or attain some arbitrary extent of dissociation (such as 50%).  Since IRAL-1 
has a greater number of atoms (and thus more vibrational modes) as compared to 2,2’-
bipyridine, a correction for the degrees of freedom was incorporated into the 
measurements.  Because compounds that have a greater number of atoms have more 
degrees of freedom (DOF) for energy distribution, more energy is consequently required 
to break a bond in a larger molecule than an equivalent bond in a smaller molecule.50  
This correction was made using the following formula: 
 ECAD, corrected = ECAD * Nref/Ncomplex  
where N = 3n – 6 and n is the number of atoms in the complex. 
This equation is based on the assumption that there is a linear relationship 
between the collision energy and DOF.  While the exact correlation between the 
excitation voltage and the internal energy of ions is not well described, it has been shown 
that they are correlated.51, 52 
Figure 5-5 shows a plot of the percentage fragmentation of the complexes 
observed as a function of the corrected CAD voltages for the [Cu2+ + (neodisomin – H) 
2,2-bpy]+ and  [Cu2+ + (neodisomin – H) IRAL-1]+  complexes.  Since the curves nearly 
overlay each other, it indicates that the complexes have very similar CAD dissociation 
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energies and efficiencies.  At 50% dissociation, the difference between the corrected 
CAD voltages for the 2,2’-bipyridine and IRAL-1 complexes are <0.05 V (1.08 V for 
2,2’-bipyridine complex and 1.04 V for the IRAL-1 complex).  Therefore it is surmised 
that the increase in fragmentation efficiencies of the IRAL-1 (and IRAL-2) complexes 
upon IRMPD is directly related to their greater IR absorptivities, not due to lower 
intrinsic dissociation energies.  
[Cu2+ (neodiosmin – H) 2,2’-bipy]+






















Figure 5-5. Energy-variable CAD of the [Cu2+ (neodiosmin-H) auxiliary ligand]+ 
complexes containing 2,2’-bipyridine or IRAL-1.   
The absorption of IR radiation by the three auxiliary ligands was further 
investigated by using attenuated total reflectance (ATR) Fourier transform infrared 
(FTIR) spectroscopy.  The resulting spectra are shown in Figure 5-6.  The absorption in 
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the wavelength range of the IR laser centered at 10.6 µm increases in the order IRAL-2 > 
IRAL-1 >>> 2,2’-bipyridine, consistent with the IRMPD efficiencies noted in Figure 5-4.  
This result for the IR-active ligands is consistent with the FTIR data obtained by Flora 
and Muddiman for phosphopeptides36 which showed an increase in the IR absorption at 
10.6 µm with an increase in the degree of phosphorylation of the peptides.  In addition, 
since both IRAL-1 and IRAL-2 have the same overall degree of phosphonation, the FTIR 
spectra confirm that the IR absorptivity increases when the phosphonate group is not 
directly attached to the aromatic ring.  The FTIR results support the reason for the 
excellent IRMPD characteristics of the flavonoid complexes containing the IRALs.   


















Figure 5-6. FTIR ATR spectra of the ligands used in this chapter, showing the enhanced 
absorption of the IR-active ligands, IRAL-1 and IRAL-2,  at 10.6 µm as 
compared to 2,2’-bipyridine. 
5.4.3 Comparison of IRMPD Spectra of the Cobalt Complexes 
The IRMPD spectra of the cobalt/IRAL complexes with the flavonoids in Figure 
5-2 were also acquired for neodiosmin and the other flavonoids.  The major 
fragmentation routes include loss of the disaccharide group, the loss of the rhamnose 
moiety, and loss of ethylene units, consistent with losses observed in previous CAD 
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spectra.  For the IRAL-2 complexes, some new fragment ions that emerge in the m/z 
range of 350 – 520 are ones in which the flavonoid has been lost.  A comparison of the IR 
irradiation time needed to cause 90-95% dissociation of the parent complexes was 
undertaken for each metal/neodiosmin/IRAL complex in order to obtain a relative 
comparison of the dissociation efficiencies as  a function of the metal ion (Cu or Co) and 
auxiliary ligand (IRAL-1 or IRAL-2). For the IRAL-2 complexes containing either Cu or 
Co, the irradiation times needed to promote 90-95% dissociation of the complexes were 
15 ms.  For the corresponding IRAL-1 complexes, the irradiation times were 25 to 50 ms, 
thus again reflecting the higher IR absorption efficiencies of the IRAL-2 complexes.  The 
IRMPD spectra for eight other flavonoids (shown in Figure 5-2) were also obtained.  The 
same types of fragment ions summarized above (loss of disaccharide group, loss of 
rhamnose moiety, loss of aglycon group) were also observed for these complexes 
containing the IRALs. 
To further evaluate the ability of the complexes containing the IRALs to undergo 
sequential dissociation upon IR irradiation, the fragmentation patterns of the neodiosmin 
complexes ([Co+ (neodisomin – H) IRAL-1]+) were obtained as the IR irradiation period 
was increased (Figure 5-7).   As the irradiation time was increased, the mid m/z ions (m/z 
750 - 950 decreased in abundance while the lower m/z ions (m/z 350 - 750) increased in 
abundance.  This result supports a sequential fragmentation process due to efficient IR 
absorption by the mid m/z fragment ions, thus resulting in secondary dissociation to form 
the lower m/z fragment ions.  The ability to vary the irradiation time provides an easy 
way to tune the fragmentation patterns and obtain MSn information at longer irradiation 
times.   
Figure 5-8 shows a comparison of the IRMPD spectra acquired for complexes 
containing two flavanone isomers (naringin versus narirutin) with cobalt and the two 
 106
different IR-active ligands.  The irradiation time was adjusted to promote 90-95% 
dissociation of the selected complexes.  The dominant fragmentation pathways are ones 
that are diagnostic for the structures of flavanones, including loss of the rhamnose group, 




















Irradiation Time (ms)  
[Co2+ (neodiosmin – H) IRAL-1]+
mid m/z fragment ions
low m/z fragment ions  
Figure 5-7. Time-resolved plot of the irradiation of the [Co2+ (neodiosmin-H) IRAL-1]+ 
complexes as a function of irradiation time. 
  The irradiation times needed to obtain the IRMPD spectra for these two 
flavanone complexes (narirutin and naringen) are lower than those needed for the flavone 
(neodiosmin and diosmin) IRAL-1 complexes, and the irradiation time needed for 
efficient dissociation of the naringin complexes is substantially lower than that needed for 
the narirutin complexes.  These variations in irradiation time may be in part related to the 
IR radiative relaxation rates of the various complexes, in addition to changes in the 

























































Figure 5-8. IRMPD spectra of the cobalt/flavanone complexes containing either IRAL-1 
or IRAL-2.  A) [Co2+ (naringin – H) IRAL-1]+, 50 W for 12 ms,  B) [Co2+ 
(narirutin – H) IRAL-1]+,  50 W for 25 ms,   C) [Co2+ (naringin – H) IRAL-
2]+,  50 W for 10 ms,  and D) [Co2+ (narirutin – H) IRAL-2]+, 50 W for 25 
ms.   
In general, IRMPD of the cobalt complexes is more successful for differentiation 
of isomers, such as those shown in Figure 5-2, than the copper complexes.  A diagnostic 
ion due to the loss of the aglycon and rhamnose moieties can be used for differentiation 
of the neohesperidosides versus rutinosides, as demonstrated in Figure 5-8 for complexes 
containing either IRAL-1 or IRAL-2 ligand.   
5.5 CONCLUSIONS 
The IRMPD efficiency in a QIT has been substantially improved by use of a 
metal complexation strategy that incorporates an IR-active ligand, in this case containing 
two phosphonate groups.   Complexes of the type [M2+ (flavonoid-H) IRAL]+ were 
formed, where M was a transition metal such as copper or cobalt and IRAL is a  
phosphonated bipyridine ligand.  The flavonoids undergo substantial and informative 
dissociation indicating that the IR energy is efficiently transferred throughout the entire 
non-covalent complex.  The complexes containing the IR-active ligands dissociated with 
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high efficiencies upon irradiation times of ~15 msec, whereas complexes without IR-
active ligands did not dissociate even when irradiated for 2.5 sec.  This strategy, which 
does not involve covalent modification of the analyte but only entails self-assembly of 
the complexes in solution directly prior to ESI-MS analysis, should be generally 
applicable to many other classes of compounds, thus greatly increasing the versatility of 
IRMPD methods in quadrupole ion traps. 
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Chapter 6:  Sequencing and Characterization of Oligosaccharides Using 
Infrared Multiphoton Dissociation and Boronic Acid Derivatization in a 
Quadrupole Ion Trap 
6.1 OVERVIEW  
A simplified method for determining the sequence and branching of 
oligosaccharides using infrared multiphoton dissociation (IRMPD) in a quadrupole ion 
trap (QIT) is described in this chapter.  An IR-active boronic acid (IRABA) reagent is 
used to derivatize the oligosaccharides prior to IRMPD analysis.  The IRABA ligand is 
designed to both enhance the efficiency of the derivatization reaction and to facilitate the 
photon absorption process.  The resulting IRMPD spectra display oligosaccharide 
fragments that are formed from primarily one type of diagnostic cleavage, thus making 
sequencing straightforward.  The presence of sequential fragment ions, a phenomenon of 
IRMPD, permit the comprehensive sequencing of the oligosaccharides studied in a single 
stage of activation.  We demonstrate this approach for two series of oligosaccharides, the 
lacto-N-fucopentaoses (LNFPs) and the lacto-N-difucohexaoses (LNDFHs).  
6.2 INTRODUCTION 
Oligosaccharides are in many ways more structurally complex than other 
biologically important molecules such as proteins and nucleic acids in that they are often 
highly branched and have several different linkage types between their fundamental 
monosaccharide units.  Even excluding stereochemistry, a glycosidic bond between two 
hexoses can be formed at any of five positions.  This results in a great number of 
structural possibilities that make characterization of oligosaccharides a challenging but 
vital task because they have important roles in numerous biological processes.  
Oligosaccharides are known to play roles in cell-cell signaling, cellular differentiation, 
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regulation of biochemical pathways, viral replication, parasitic infection, immune 
response and inflammation.1-7  More than half of mammalian proteins are glycosylated,1 
and the functions attributed to the oligosaccharides are broadly grouped as 
structural/modulatory and specific recognition by receptors.8  For example, some 
oligosaccharides are involved in cell wall formation and have protective and stabilizing 
roles while others are very specific receptors for bacteria and viruses.  In addition, the 
alteration of oligosaccharide expression has been associated with disease progression, 
suggesting that oligosaccharides may be used as biomarkers.9  For instance, malignancy 
has been correlated with changes in the glycosylation process, and some cell surface 
oligosaccharides are linked with prognosis in human cancers.10, 11  To fully understand 
the roles of glycosylation in these biological processes, it is critical to develop sensitive 
methods of characterization. 
Mass spectrometry (MS) has become an invaluable tool for the structural 
determination of oligosaccharides mainly due to the minimal sample consumption and 
specificity of the information obtained.  Matrix assisted laser desorption ionization 
(MALDI) time-of-flight (TOF) MS has been used for the analysis of native, metal 
adducted and derivatized oligosaccharides.12-15  Structural isomers have been 
differentiated successfully by comparing the intensities of post source decay (PSD) 
fragment ions.  While MALDI-TOFMS has provided some detailed information about 
isomers, more detailed structural analysis is generally performed by using tandem mass 
spectrometry.   
Trapping instruments such as the quadrupole ion trap (QIT) and Fourier transform 
ion cyclotron resonance (FTICR) mass spectrometers have also been used for the analysis 
of oligosaccharides because of the ability to undertake MSn experiments which is often 
required to fully map the branching patterns and sequences of oligosaccharides.  
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Collisionally activated dissociation (CAD) of oligosaccharides primarily leads to 
fragment ions due to B-/Y- and C-/Z-type cleavages.15-25  The number of cleavages in the 
first stage of activation is often limited, and thus frequently it requires several stages of 
activation to obtain partial sequence information, particularly for larger oligosaccharides.  
In addition, CAD often leads to cleavages from both the reducing and non-reducing ends 
of oligosaccharides in addition to internal losses, thus complicating spectral 
interpretation.  To provide more extensive structural information and alleviate the need 
for elaborate MSn strategies, other activation methods have also been applied to 
glycopeptides and oligosaccharides in trapping instruments.  For example, Adamson et 
al. used  electron capture dissociation (ECD) in an FTICR to promote cross-ring over 
glycosidic cleavages and increase the amount of linkage information obtained.26  Wolff et 
al. used electron detachment dissociation (EDD) to promote cross-ring cleavages and 
identify sites of sulfation in glycosaminooligosaccharide tetrasaccharides.27  Most 
recently, Devakumar et al. 157-nm UV light to photofragment glycans in an ion trap.  
Extensive high energy cross-ring cleavages were observed that provided branching 
information.28 
Infrared multiphoton dissociation (IRMPD) is another alternative activation 
method that has generated substantial recent interest.  Several studies have explored the 
use of IRMPD in an FTICR mass spectrometer for the analysis of oligosaccharides.16, 29-33  
For example, Lancaster et al. compared the IRMPD spectra of O-linked and N-linked 
type oligosaccharides and found that cross-ring cleavages were observed only for the N-
type oligosaccharides that are not readily fragmented by using CAD.16  Goldberg et al. 
used IRMPD in an FTICR instrument and developed a strategy using a computer 
algorithm to determine oligosaccharide sequence.   While the spectra were informative, 
poor signal-to-noise ratios often made spectral interpretation difficult.  Fukui et al. used 
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wavelength-tunable IRMPD in an FTICR mass spectrometer to determine the optimal 
dissociation wavelengths for sodium-cationized oligosaccharides.   While this technique 
is powerful, these types of lasers are not readily available.  Zhang et al. used IRMPD in 
an FTICR instrument on oligosaccharide alditols and discovered specific fragments 
corresponding to structural motifs that revealed sequence and linkage information.   
IRMPD has also been implemented in quadrupole ion traps for the analysis of 
flavonoids, antibiotics, peptides, and oligonucleotides34-44 and affords a promising 
alternative to CAD for the characterization of oligosaccharides as described in this 
chapter.  The IRMPD process is independent of the rf trapping voltage, meaning that 
storage and detection of ions over a wide m/z range is possible, including very low m/z 
fragment ions at the same time as high m/z precursors.   Since IRMPD is not a collision-
based method, there are fewer ion losses due to scattering.  This reduction of ion losses is 
a critical feature when ion populations are low, which is often the case for 
oligosaccharides.  Another potential advantage of IRMPD involves the ease of 
controlling photon flux to enhance or limit sequential fragmentation processes.  Since 
IRMPD is not a resonant process, energy absorption by primary fragment ions during the 
activation period may result in secondary fragmentation, and the extent can be varied by 
adjusting the activation time or laser power.  The secondary fragments often provide 
important structural information without the need for more elaborate MSn strategies.  One 
drawback to IRMPD in a quadrupole ion trap stems from the relative slow rate of energy 
accumulation (only ~ 0.1 eV per photon) that allows competition from collisional cooling 
due to the helium bath gas.  In addition to other recent methods designed to overcome 
this drawback, such as thermally assisted IRMPD and collision-activated IRMPD,45-49 a 
method that incorporates chromophores that absorb IR radiation very efficiently into 
analytes of interest was developed.  For example, the use of IR-active ligands (IRALs) 
 116
for the enhancement of IRMPD efficiency of flavonoids in a quadrupole ion trap was 
described in Chapter 5.34  In this previous chapter, IR-active phosphonate groups were 
attached to chelating ligands that were then noncovalently bound to the analytes of 
interest via metal coordination through a self-assembly process.  The resulting complexes 
underwent highly efficient IRMPD.  Companion FTIR and energy-variable CAD results 
confirmed that the chromogenic ligands were effective because of the high IR 
absorptivities of the phosphonate groups, thus providing strong IR chromophores for 
rapid energy accumulation.  The use of a phosphonate-based IR chromophore is also 
exploited in this chapter.  
While it has become common practice to form chromophore-labeled carbohydrate 
derivatives for UV and fluorescence detection following chromatographic separation, 
various chemical derivatization strategies of oligosaccharides have also been used in 
conjunction with mass spectrometry to increase ionization sensitivity, as well as yield 
more informative fragmentation patterns that reveal linkage and anomeric 
configuration.52-58  Some of the derivatization techniques used for ESI-MS analysis of 
carbohydrates include permethylation for linkage information,50, 51 reductive amination 
for attachment of chromophores for HPLC detection,52 p-aminobenzoic ethyl ester 
derivatization via formation of a glycosylamine for determination of linkage and 
branching information,53 and  modification of cis-diol groups of disaccharides with 
boronic acids for stereochemical determination.54, 55 Most recently, phenylboronic acid 
was used as a reagent ion for the analysis of biologically active diol compounds by 




LNFP-I     Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glc
LNFP-II     Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glc
LNFP-III     Galβ1-3(Fucα1-3)GlcNAcβ1-3Galβ1-4Glc
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Figure 6-1. Chemical and cartoon structures of the oligosaccharides used in this chapter. 
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In the work presented in this chapter, we develop a method for the 
characterization of oligosaccharides in a quadrupole ion trap using IRMPD to attain 
complete sequencing and branching information.  In contrast to other recent methods 
developed to promote cross-ring cleavages to enhance linkage information, the goal of 
the study in this chapter was to simplify and limit the spectra to glycosidic cleavages for 
comprehensive and straightforward sequencing.  The sequence and branching positions 
of two series of isomeric oligosaccharides were determined (Figure 6-1).   
The first series, the lacto-N-fucopentaoses (LNFPs), all have the same backbone 
sequence but differ either in the connectivity of fucose (Fuc) or the linkage of their 
terminal Gal and Fuc moieties.  The second series, the lacto-N-difucohexaoses 
(LNDFHs), also have the same backbone structure but have two Fuc residues and differ 
either in the connectivity or linkage of one of the Fuc residues.  These series were natural 
choices for method development since they have been characterized by different mass 
spectrometric techniques previously.12, 19-21, 23, 33, 57  For example, MALDI-MS methods 
have been developed that differentiate some of the LNFP isomers based on ions due to 
internal losses and others that reveal the interglycosidic linkage.12, 33, 57  While several of 
these fragment ions facilitate isomer differentiation, they often do not provide complete 
sequence information and may complicate spectral interpretation of unknown 
oligosaccharides since they are a product of cleavage from both the reducing and non-
reducing ends coupled with internal and unidentified fragments.   Several methods using 
ESI-MS for characterization of the LNFPs and LNDFHs have also been reported.  For 
example, Konig and Leary used metal ion coordination to alter the fragmentation 
pathways of the LNFPs; however, the study was focused on specific linkage 
determination and not sequencing.23  Chai and Lawson used ESI-MS in conjunction with 
a Q-TOF mass spectrometer and identified specific “D-type” fragments that differentiated 
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the LNFPs and LNDFHs.21  These fragments and several other lower mass fragments are 
only observed upon several stages of CAD (MSn) in the QIT.19-21  Pfenninger and Karas 
developed an elaborate and comprehensive method for the isomer differentiation of 
oligosaccharides19-21 that also provides linkage information, although the resulting spectra 
are complicated by several different types of fragment ions.   
In this chapter, a simplified method for the sequencing of oligosaccharides in a 
single stage of activation by exploiting the supplementary information obtained from 
sequential fragmentation that is promoted by non-resonance IRMPD is described.  
Additionally, our method is further extended to an oligosaccharide with two acidic sialic 
acid moieties. To increase the IR absorption efficiency of the oligosaccharides, a 
phosphonate group was incorporated into a boronic acid that was used as a derivatizing 
reagent.  The IR-active boronic acid (IRABA) was designed so that a nitrogen atom was 
adjacent to the boron atom to enhance the reactivity of the boronic acid functionality to 
the oligosaccharides.58  When the IRABA is added to a solution containing an 
oligosaccharide of interest, the chemical reaction between the IRABA and diol 
functionalities of the oligosaccharide is responsible for the covalent addition of the IR-
active phosphonate group.  The modified analytes proved to be ideal for characterization 
and differentiation using IRMPD.  The LNFP and LNDFH series provide a considerable 
challenge for differentiation and thus allow a convenient means of assessing the 
analytical merits of the new IRMPD method. 
6.3 EXPERIMENTAL 
6.3.1 Chemical Reagents 
LNFP-I, II, III, V, LNDFH Ia and II and DSLNT were purchased from V-Labs 
(Covington, LA).  LNDFH-Ib was purchased from Sigma (St. Louis, MO).  
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Diethyl(aminomethyl)phosphonate oxalate was purchased from Acros (Belgium).  2-
formylphenylboronic acid, methanol and methylene chloride were purchased from Fisher 
(Somerville, NJ).  All chemicals were used without further purification. 
6.3.2 Derivatization 
Stock solutions of the oligosaccharides (500 µM) and the IRABA (mM) were 
mixed to form a 1:10 molar ratio and a 5 µL aliquot of 0.5% TEA was added to achieve a  
pH ~9.  The reaction is reversible and a lower pH would result in a competition of 
hydrolysis of the new bonds formed.  The solutions were then sonicated for 1 min and 
diluted with 0.1% TEA to pH ~8 and spiked with ammonium acetate (to 0.01%) to 
eliminate the domination of derivatized sodium adducts.  The final solution had an 
oligosaccharide concentration of 10 µM.   
6.3.3 Mass Spectrometry 
A Finnigan LCQ Deca XP mass spectrometer equipped with an electrospray 
ionization source and interfaced with a Synrad CO2 50 W laser (10.6 µm) was used for 
the work presented in this chapter.  The details of the system were previously described.35  
The solutions analyzed were 10 µM in oligosaccharide.  Typical IRMPD parameters 
included an irradiation time of 5 - 25 msec at a power of 50 W.  The helium pressure for 
IRMPD experiments of the derivatized oligosaccharides and comparative CAD 
experiments was nominally 2.8 x 10-5 Torr (corresponding to approximately 1 mtorr 
normally used in the quadrupole ion trap) as measured by an ionization gauge.  For the 
underivatized oligosaccharides (i.e. without IR chromophores), the helium pressure was 
lowered to nominally 2.7 x 10-5 Torr to promote the IRMPD process. 
Throughout this chapter, the laser power was 50W and the irradiation time was 
adjusted to tune sequential fragmentation such that the most complete structural 
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information was obtained.  At prolonged irradiation times sequential fragmentation was 
extensive and higher mass fragments were not observed.  
6.3.4 Synthesis OF IRABA 
The procedure used was a modification of the synthesis described by Zhu and 
Anslyn.59 3.9 mmol 2-formylphenylboronic acid (mM) was dissolved in anhydrous 
CH3OH under argon protection.  16 mmol (4X) Hunig’s base was added followed by 3.9 
mmol diethyl(aminomethyl)phosphonate oxalate and the solution was stirred for 16 hours 
before 2.9 mmol NaBH4 was added slowly.  The solution was stirred at rt for 1 hour, 
followed by addition of another batch of NaBH4.  One hr later, the solvent was removed 
under vacuum and the residue was diluted with CH2Cl2.  The white ppt was removed with 
vacuum filtration, with the filtrate subsequently concentrated.  The residue was purified 
by flash chromatography on neutral alumina (2-5% NH3-saturated CH3OH in CH2Cl2).   
1H NMR (400 MHz, CD3OD) δ 1.39 (t, J=7.04, 6H, CH3) δ 3.23 (d, J=11.6, 2H CH’s) δ 
4.17 (s, 2H CH’s) δ 4.20-4.26 (m, 4H CH’s) δ 7.15-7.43 (m, 4H CH’s).  13C 
NMR(CD3OD): = 16.8, 42.2, 43.4, 56.2, 64.4, 124.1, 127.9, 128.7, 131.4, 142.9.  HRMS:  
calcd. (M + Na)+ 324.1148, found 324.1135. 
6.4 RESULTS AND DISCUSSION 
The goal in this chapter was to develop a method for sequencing the backbone of 
the LNFPs and to pinpoint the sites of attachment of the fucose moieties.  To allow the 
comprehensive evaluation of the new IRABA derivatization/IRMPD strategy for the 
characterization of oligosaccharides, companion CAD and IRMPD studies of the 
underivatized oligosaccharides were undertaken to provide benchmark comparisons.  
These studies are briefly described in the first section prior to presentation of the results 
for the IRABA-derivatized oligosaccharides.  
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6.4.1 LNFP Oligosaccharides 
The LNFP oligosaccharides used in this chapter (Figure 6-1) differ only in the 
branching position of the fucose moiety (LNFP I vs. II and III vs. V) or have the same 
position but differ only in the linkage (LNFP II vs. III).  The oligosaccharides are 
characterized using the residue masses for the monosaccharide units that are listed in 
Table 6-1 and are further described using the nomenclature of Domon and Costello 60.  
Since the structures of the oligosaccharides used in this chapter are known, it was 
possible to also include specific hexose identification upon analysis.  In the case of an 
unknown, less specific identifications (unknown identifications such as Hex instead of 
Gal) would be determined.  The abbreviations, residue masses and unknown 
identifications used are provided in Table 6-1.   






Fucose Fuc Fuc 146 
Galactose Gal Hex 162 
Glucose Glc Hex 162 
N-acetyl-
glucosamine GlcNAc HexNAc 203 
Hexose Hex Hex 162 
N-acetyl-
hexosamine HexNAc HexNAc 203 
Sialic acid Sia Sia 219 
6.4.1.1  CAD and IRMPD of Deprotonated Oligosaccharides 
The CAD mass spectra of the four deprotonated oligosaccharides, ([L - H]-), are 
shown in Figure 6-2, a-d, and the data is tabulated in Table 6-2.  Losses of the residue 
masses are labeled with the corresponding residues (e.g., loss does not include the 
intersaccharide oxygen atom).  Losses that include the intersaccharide oxygen atom are 
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labeled with the monosaccharide identity and an asterisk.  The types of fragments 
observed in the CAD and IRMPD spectra (shown in Figure 6-2, e-h, and briefly 
described below) are consistent with those previously reported, although the IRMPD 
spectra exhibit several additional sequential fragment ions.  The spectra include mainly 
Z- or C- and B- or Y-type cleavage.  The detailed fragmentation pathways of the 
deprotonated LNFPs have been described previously 19-21.  The CAD spectra do not 
display as many fragment ions as were observed in the previous studies (Figure 6-2); 
however the IRMPD spectra (described below) display even more.  In several cases there 
is limited information in the first stage of fragmentation and further analysis of these 
oligosaccharides using multiple sequential stages of tandem mass spectrometry is not 
generally viable since ion populations are too low.    
The IRMPD mass spectra of the underivatized oligosaccharides were acquired to 
exploit the benefits of sequential fragmentation that often occur when using this non-
resonant activation method.  Sequential fragmentation was evident for the 
oligosaccharides because increases in the laser irradiation time resulted in an increase in 
the abundance of lower mass fragments coupled with a decrease in the abundance of 
higher mass fragments.  For these experiments, a slightly reduced helium pressure was 
necessary to enhance energy accumulation at the expense of trapping efficiency (less 
effective collisional cooling of ions).  The irradiation time was adjusted to optimize the 
number of informative fragment ions, and the resulting spectra are shown in Figure 6-2, 
e-h.  The data is tabulated in Table 6-2.   
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Figure 6-2. CAD and IRMPD spectra of the deprotonated oligosaccharides used in the 
chapter.  CAD:  a) [LNFPI-H]-, b) [LNFPII-H]-, c) [LNFPIII-H]-, d) 




Table 6-2. Underivatized LNFP Oligosaccharide Fragment Ion Abundances 
(M - H)- CAD C4a, C3b,c Z1β C3α C2 C3β/C2 Z3α 
LNFP-I 91 - - - - - 
LNFP-II 89 - - - - - 
LNFP-III 89 - - - - - 
LNFP-V - 24 71 - - - 
(M - H)- IRMPD C4a, C3b,c Z1β C3α C2 C3β/C2 Z3α 
LNFP-I 48 - - - - - 
LNFP-II 28 - - 2 2 32 
LNFP-III 29 - - 2 35 - 
LNFP-V - 11 49 - - - 






Y3β/B2, B2 X22,3 X32,4 
LNFP-I 83 6 3 - - - 
LNFP-II 68 14 7 - - - 
LNFP-III 68 14 5 - - - 
LNFP-V 83  3 - - - 




Y3β/B3b,c, B3d Y2/B4 X22,3 X32,4 
LNFP-I 35 - 2 - 13 11 
LNFP-II 40 - 4 12 - - 
LNFP-III 34 - 4 20 - - 
LNFP-V 49 - 2 2 - - 
       
* as a percentage of total sequence and parent ion abundances, +/- 5%   
aLNFP-I       
bLNFP-II       
cLNFP-III       
dLNFP-V       
 
Inspection of the IRMPD spectra indicates that the four isomers are differentiated 
due to the presence of ions derived from sequential fragmentation.  The spectrum for 
deprotonated LNFP-I displays only a single loss of Hex, whereas the spectra for 
deprotonated LNFP-II and III display a second loss of Hex.  The next sequential 
fragments observed for LNFP-II and III differ and are due to the loss of Hex (Z3α/C2) or 
Fuc (Z3β/C2), respectively.  The overall sequence of losses is consistent with the final loss 
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being identified as the monosaccharide unit that is linked to the GlcNAc for each of these 
isomers (Gal for LNFP-II and Fuc for LNFP-III), indicating that loss of the terminal 1→3 
linked monosaccharides is a much more facile loss than the loss of the terminal 1→4 
linked monosaccharides.  The IRMPD spectrum for LNFP-V is unique in that there are 
two types of cleavages involving Fuc; the first being the loss of Fuc (Z1β) and another the 
loss of Fuc in conjunction with a loss of Hex (C3α).  Examination of the LNFP structures 
suggests that the first losses from the non-reducing end generally occur as a Z-type 
cleavage and losses from the reducing end occur as a C-type cleavage.  Unfortunately, for 
each isomer there is a lack of a significant amount of information for sequencing the 
backbone and Fuc position.  In addition, the sequential losses are limited to one to three 
monosaccharide units, thus restricting the sequence coverage.  Overall, the CAD and 
IRMPD spectra of the deprotonated oligosaccharides display losses that cannot be 
immediately identified as occurring from the reducing or non-reducing end of the 
oligosaccharides.  Additionally, some ions (e.g., 348 Da and 364 Da in Figure 6-2, f and 
g, respectively) cannot be confidently identified as being a result of a sequential loss or 
an internal loss (e.g., “D-type loss”).  Even with the correct identification of losses, it 
would require several stages of dissociation to completely characterize the 
oligosaccharides.  In general, neither the negative ion mode CAD nor IRMPD spectra not 
provide enough information to sequence these isomers with confidence.  
6.4.1.2  CAD and IRMPD of Sodium-Cationized Oligosaccharides 
Due to the unsatisfactory structural characterization of the deprotonated 
oligosaccharides, the CAD and IRMPD spectra of the sodium-cationized 
oligosaccharides were obtained for comparison. In the positive ion mode, sodium-
cationized complexes were formed almost exclusively over the protonated species, and 
thus they were used for the analyses.  The types of losses observed for the sodium 
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complexes were similar to those observed for the deprotonated oligosaccharides (Figure 
6-3).  The residue losses observed for all isomers are tabulated in Table 6-2.  The CAD 
spectra are all highlighted by a predominant loss of Fuc, rendering these spectra 
uninformative.   



































Figure 6-3. CAD and IRMPD spectra of sodiated LNFPI in the positive ion mode:  a) 
CAD, b) IRMPD. 
The IRMPD spectra are highlighted by a loss of Fuc followed by a sequential loss 
of Hex*, the asterisk indicating the inclusion of the intersaccharide oxygen in the neutral 
loss.  Following the Hex* loss, the LNFP-I isomer undergoes cross-ring cleavages of the 
type X32,4 and X32,3, using the nomenclature of Domon and Costello 60, while the other 
isomers undergo an additional Hex loss.  Inspection of the data summarized in Table 6-2 
reveals why tandem mass spectrometric analysis of the sodium-cationized 
oligosaccharides suffers from the same general limitation as that observed for the 
deprotonated oligosaccharides in that there is limited structural or sequence information 
provided in any of the spectra.  Since losses observed in the spectra cannot be 
immediately identified as occurring from the reducing or non-reducing end of the 
oligosaccharides, it is difficult to obtain confident sequence data.  It would require 
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several stages of dissociation for more complete structural information which is 
unfeasible with the low ion populations obtained for the sodium-cationized 
oligosaccharides.  Since neither the CAD nor the IRMPD spectra of the underivatized 
LNFPs yielded diagnostic fragment ions or sufficient sequencing information for the 
isomers, the boronic acid derivatization strategy was explored next. 
6.4.1.3  Derivatized LNFP Oligosaccharides 
We envisioned a special boronic acid derivatization reagent that would react 
efficiently with the oligosaccharides and would incorporate a strong IR chromophore.  
The IR-active boronic acid (IRABA) shown in Scheme 6-1 was designed to meet these 
criteria.   The strategically placed nitrogen atom adjacent to the boronic acid functionality 
accelerates the derivatization reaction 58.  Without the nitrogen atom, the reaction with 
oligosaccharides proceeds with low efficiency.  The phosphonate group provides an 
excellent IR chromophore at 10.6 um.  Simple addition of the IRABA ligand to the 
oligosaccharide solutions results in formation of two covalent bonds between the boronic 
acid and the oligosaccharides in conjunction with two water losses.  An example of this 
type of reaction for Glc is detailed in Scheme 6-1.  Typical ESI mass spectra for the 
IRABA-derivatized LNFP-I reaction mixture are depicted in Figure 6-4 in both the 
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Scheme 6-1. Example reaction of IRABA with glucose (Glc). 
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Figure 6-4. Full scan spectra of solutions of LNFPI after derivatization with the IRABA:  
a) negative ion mode, b) positive ion mode.  ‘E’ indicates the loss of ethene. 
In the negative ESI mode, the abundances of the IRABA-derivative is greater than that of 
the deprotonated oligosaccharide.  In addition, there is a product attributed to the 
derivatized oligosaccharide with a loss of 28 Da, corresponding to a loss of ethylene from 
the diethylphosphonate functionality.  In the positive ESI mass spectra, the IRABA-
derivatized and sodium-cationized oligosaccharides are observed.  Yields of the 
derivatized products are high, and sample clean-up is unnecessary.  Following successful 
formation of the derivatized oligosaccharides, the diagnostic value of the fragmentation 
patterns obtained by CAD or IRMPD was evaluated. 
6.4.1.4  CAD and IRMPD of Derivatized Oligosaccharides 
The CAD and IRMPD data for the IRABA-derivatized LNFPs in the negative ion 
mode were collected by activation of the [LNFPI+IRABA-2H2O-H]- species, and the 
resulting spectral data tabulated in Table 6-3.  While the fragment ions in the IRMPD 
spectra of the underivatized oligosaccharides are a result of cleavages from both the 
reducing and non-reducing ends of the oligosaccharides, the most prominent fragment 
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ions in the IRMPD spectra of the derivatized analogs are a result of cleavages from the 
non-reducing end, particularly in the IRMPD spectra.   
The CAD spectra for the derivatized LNFPs of the type [LNFP+IRABA-
2H2O+H]+ are shown in Figure 6-5, and the complete series of data is tabulated in Table 
6-3.  The data suggests that there are two general dissociation pathways:  the most 
prominent one from sequential losses from the non-reducing end of the oligosaccharides 
(a result of Y-type cleavages) and the other entailing losses from the reducing end (a 
result of B-type cleavages).  In addition, there are also losses of the entire phosphonate 
moiety from the precursor ions, and these are indicated with a ‘●’ in the spectra.  The 
first general type of pathway is defined by sequential losses from the non-reducing end of 
the oligosaccharides (losses highlighted in bold type) and correspond to a loss of Fuc and 
a combined loss of Hex and HexNAc for the LNFPs.  The persistent combined loss of 
Hex and HexNAc suggests that cleavage at the non-reducing end of the GlcNAc is not a 
facile process.   
The LNFP-V isomer, with the Fuc attached to the reducing Glc, is differentiated 
from the other three by the initial loss of combined Hex and HexNAc which is observed 
as a prominent fragment ion of m/z 754 Da in the spectrum.  Since the Fuc moiety 
associated with LNFP-I is the terminal saccharide at the non-reducing end, an initial loss 
of Hex,HexNAc could only occur via an internal loss, a type of cleavage not observed 
with the oligosaccharides studied using our derivatization strategy.  For the LNFP-II and 
III isomers, both the Gal and Fuc are attached to the GlcNAc which also makes this 
fragment much less likely.  The second general pathway observed in Figure 6-5 involves 
the combined loss of Hex, Hex*.  Since fragmentation occurs from both the reducing and 
non-reducing ends, in most cases there is no indication from which end the sequential 
residue losses stem. Hex Hex* loss is consistent for all of the other compounds and arises 
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from cleavage at the reducing end of the oligosaccharide.  In addition, the spectral data 
suggests that the inclusion of the oxygen atom in the fragments in this type of pathway is 
characteristic for losses initiated from the reducing end of the oligosaccharides for the 
IRABA-derivatized species. 
Table 6-3. IRABA Derivatized LNFP Oligosaccharide Fragment Ion Abundances 
[LNFP + IRABA - 2H2O - H]- 
CAD C4, C3 C3               
LNFP-I 60 -               
LNFP-II 79 -               
LNFP-III 50 -               
LNFP-V - 86               
[LNFP + IRABA - 2H2O - H]- 
IRMPD C4, C3 C2 C3α             
LNFP-I 42 3 -             
LNFP-II 30 1 -             
LNFP-III 17 - -             
LNFP-V - - 45             
                    
[LNFP + IRABA - 2H2O + H]+ 
CAD Y4,Y3β,Y1β Y3 B3,B2 Y2α B2 Y2 Y2,Y2α/Y1β B1 Y0 
LNFP-I 13 - 55 - 4 - 21 - - 
LNFP-II 18 - 43 - 4 - 31 - - 
LNFP-III 31 - 52 - 2 - 10 - - 
LNFP-V 47 -   15 29 - 3 - - 
[LNFP + IRABA - 2H2O + H]+ 
IRMPD Y4,Y3β,Y1β Y3 B3,B2 Y2α B2 Y2 Y1 B1 Y0 
LNFP-I 4 6 - - 3 20 10 8 17 
LNFP-II 6 - 2 - 7 25 14 5 8 
LNFP-III 12 - 2 - 5 23 10 2 17 
LNFP-V 15 - - 5 3 17 17 6 13 
          
* as a percentage of total sequence and parent ion abundances, 
+/- 5%      
 
 While these CAD spectra do include some diagnostic structural information and 
allow limited isomer differentiation, the sequence coverage of the oligosaccharides is 
minimal.  It may be possible to obtain more structural information by performing further 
stages of CAD; however, multiple stages are frequently not feasible since the ion 
 132
populations for oligosaccharides are generally not sufficient for these experiments.  For 
these reasons, IRMPD was employed so that the sequential fragmentation that is 
commonly promoted by the non-resonant nature of IR photoactivation may be exploited 
for characterization of the oligosaccharides. 












































































Figure 6-5. Positive ion mode CAD spectra of oligosaccharides after derivatization with 
IRABA:  a) [LNFPI+IRABA-2H2O+H]+, b) [LNFPII+IRABA-2H2O+H]+, 
c) [LNFPIII+IRABA-2H2O+H]+, d) [LNFPV+IRABA-2H2O+H]+.  
Fragments ions that stem from loss of a phosphonate moiety are indicated 
with a ‘•’.   
The IRMPD spectra for the IRABA derivatized LNFPs are depicted in Figure 6-6, 
and the entire series of mass spectral data is tabulated in Table 6-3.  As with the CAD 
spectra, there are two general fragmentation pathways observed.  The most prominent 
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pathway (bold type) results from sequential cleavages from the non-reducing end of the 
oligosaccharides.  The secondary pathway results from cleavages that begin at the 
reducing end of the oligosaccharides, and the series of losses include the intersaccharide 
oxygen atom that is indicative of cleavages from the reducing end of the IRABA 
derivatized oligosaccharides. 
In addition to the same losses observed in the CAD spectra, the IRMPD spectra 
also reveal ions that have undergone subsequent dissociation.  These secondary IRMPD 
events are responsible for the two additional Hex losses observed for all of the LNFPs in 
Figure 6-6 (-Gal, 446 Da and -Glc, 284 Da).  As a result, there is complete sequence 
coverage for each of the LNFPs.  In addition, the diagnostic pathway for the LNFP-V is 
present (initial loss of Gal + GlcNAc) along with a diagnostic ion for the LNFP-I isomer 
that was not observed in the CAD spectra (Y3).  It is surmised that this ion is due to 
sequential fragmentation of the fragment ion at 973 Da due to the initial loss of Fuc.  
However, there is still not a single diagnostic ion that differentiates the LNFP-II and III 
isomers.  These two isomers only differ in the reversed linkage positions of their non-
reducing terminal Fuc and Gal moieties.   
The primary fragmentation pathway (i.e. the sequence of losses initiated from the 
non-reducing end) is the key to reliable sequencing of the oligosaccharides.  Since the 
fragments that arise from this pathway only stem from the non-reducing end of the 
oligosaccharide, the resulting sequential losses (masses of individual residues) map out 
the structure of the oligosaccharides.  In contrast, the secondary pathways include 
cleavages from both ends of the oligosaccharides and therefore do not reliably map the 
structures.   
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Figure 6-6. IRMPD spectra of LNFP oligosaccharides after derivatization with IRABA:  
a) [LNFPI+IRABA-2H2O+H]+, b) [LNFPII+IRABA-2H2O+H]+, c) 
[LNFPIII+IRABA-2H2O+H]+, d) [LNFPV+IRABA-2H2O+H]+.  Fragments 
ions that stem from loss of a phosphonate moiety are indicated with a ‘•’.   
This primary fragmentation pathway is observed only when the oligosaccharides 
are derivatized.  Without derivatization, there are mixtures of losses that define the 
different types of secondary pathways with losses occurring from both the reducing and 
non-reducing ends of the oligosaccharides.  Therefore, derivatization coupled with 
IRMPD has proven to be an excellent technique for sequencing the LNFPs in one 
activation event.   
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6.4.1.5  Site of Derivatization 
The nature of the neutral losses related to the primary fragmentation pathway in 
the IRMPD spectra suggests that the IRABA is attached to the reducing sugar.  Since the 
reducing sugar is the most reactive and may have both the alpha and beta configuration, it 
may bear the cis-diol functionality that readily reacts with boronic acids.  The existence 
of the secondary pathway suggests that there is at least one other site of derivatization.  
Since the first losses in the secondary pathway include two Hex and Fuc, it is surmised 
that the secondary site of attachment is at one of the Gal moieties that also possess the 
cis-diol functionality.   
To further elucidate the site of attachment, the reducing end of the LNFP-II 
isomer was reduced with sodium borohydride.  The reduction converts the aldehyde of 
the reducing sugar to an alcohol forming an alditol.  After the reduction reaction, the 
mixture was cleaned up using a Carbograph SPE cartridge, dried and rediluted prior to 
ESI-MS analysis.  The resulting ESI mass spectra of the reaction product indicates 
complete conversion to the alditol since there is a prominent ion at m/z 878 
corresponding to [LNFP-II(alditol) + Na]+.  In contrast, the ESI mass spectra of the 
oligosaccharide after the reduction reaction did not display an ion due to any unreduced 
species.  The alditol form of LNFP-II was then reacted with the IRABA ligand, and no 
IRABA derivatization products were observed in the spectra, thus indicating that LNFP-
II in the reduced form did not react with the IRABA reagent.  Given these results, it is 
surmised that the IRABA reacts primarily at the reducing sugar and that any other sites of 
derivatization are minor products. 
6.4.2 LNDFH Oligosaccharides 
Since the derivatization of the LNFP series with the IRABA ligand followed by 
IRMPD was such an effective structural characterization strategy, the method was 
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expanded to another series of oligosaccharides, the LNDFH series shown in Figure 6-1.  
The IRMPD spectra of these IRABA derivatized oligosaccharides indicate that they 
dissociate by the same two pathways that were observed for the LNFP series (Figure 6-
7).  This data for the underivatized species is tabulated in Table 6-4 and the derivatized 
species in Table 6-5.  As with the LNFP series, the primary fragmentation pathway 
consists of cleavages of one type that take place sequentially from the non-reducing to the 
reducing end. 
The primary fragmentation pathway provides detailed sequence information for 
the LNDFH oligosaccharides with the exception of the two isomers that only differ in 
their reversed Gal and Fuc linkages to the central GlcNAc (Ia and Ib).  Following the loss 
of terminal or branching Fuc moieties, fragmentation of the backbone for each of the 
isomers from the non-reducing end starts with the combined Gal-GlcNAc losses followed 
by two sequential Hex losses (Gal and Glc).  Further, it is evident from the IRMPD 
spectra of LNDFH-Ia and Ib that there is a Fuc attached to both the non-reducing 
terminal Gal and the GlcNAc since there is an initial Fuc loss followed by a combined 
Fuc-Gal-GlcNAc loss.  This result further confirms the sequential nature of the losses that 
correspond to the primary pathway.  Other possible alternative sequences of these 
oligosaccharides, Fuc-(Fuc)-HexNAc-Hex- or Fuc-HexNAc-(Fuc)-Hex-, are discounted 
because in each of the IRMPD spectra throughout this chapter there has been a key 
intersaccharide cleavage at the reducing end of GlcNAc that would yield characteristic 
ions for Fuc-(Fuc)-HexNAc and Fuc-HexNAc, respectively.   These fragments ions are 
not observed in the IRMPD mass spectra, thus discrediting these alternative sequences.  
Therefore the two Fuc must reside on the non-reducing ends Gal and GlcNAc. 
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(a) or Y4α  
Figure 6-7. IRMPD spectra of LNDFH oligosaccharides after derivatization with 
IRABA:  a) [LNDFHIa+IRABA-2H2O+H]+, b) [LNDFHIb+IRABA-
2H2O+H]+, c) [LNDFHII+IRABA-2H2O+H]+.  Fragments ions that stem 
from loss of a phosphonate moiety are indicated with a ‘•’.   
The difference in the IRMPD spectrum for the LNDFH-II isomer is a result of one 
Fuc having a different position.  Since the initial Fuc loss precedes the Gal-GlcNAc 
combined loss, it is evident that this Fuc resides on either the Gal or GlcNAc.  However, 
if the Fuc residue were attached to the terminal Gal, one would expect an ion of m/z 957 
that corresponds to a loss of Gal following the loss of Fuc.  The LNFP-I isomer has this 
type of Fuc-Gal linkage and the corresponding fragment ion was observed in its IRMPD 
spectrum (Figure 6-6, m/z 811).  Therefore the initial Fuc loss must be attached to the 
GlcNAc.  With only two Hex left on the backbone, the remaining Fuc must be attached to 
one or the other.  Since this Fuc loss precedes the loss of both of these Hex moieties, it 
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could be attached to either one.  If the sequence continued beyond these two Hex 
moieties, there may be more fragment ions observed that would make it possible to 
pinpoint the precise location of the remaining Fuc. 
Table 6-4. Underivatized LNDFH Oligosaccharide Fragment Ion Abundances  
(M - H)- CAD C4, C3   
LNDFH-Ia 88   
LNDFH-Ib 86   
LNDFH-II 90   
(M - H)- IRMPD C4, C3   
LNDFH-Ia 92   
LNDFH-Ib 97   
LNDFH-II 86   
(M + Na)+ CAD Y3β, Y3α''   
LNDFH-Ia 91   
LNDFH-Ib 91   
LNDFH-II 91   
(M + Na)+ IRMPD Y3β, Y3α'' Y3β/Y4α, Y3α''/Y1β Y3β/Z3α, Y3α''/B3 
LNDFH-Ia 32 14 7 
LNDFH-Ib 28 19 3 
LNDFH-II 43 17 5 
 
* as a percentage of total sequence and parent ion abundances, +/- 5% 
 
6.4.3 DSLNT Oligosaccharide 
The IRABA derivatization strategy was further extended to an acidic 
hexasaccharide, disialyllacto-N-tetraose (DSLNT), shown in Figure 6-1.  As observed 
with the previous oligosaccharide series, the principal fragments are a series that arise 
from the backbone from the non-reducing to reducing end of the oligosaccharide (Figure 
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6-8).  Following the loss of the two Sia moieties, a combined loss of Gal-GlcNAc 
resulting from cleavage at the reducing end of GlcNAc indicates the sequence Sia-Gal-
(Sia)-GlcNAc.  Subsequent losses reveal the completion of the sequence, Gal-Glc.  The 
successful sequencing of this oligosaccharide indicates that the method may be further 
applied to larger and different types of oligosaccharides.  
Table 6-5. IRABA Derivatized LNDFH Oligosaccharide Fragment Ion 
[LNDFH + IRABA - 2H2O - H]- 
CAD C4 Z1β           
LNDFH-Ia 86 -           
LNDFH-Ib 80 -           
LNDFH-II - 96           
[LNDFH + IRABA - 2H2O - H]- 
IRMPD C4 C4/Y3β/Y3α Y3α'/Y3α''         
LNDFH-Ia 17 40 -         
LNDFH-Ib 12 49 -         
LNDFH-II - - 56         







Y1β/Y2α     
LNDFH-Ia 31 35 8 - 24     
LNDFH-Ib 34 44 4 - 11     
LNDFH-II 29 - 23 24 5     










LNDFH-Ia 8 3 10   61 19 19
LNDFH-Ib 16 6 6   19 6 13
LNDFH-II 39   7 29 17 9 8 
        
* as a percentage of total sequence and parent ion abundances, 






































(a) or Y3β  
Figure 6-8. IRMPD spectrum of DSLNT after derivatization with IRABA.  Fragments 
ions that stem from loss of a phosphonate moiety are indicated with a ‘•’.   
6.5 CONCLUSIONS 
The sequencing of oligosaccharides has been simplified by the use of IRMPD in a 
QIT.  This was accomplished with the use of a boronic acid derivatizing reagent that was 
also functionalized with an IR-active phosphonate group to facilitate the photon 
absorption process.  The oligosaccharides underwent modification by simple addition of 
the IRABA with reaction times of ~ 1 min and did not require sample cleanup prior to 
analysis by ESI-MS.  The oligosaccharide products dissociated with high efficiency upon 
IR irradiation, and the degree of secondary fragmentation may be controlled by adjusting 
the irradiation time.  The resulting IRMPD mass spectra display a characteristic primary 
fragmentation pathway resulting from cleavage from only the non-reducing ends, thereby 
simplifying the determination of oligosaccharide sequence.  As a result, the method 
should be generally applicable to the sequencing of even larger oligosaccharides. 
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Chapter 7:  Synthesis 
To complete the studies presented in the previous chapters, several different 
compounds were synthesized.  These included a series of pyridyl ligands with electron-
withdrawing substituents added to modulate their metal binding affinities.  Five ligands 
were synthesized with bromine as the electron-withdrawing group, namely 4,4’-dibromo-
2,2’-bipyridine, 4,4’-bis(bromomethyl)-2,2’-bipyridine, 5,6-dibromo-1,10-
phenanthroline, 3,5,6-tribromo-1,10-phenanthroline and 3,5,6,8-tetrabromo-1,10-
phenanthroline.  In addition, pyridyl ligands with phosphonate groups incorporated to 
make them IR-active chelating agents were also synthesized.  These included 4,4-
(diethylphosphonate)-2,2’-bipyridine and 4,4’-bis(diethylmethylphosphonate)-2,2’-
bipyridine.  A derivatizing reagent for oligosaccharides was also synthesized.  The 1-(N-
(ortho-diethylmethylphosphonate))aminoethylbenzene boronic acid also incorporated a 
phosphonate group to yield an IR-active species.  
7.1 BROMINATED PYRIDYL LIGANDS 
The advantages of using a metal complexation strategy with neutral pyridyl 
ligands for the analysis of several groups of flavonoids was presented in Chapters 1 and 
2.  Because of the limited commercial availability of pyridyl ligands, it was not possible 
to purchase a set of ligands with electron-withdrawing substituents that would enable a 
logical systematic study (e.g., only differed in the number and type of substituents present 
on the ligands).  Therefore, a set was synthesized using bromine atoms as the electron-
withdrawing substituents to accomplish the study presented in Chapter 2.  These included 




4,4-Dibromo-2,2’-bipyridine 5 was synthesized from 2,2’-bipyridine 1 based on a 
literature procedure1, 2 and this is presented in Scheme 7-1.  To obtain the 4-substituted 
pyridine, a well known nitration procedure was used followed by a nucleophilic aromatic 
substitution.  The resulting brominated bipyridine-N-oxide 4 was then reduced to the 
bipyridine 5 using phosphorus tribromide. 























Scheme 7-1. Synthesis of 4,4’-dibromo-2,2’-bipyridine. 
2,2’-bipyridine 1 (30.1 g, 193 mmol) was transferred to a round bottom flask and 
glacial acetic acid (125 mL, 2.19 mol) was added with stirring.  The solution was heated 
to 80 °C and 30% H2O2 was added dropwise (96 mL, 974 mmol).  The solution was 
stirred for two hours at 80 °C and another aliquot of 30% H2O2 was added dropwise (82 
mL, 832 mmol).  The resulting solution was stirred for ~24 hours at 80 °C.  The solvents 
were then removed by rotary evaporation and the solids were recrystallized from H2O 
and dried to yield 18.7 g (99 mmol) 2,2’-bipyridine-N,N-dioxide 2 in 51% yield. 
 2,2’-bipyridine-N,N-dioxide 2 (18.7 g, 99 mmol) was transferred to a round 
bottom flask and fuming sulfuric acid was added (35 mL, 377 mmol).  The resulting 
solution was heated to 100 °C and fuming nitric acid (45 mL, 1.1 mol) was added.  The 
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resulting solution was allowed to react for 7 hours.  The solution was cooled to room 
temperature and poured onto ice, forming a yellow precipitate.  The 4,4’-dinitro-2,2’-
bipyridine-N,N-dioxide 3 precipitate was filtered, washed with water and dried to yield 
7.2 g (25.9 mmol) 4,4’-dinitro-2,2’-bipyridine-N,N-dioxide 3 in 26% yield. 
4,4’-dinitro-2,2’-bipyridine-N,N-dioxide (7.2 g, 25.9 mmol) was transferred to a 
round bottom flask and glacial acetic acid (60 mL, 1.05 mol) was added and the flask and 
condenser were purged with argon.  The solution was heated to 50 °C and acetyl bromide 
(40 mL, 540 mmol) was added dropwise with stirring.  The solution was refluxed for ~12 
hours.  The solution was then cooled to room temperature and poured onto ice.  The 
solution was then brought to ~pH 12 using potassium carbonate and a precipitate formed.  
The 4,4’-dibromo-2,2’-bipyridine-N,N-dioxide 4 precipitate was then filtered and washed 
with water.  The precipitate was then dried to yield 5.01 g (14.6 mmol) 4,4’-dibromo-
2,2’-bipyridine-N,N-dioxide 4 in 56% yield. 
4,4’-dibromo-2,2’-bipyridine-N,N-dioxide 4 (5.01 g, 14.6 mmol) was transferred 
to a round bottom flask.  A condenser was added and the system was purged with argon.  
Phosphorus tribromide (15 mL, 155 mmol) was added and the resulting mixture was 
refluxed for ~12 hours.  The solution was then brought to room temperature and poured 
onto ice.  The solution was then brought to ~pH 12 using potassium carbonate.  The 
resulting solution was then extracted with 50 mL of CHCl3 five times.  The combined 
organic layers were then dried using sodium sulfate, filtered, and the solvent was 
removed using rotary evaporation.  The solids were then purified on silica gel using 
CHCl3 and CH3OH to yield 3.73 g (12 mmol) 4,4’-dibromo-2,2-bypridine 5 in 82% yield.  
1H NMR (CD3Cl3) δ = 7.509 (2H, dd, J = 5.2 Hz, 1.6 Hz), 8.486 (2H, d, J = 5.2 Hz), 
8.608 (2H, d, J = 1.6 Hz). 
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7.1.2 4,4’-Bis(bromomethyl)-2,2’-bipyridine 
4,4-Bis(bromomethyl)-2,2’-bipyridine 8 was synthesized from 4,4’-dimethyl-2,2’-
bipyridine 6 based on a literature procedure3 and this is presented in Scheme 7-2.  The 
bromomethyl pyridine was obtained via activation and substitution of a 4-methyl 
pyridine.  The benzylic anion was formed by deprotonation with a strong base and 
trapping with a silyl protecting group.  The TMS-protected compound was deprotected 
with cesium fluoride and brominated with a mild brominating agent. 
LDA, THF










Scheme 7-2. Synthesis of 4,4’-bis(bromomethyl)-2,2’-bipyridine. 
  A solution of 4,4’-dimethyl-2,2’-bipyridine 6 (0.51 g, 2.77 mmol) was dissolved 
in THF (13 mL) under a nitrogen atmosphere in a round bottom flask.  A two-necked 
round bottom flask with a nitrogen inlet was charged with THF (9 mL) and 
diisopropylamine (1 mL).  The reaction mixture was then cooled to -78 °C and 
butyllithium (1.7 M in hexanes, 3.6 mL) was added.  The reaction mixture was then 
stirred at -78 °C for 10 mins., warmed to 0 °C and stirred for 10 mins., and cooled back to 
-78 °C.  The previously prepared 4,4’-dimethyl-2,2-bipyridine 6 solution in THF was 
then added via cannula to the cold lithium diisopropylamide (LDA) solution.  The 
mixture turned black and was stirred at -78 °C for 1 hr.  Chlorotrimethylsilane (TMSCl, 
0.885 mL, 7 mmol) was then rapidly added to the reaction mixture via syringe.  In ~1 s 
the reaction mixture turned pale green and the reaction was quenched by the rapid 
addition of ethanol (1 mL).  The cold reaction mixture was then poured into a separatory 
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funnel containing saturated sodium bicarbonate (20 mL) and was warmed to ~25 °C.  The 
mixture was then extracted with dichloromethane (3 X 30 mL).  The combined organic 
fractions were then shaken with brine (~20 mL) and then dried over sodium sulfate.  The 
mixture was then filtered and the solvent removed by rotary evaporation.  The remaining 
solid was then dried to yield 0.701 g (2.13 mmol) 4,4’-bis[(trimethylsilyl)methyl]-2,2’-
bipyridine 7 in 77% yield. 
4,4’-bis[(trimethylsilyl)methyl]-2,2’-bipyridine 7 (0.361 g, 1.1 mmol) was 
transferred to a two-necked round bottom flask.  Anhydrous cesium fluoride was added 
(0.68 g, 4.48 mmol).  The flask was then flushed with nitrogen and hexabromoethane 
(0.55 mL, ~4 mmol) was added via syringe.  N,N-dimethylformamide (5 mL) was added 
via syringe and the reaction mixture was stirred for 3 hours at room temperature, 
monitored by TLC on silica (EtOAc:hexanes, 1:4).  The reaction mixture was then 
transferred to a separatory funnel containing 10 mL water and 10 mL EtOAc and was 
extracted with EtOAc (3 X 10 mL).  The organic fractions were combined and shaken 
with brine and dried over sodium sulfate.  The crude product mixture was then filtered 
and the solvent was removed by rotary evaporation.  The crude product mixture was then 
dried overnight under vacuum and then purified by flash chromatography using 
deactivated silica gel (EtOAc: hexanes, 3:2) and yielded 0.269 g (0.79 mmol) in 72% 
yield.  1H NMR (CD3Cl3) δ = 7.507 (2H, d, J = 8 Hz), 7.671 (2H, t, J = 7.6 Hz, 8Hz), 
8.378 (2H, d, J = 7.6 Hz). 
7.1.3 Bromo-1,10-phenanthrolines 
5,6-dibromo-1,10-phenanthroline 10, 3,5,6-tribromo-1,10-phenanthroline 11 and 
3,5,6,8-tetrabromo-1,10-phenanthroline 12 were synthesized from 1,10-phenanthroline 9 
based on a literature procedure4 and this is presented in Scheme 7-3.  The bromo 
substituted 1,10-phenanthrolines were synthesized by electrophilic aromatic substitution 
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with bromine.  As expected, a mixture of multiple bromination products were obtained 
but several were separated by multiple recrystallization steps. 
SOCl2
Br2



















diluted to DMF:H2O, 1:4
extracted 3X w/ CHCl3, dried
solvent removed
recrystallized from benzene: pet ether, 1:1 N N
Br Br





Scheme 7-3. Synthesis of bromo-1,10-phenanthrolines. 
1,10-phenanthroline 9 (2.125 g, 11.8 mmol) was transferred to a round bottom 
flask that was equipped with a condenser.  Thionyl chloride (100 mL, 1.37 mol) was then 
added and the 1,10-phenanthroline 9 dissolved on heating.  Bromine (3 mL, 58 mmol) 
was then added and the reaction mixture was refluxed at 95 °C for 24 hours.  The excess 
thionyl chloride and bromine were then removed under vacuum.  Water (200 mL) was 
then added to the residue and it was neutralized with ammonium hydroxide.  The mixture 
was then filtered and dried under vacuum to yield 4.7 g of crude product.  By selective 
crystallizations and precipitations the three bromophenanthrolines were separated as 
outlined in the next three sections. 
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7.1.3.1  3,5,6,8-Tetrabromo-1,10-phenanthroline 
The crude product (4.7 g) was dissolved in N,N-dimethylformamide (400 mL) on 
heating to 150 °C.  Upon cooling, a precipitate formed that was filtered and recrystallized 
twice more from N,N-dimethylformamide.  The precipitate was filtered and dried in an 
oven at 100 °C for one hour and overnight under vacuum to yield 1.76 g 3,5,6,8-
tetrabromo-1,10-phenanthroline 12.  1H NMR (CD3Cl3) δ = 8.920 (2H, d, J = 2.2 Hz), 
9.190 (2H, d, J = 2 Hz).   
7.1.3.2  3,5,6-Tribromo-1,10-phenanthroline 
The filtrate of the above separation was diluted with an equal volume of water 
(675 mL).  A precipitate formed, was filtered and then recrystallized from N,N-
dimethylformamide:water, 1:1.  The precipitate was filtered and dried overnight under 
vacuum to yield 1.57 g 3,5,6-tribromo-1,10-phenanthroline 11.  1H NMR (CD3Cl3) δ = 
7.748 (1H, dd, J = 8.8 Hz, 4.2 Hz), 8.765 (1H, dd, J = 8.8 Hz, 1.6Hz), 8.928 (1H, d, J = 2 
Hz), 9.201 (2H, m).   
7.1.3.3  5,6-Dibromo-1,10-phenanthroline 
The filtrate of the above separation was diluted with water (3.2 L) and extracted 
one liter at a time with chloroform (3 X 100 mL).  The organic layers were combined and 
dried with sodium sulfate and filtered.  The chloroform was then removed by rotary 
evaporation and excess N,N-dimethylformamide removed by vacuum distillation.  The 
residue was recrystallized from petroleum ether:benzene, 1:1, filtered and dried to yield 
0.73 g 5,6-dibromo-1,10-phenanthroline 10.  1H NMR (CD3Cl3) δ = 7.740 (2H, dd, J = 
8.4 Hz, 8.0 Hz), 8.782 (2H, dd, J = 8.8 Hz, 1.2Hz), 9.226 (2H, dd, J = 4.4 Hz, 1.2 Hz).   
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7.2 PHOSPHONATED PYRIDYL LIGANDS 
As detailed in Chapters 5 and 6, the presence of a phosphate or phosphonate 
group greatly increases an ion’s absorptivity upong IR irradiation.  For this reason, the 
metal complexation technique presented in Chapters 1 and 2 was exploited as a means of 
adding a phosphonate group to analytes, ultimately to make them more amenable to 
IRMPD.  The phosphonate groups were covalently attached to the auxiliary ligands 
thereby permitting addition of the phosphonate group without covalent modification to 
the analyte.  The synthesis of these ligands is presented in this section.   
7.2.1 4,4-(diethylphosphonate)-2,2’-bipyridine 
4,4-(diethylphosphonate)-2,2’-bipyridine 13 was synthesized from 4,4’-dibromo-
2,2’-bipyridine 5 (section 7.1.1) based on a literature procedure5, 6 (Scheme 7-4).  The 
4,4-dibromo-2,2’-bipyridine 5 was converted to the phosphonate via a palladium 















Scheme 7-4. Synthesis of 4,4-(diethylphosphonate)-2,2’-bipyridine. 
4,4’-dibromo-2,2-bypridine 5 (0.43 g, 1.37 mmol) and tetrakis 
(triphenylphosphine) Palladium(0) (0.32 g, 0.27 mmol) were transferred to a round 
bottom flask equipped with a condenser and the system was flushed with argon and the 
remaining additions were made under the protection of argon.  Dry toluene (5 mL) was 
then added via syringe with stirring.  Diethyl phosphite (0.5 mL, 3.8 mmol) and 
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triethylamine (0.55 mL, 3.8 mmol) were then added via syringe.  The reaction mixture 
was heated under argon protection and then refluxed for 4 hours.  The reaction mixture 
was then cooled to room temperature and diethyl ether was added to precipitate 
triethylamine hydrobromide formed during the reaction.  The mixture was then filtered 
and the solvent removed using rotary evaporation.  The crude product was purified by 
flash chromatography on silica gel with CHCl3:CH3OH to yield 0.1868 g (0.44 mmol) 
4,4-(diethylphosphonate)-2,2’-bipyridine 13 in 32% yield.  1H NMR (CD3OD) δ = 1.29 
(12H, t), 4.13 (8H, m), 7.69 (2H, ddd), 8.68 (2H, d), 8.81 (2H, t). 
7.2.2 4,4’-bis(diethylmethylphosphonate)-2,2’-bipyridine 
4,4’-bis(diethylmethylphosphonate)-2,2’-bipyridine 14 was synthesized from 4,4-
bis(bromomethyl)-2,2’-bipyridine (Section 7.1.2) based on a literature procedure7, 8 and 
this is presented in Scheme 7-5.  The phosphonate was synthesized from the 4,4-
bis(bromomethyl)-2,2’-bipyridine 8 using the Arbuzov reaction.  In this reaction the 
phosphorus does an SN2 substitution of the bromide.  The bromide then attacks the 















Scheme 7-5. Synthesis of 4,4’-bis(diethylmethylphosphonate)-2,2’-bipyridine. 
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4,4-bis(bromomethyl)-2,2’-bipyridine 8 (2.294 g, 0.87 mmol) was transferred to a 
round bottom flask and triethylphosphite (TEPH, 3 mL, 17 mmol) was added.  The 
reaction mixture was stirred and refluxed for five hours.  The mixture was then cooled to 
room temperature and the excess triethylphosphite was removed by vacuum distillation.  
The crude product was purified by flash chromatography on silica gel with 
EtOAc:CH3OH to yield 0.0736 g (0.16 mmol) 4,4-(diethylphosphonate)-2,2’-bipyridine 
14 in 18% yield.  1H NMR (CD3OD) δ = 1.29 (12H, t), 3.23 (4H, d), 4.16 (8H, q), 7.34 
(2H, m), 8.41 (2H, m), 8.68 (2H, d). 
7.3 PHOSPHONATED BORONIC ACID DERIVATIZING REAGENT 
In Chapter 6, a study that uses a derivatization technique that exploits the reaction 
between boronic acids and cis diols was described.  The phosphonate group was added to 
oligosaccharides via the reaction between a novel phosphonated boronic acid chemical 
derivatization reagent and a diol functionality on the reducing end monosaccharide.  The 
synthesis of the phosphonated boronic acid is presented in this section. 
7.3.1 1-(N-(ortho-diethylmethylphosphonate))aminoethylbenzene 
1-(N-(ortho-diethylmethylphosphonate))aminoethylbenzene 18 was synthesized 
from 2-formylphenylboronic acid 15 and diethyl(aminomethyl)phosphonate oxalate 16 
based on a literature procedure9 and this is presented in Scheme 7-6.  The boronic acid 
product was obtained by condensation of the aldehyde of the boronic acid with the amino 
phosphonate.  This gave the imine which was subsequently reduced to the amine using 
sodium borohydride without the need for protection of the boronic acid. 
  2-formylphenylboronic acid 15 (0.589 g, 3.9 mmol) was dissolved in anhydrous 
CH3OH under argon protection.  N,N-diisopropylethylamine (Hunig’s base, 2.74 mL, 16 
mmol) was added followed by diethyl(aminomethyl)phosphonate oxalate 16 (1.011 g, 3.9 
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mmol) and the solution was stirred for 16 hours before NaBH4 (0.11 g, 3.9 mmol) was 
added slowly.  The solution was stirred at room temperature for 1 hour, followed by 
addition of another batch of NaBH4.  One hour later, the solvent was removed by rotary 
evaporation and the residue was diluted with CH2Cl2.  The precipitate was removed with 
vacuum filtration, with the filtrate subsequently concentrated.  An aliquot of the residue 
(0.30 g) was purified by flash chromatography on neutral alumina (2-5% NH3-saturated 
CH3OH in CH2Cl2) and dried to yield 0.1632 g 1-(N-(ortho-
diethylmethylphosphonate))aminoethylbenzene 18.   1H NMR (400 MHz, CD3OD) δ 
1.39 (t, J=7.04, 6H, CH3) δ 3.23 (d, J=11.6, 2H CH’s) δ 4.17 (s, 2H CH’s) δ 4.20-4.26 
(m, 4H CH’s) δ 7.15-7.43 (m, 4H CH’s).  13C NMR(CD3OD): = 16.8, 42.2, 43.4, 56.2, 




























Scheme 7-6. Synthesis of 1-(N-(ortho-diethylmethylphosphonate))aminoethylbenzene 
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Chapter 8:  Conclusions 
The characterization of glycosides and oligosaccharides is a challenging task 
since they are much more structurally complex than other biologically important 
molecules such as proteins and nucleic acids.  In the work presented in this dissertation, 
several novel methods for the analysis of glycosides and glycans in a quadrupole ion trap 
(QIT) mass spectrometer have been presented.  The methods involve activation using two 
different techniques known as collisionally activated dissociation (CAD) and infrared 
multiphoton dissociation (IRMPD).  Unique chemical methods such as metal 
complexation in conjunction with the use of specifically tailored neutral auxiliary ligands 
and derivatization reagents were studied using CAD and IRMPD to increase the 
understanding of how more structural information may be obtained using QIT mass 
spectrometry. 
In Chapter 3, the structures of flavonoid diglycoside isomers were elucidated 
using CAD, primarily for characterization of the carbohydrate portion of the molecules.  
The CAD spectra of the protonated and deprotonated spectra were compared for their 
utility in isomer differentiation.  Due to the unsatisfactory results, a metal complexation 
strategy that also uses a neutral auxiliary ligand was introduced.  By addition of a metal 
salt and a suitable neutral auxiliary ligand to flavonoids in solution complexes of the type 
[M(II) (flavonoid-H) ligand]+ were formed which, upon CAD, resulted in more 
distinctive fragmentation patterns.  Since most of the fragments observed involved 
cleavages within the flavonoid molecules and not simple losses of the auxiliary ligands, it 
was concluded that the binding affinities of the flavonoid and auxiliary ligands to the 
metal are similar.  Pyridyl ligands that incorporate different electron-releasing 
substituents such as 4,4’-dimethyl-2,2’-bipyridine and 4,7-diphenyl-1,10-phenanthroline 
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were compared and the CAD spectra often varied depending on the ligand used.  Based 
on these results, it was concluded that the fragment ions observed may be tuned by using 
ligands with different electron-releasing substituents thereby altering the metal binding 
affinity of the ligand.   
The types of ligands used in the metal complexation strategy were further 
expanded in Chapter 4.  In this work, the metal binding affinities of the auxiliary ligands 
and therefore the resulting CAD spectra were modified by incorporation of electron-
withdrawing substituents into the ligands instead of electron-releasing substituents.  
Because of the limited commercial availability of pyridyl ligands with electron-
withdrawing substituents, it was not possible to purchase a set of ligands with electron-
withdrawing substituents that would enable a logical systematic study (e.g., only differed 
in the number and type of substituents present on the ligands).  Therefore, a set was 
synthesized with bromine atoms as the electron-withdrawing substituents.  The CAD 
spectra of a series of flavonoid diglycosides using the metal complexation strategy with 
five different brominated pyridyl ligands were compared.  The fragmentation pathways 
observed in these spectra were even more varied than the series of spectra collected using 
electron-releasing substituents (Chapter 3).  A direct correlation was made between the 
types of fragments observed and the metal binding affinity of the ligands in solution.  It 
was concluded that the variations in the metal/ligand binding energies influence the 
energetics of dissociation pathways and also affect the preferred metal coordination sites 
in the flavonoid complexes.  It was further determined that the ligand also has an impact 
on the way the disaccharide moiety of the flavonoid interacts with the metal since the 
addition of bromo substituents changes the steric environment of the auxiliary ligands, 
which may influence the conformations of the complexes and thus the degree of 
interaction of the disaccharide group with the metal center. 
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In Chapter 5, the flavonoid metal complexation strategy was used as a means of 
incorporating an IR-active group, a phosphonate moiety, into the flavonoid metal 
complexes as a substituent on the auxiliary ligand.  This study was not only an approach 
to increase the efficiency of IRMPD in the QIT for the analysis of flavonoids, but also as 
a general method to incorporate the IR-active phosphonate moiety into an analyte 
complex without necessitating covalent modification.  Two phosphonated pyridyl ligands 
were synthesized, one in which the phosphonate moiety is attached directly to the 
aromatic rings and one in which the phosphonate groups are removed from the aromatic 
rings by one methylene group.  As compared with the IRMPD spectra of the flavonoid 
complexes without phosphonated substituents on the auxiliary ligands, it was concluded 
that the dissociation efficiency of the flavonoids complexes containing the phosphonated 
auxiliary ligands was greatly increased.  It was additionally determined, based on the 
irradiation times used and the degree of fragmentation observed, that the phosphonate 
groups removed from the aromatic ring by one methylene group underwent dissociation 
more efficiently than when the phosphonate groups were attached directly to the aromatic 
ring, indicating more efficient IR absorption for the former.  This finding was further 
supported by Fourier transform infrared absorption attenuated total reflectance (FTIR-
ATR) that indicated that the high IRMPD efficiencies stem from the very large IR 
absorptivities of the IR-active ligands. 
In the study presented in Chapter 6, the IR-active phosphonate moiety was 
incorporated into a boronic acid resulting in a novel IR-active boronic acid (IRABA) 
derivatizing reagent that was used for the structural analysis of oligosaccharides using 
IRMPD.  The IRABA reacted readily with oligosaccharides and this resulted in a 
simplified method for determining the sequence and branching of oligosaccharides.  The 
IRABA reagent was designed to both enhance the efficiency of the derivatization reaction 
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and to facilitate the photon absorption process.  Based on the IRMPD spectra, it was 
revealed that oligosaccharide fragments are formed from primarily one type of diagnostic 
cleavage, thus making sequencing straightforward.  It was further concluded that the 
presence of sequential fragment ions, a phenomenon of IRMPD, permit the 
comprehensive sequencing of the oligosaccharides studied in a single stage of activation.  
In summary, four different methods for altering the energetics of activation and 
the types of fragments observed were presented.  It was shown that a metal complexation 
strategy including neutral auxiliary ligands alters the types of fragments observed for 
flavonoid isomers upon dissociation.  It was also illustrated that the substituents residing 
on the ligands alter the metal binding affinity and as a result the types and abundances of 
fragment ions observed.  The benefits of IRMPD in a QIT were also shown in two 
studies.  For example, it was shown how incorporation of IR-active phosphonate groups 
into ligands results in increased photon absorption efficiencies by the complexes.  This 
strategy was extended to a derivatization reagent that was used for the analysis of 
oligosaccharides using IRMPD in a QIT.     
This dissertation provides a framework for several future avenues of research that 
build on the results presented herein or expand into new areas.  For example, the research 
that involves the metal complexation of flavonoid diglycosides has opened up a new 
means for identification of carbohydrate moieties that is valuable particularly when there 
is limited sample available and this method may be applied to other classes of glycosides.  
By using this metal complexation strategy with IR-active ligands, a method of making 
analytes more susceptible to IRMPD without covalent modification was introduced that 
may be applied to different classes of compounds.   The derivatization technique that was 
developed for the analysis of oligosaccharides has exciting implications for more 
complete sequencing of larger oligosaccharides since the information is obtained in one 
 161
stage of activation and is not reliant upon a substantial ion population surviving several 
stages of collisional activation.  This technique may be used for the sequence 
characterization of N-linked glycans in a quadrupole ion trap with minimal sample 
consumption.  Each of the studies has resulted in a novel method that will substantially 
increase the structural information obtained in future studies using quadrupole ion trap 
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